syndrome	score	normalized_score
EARLY-ONSET SCHIZOPHRENIA	8.079415690000001	100.0
SMITH-MAGENIS SYNDROME; SMS	5.127454474	63.463184353124916
PANDAS	2.62987681	32.55033421853802
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	2.2147148499999996	27.41181955449057
KLEINE-LEVIN HIBERNATION SYNDROME	2.0192308	24.992287530139443
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	24.754265366930262
NARCOLEPSY 1; NRCLP1	1.8373013	22.740521969602977
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	1.42459584	17.632411731992466
TRICHOTHIODYSTROPHY	1.227942884	15.198412002984831
BRAIN-LUNG-THYROID SYNDROME	1.221783774	15.122179881302774
16P12.1P12.3 TRIPLICATION SYNDROME	1.2215288999999998	15.119025271987208
CITRULLINEMIA TYPE II	1.1880606040000001	14.704783731705726
MOWAT-WILSON SYNDROME; MOWS	1.1169643	13.824815343793754
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	1.1105442	13.74535291425264
SCHIZOPHRENIA	1.0894928	13.484796943279939
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	1.0666666999999999	13.202275274933895
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	1.0426139199999997	12.904570825467696
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	1.00740741	12.468815179875957
CHAR SYNDROME	1.000545554	12.383885077709126
PLUMMER-VINSON SYNDROME	1.0	12.377132683465131
KIFAFA SEIZURE DISORDER	1.0	12.377132683465131
RETINITIS PIGMENTOSA 75; RP75	1.0	12.377132683465131
IDIOPATHIC UVEAL EFFUSION SYNDROME	1.0	12.377132683465131
EHLERS-DANLOS SYNDROME, TYPE I	1.0	12.377132683465131
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.0	12.377132683465131
TARDIVE DYSKINESIA	1.0	12.377132683465131
7Q11.23 MICRODUPLICATION SYNDROME	0.87584354	10.8404317045358
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.8490228	10.50846784688708
NARCOLEPSY 3; NRCLP3	0.8373013	10.363389286137844
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.78320745	9.693862527328383
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.78174704	9.675786838986122
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.7462712499999999	9.236698279105378
CRI-DU-CHAT SYNDROME	0.71661628	8.8696547806912
FRONTOTEMPORAL DEMENTIA; FTD	0.70380691	8.711111508609601
POSTENCEPHALITIC PARKINSONISM	0.70087304	8.674798610343563
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.6642505000000001	8.221516573558056
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.66145674	8.186937835352298
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.65936251	8.161017272772604
48,XXXY SYNDROME	0.626612904	7.755671053979399
INHERITED CREUTZFELDT-JAKOB DISEASE	0.61823916	7.652028113434028
XQ12-Q13.3 DUPLICATION SYNDROME	0.57218761	7.082041968804799
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.56415163	6.9825795781031275
OBSESSIVE-COMPULSIVE DISORDER 1	0.55883255	6.916744619189162
15Q OVERGROWTH SYNDROME	0.55616517	6.883730103011941
MOMO SYNDROME	0.5495250500000001	6.801544456737811
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.5492597	6.798260184580253
COG5-CDG	0.54119421	6.698432544693092
BRACHYDACTYLY TYPE A2	0.537037	6.646978204930064
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.5365890639999998	6.641434041624361
MANGANESE POISONING	0.53548949	6.627824468331074
NON-DISTAL MONOSOMY 20Q	0.52568125	6.506426580459805
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.5248744500000001	6.496440709810786
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.5248744500000001	6.496440709810786
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.5248744500000001	6.496440709810786
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.5172414	6.401965437181261
CHROMOSOME 1P36 DELETION SYNDROME	0.517214754	6.401635636103778
ZUNICH NEUROECTODERMAL SYNDROME	0.51640336	6.391592904907211
RING CHROMOSOME 13 SYNDROME	0.51073229	6.321401319059991
WILLIAMS-BEUREN SYNDROME; WBS	0.51001775	6.31255736267235
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.506101114	6.264080639227513
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.502714754	6.222167212193533
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.5021692	6.215414817949538
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.5021692	6.215414817949538
SPONDYLOPERIPHERAL DYSPLASIA	0.50204918	6.213929314484869
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.500545554	6.195318735976561
W SYNDROME	0.500545554	6.195318735976561
BRACHYDACTYLY, TYPE D	0.5	6.188566341732566
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5	6.188566341732566
%613938 PARASOMNIA, SLEEPWALKING TYPE; PSMNSWPARASOMNIA, SLEEP TERRORS TYPE, INCLUDED; PSMNST, INCLUDED	0.5	6.188566341732566
HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY	0.5	6.188566341732566
613241 PSEUDOPILI ANNULATI	0.5	6.188566341732566
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.5	6.188566341732566
BRACHYDACTYLY TYPE C	0.5	6.188566341732566
SEMANTIC DEMENTIA	0.5	6.188566341732566
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.5	6.188566341732566
MADELUNG DEFORMITY	0.5	6.188566341732566
BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1	0.5	6.188566341732566
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.5	6.188566341732566
YOUNG-ONSET PARKINSON DISEASE	0.4861237500000001	6.016818154333634
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.476074244	5.892434085168354
16P13.2 MICRODELETION SYNDROME	0.46246782399999997	5.7240256194814
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.461298714	5.709555389889834
MUCOPOLYSACCHARIDOSIS TYPE 2	0.458526824	5.675247339575864
CONGENITAL MYASTHENIC SYNDROME	0.4547617	5.628645900258165
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.4547617	5.628645900258165
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.44987445000000004	5.5681557585509
AUTISM	0.44987445000000004	5.5681557585509
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.44987445000000004	5.5681557585509
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.44987445000000004	5.5681557585509
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.44987445000000004	5.5681557585509
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.44987445000000004	5.5681557585509
WILLIAMS SYNDROME	0.44665295000000005	5.528282825611118
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.44283220000000006	5.480992895910768
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.433169264	5.361393454926936
PRADER-WILLI SYNDROME	0.43041703	5.327328689532992
CHILDHOOD ABSENCE EPILEPSY	0.42509113	5.261409318574125
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1	0.40920604	5.06479745195534
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.406447524	5.030654933413879
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.4047616	5.0097880283716405
CHILDHOOD DISINTEGRATIVE DISORDER	0.39708261	4.914744150266638
11Q22.2Q22.3 MICRODELETION SYNDROME	0.39644612399999996	4.90686627859347
X-LINKED ADRENOLEUKODYSTROPHY	0.39616841999999997	4.903429099338741
MONOSOMY 22Q13.3	0.393769224	4.873733932113102
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.3888886	4.8133258012869975
PLACENTAL INSUFFICIENCY	0.38385355	4.751006319369116
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.37821725	4.681245086425302
CHRISTIANSON SYNDROME	0.36596514	4.529599095302893
CHROMOSOME 17Q12 DELETION SYNDROME	0.36537525	4.522297948504243
NORMAL PRESSURE HYDROCEPHALUS	0.3585671	4.4380325726253105
49,XXXXY SYNDROME	0.35426289400000005	4.384758843866344
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.352702394	4.365444328313796
ADNP SYNDROME	0.35143280999999993	4.349730518692991
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.34956927	4.326665236852047
TRICHOTILLOMANIA; TTM	0.349462	4.325337541829092
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.34453515	4.264357265667561
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.343644214	4.253330032583086
POSTERIOR CORTICAL ATROPHY	0.34280516	4.242944949896494
POLAND SYNDROME	0.34226157	4.236216864341089
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.34226157	4.236216864341089
ANGELMAN SYNDROME	0.340308434	4.212042640920236
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.33777744	4.180716192361182
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3	0.33777744	4.180716192361182
MAJOR AFFECTIVE DISORDER 1	0.33777744	4.180716192361182
SPINOCEREBELLAR ATAXIA TYPE 42	0.33777744	4.180716192361182
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.337568594	4.178131277708771
ACITRETIN/ETRETINATE EMBRYOPATHY	0.33702304	4.171378883464776
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.333333	4.125706768777483
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	4.125706768777483
ISOLATED CLEFT LIP	0.333333	4.125706768777483
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.333333	4.125706768777483
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	4.125706768777483
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.333333	4.125706768777483
MAST SYNDROME	0.333333	4.125706768777483
BRACHYDACTYLY, TYPE A6	0.333333	4.125706768777483
BETA-KETOTHIOLASE DEFICIENCY	0.3287949	4.069538102946649
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.32573161	4.031623356168717
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.31839112399999997	3.940769186985599
DUPLICATION/INVERSION 15Q11	0.31697816999999995	3.923280867851966
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.31154531	3.856037638781276
GITELMAN SYNDROME	0.31040850000000003	3.8419671905753865
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.304561894	3.7696029723654427
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.30326199	3.7535138880816756
OROMANDIBULAR DYSTONIA	0.29989924	3.711892685150354
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.296450364	3.669205489289535
2Q23.1 MICRODELETION SYNDROME	0.29409525	3.6400559308268488
MYOCLONUS-DYSTONIA SYNDROME	0.29335655	3.630912942913573
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.29239448000000007	3.6190052748727926
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.2919044700000001	3.612940356086568
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.291667	3.6100011583882243
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.291667	3.6100011583882243
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.287607014	3.5597501729732133
21Q22.11Q22.12 MICRODELETION SYNDROME	0.2869586	3.5517246668613973
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.28283142	3.500642012392854
1P21.3 MICRODELETION SYNDROME	0.282549214	3.497149111286783
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.27767456	3.4368148719427998
HYPERTRYPTOPHANEMIA; HYPTRP	0.277273234	3.431847606791475
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.27397014	3.3909647740875175
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.27339141	3.383801756089616
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.262981554	3.2549575871618504
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.25921145	3.2082945097233875
WILSON DISEASE	0.25918378	3.207952034462036
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25892857	3.2047932664298893
ESOPHAGEAL ATRESIA	0.25773862000000003	3.1900650973932
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25704225	3.181446033506415
CHOANAL ATRESIA	0.25613719999999995	3.1702441095712444
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25369004	3.1399552855535764
PRADER-WILLI-LIKE SYNDROME	0.253023834	3.131709565497056
PALLISTER-HALL SYNDROME	0.252594734	3.126398537862581
LYSINURIC PROTEIN INTOLERANCE	0.2521692	3.121131647083255
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.250545554	3.101035565110278
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.250545554	3.101035565110278
SEVERE HEMOPHILIA A	0.25	3.094283170866283
DYSTONIA 6, TORSION	0.25	3.094283170866283
GLOMUVENOUS MALFORMATION	0.25	3.094283170866283
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	3.094283170866283
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	3.094283170866283
HYPERPARATHYROIDISM 2	0.25	3.094283170866283
HEMOPHILIA B	0.25	3.094283170866283
CRYPTOMICROTIA-BRACHYDACTYLY-EXCESS FINGERTIP ARCH SYNDROME	0.25	3.094283170866283
CONGENITAL FACTOR II DEFICIENCY	0.25	3.094283170866283
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	0.25	3.094283170866283
UVEAL MELANOMA	0.25	3.094283170866283
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	3.094283170866283
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.24268294	3.0037189483934075
8Q24.3 MICRODELETION SYNDROME	0.24230595400000005	2.9990529426515993
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.23843362000000004	2.951124550938906
SPASTIC PARAPLEGIA 16, X-LINKED	0.23803409999999997	2.946179638889207
ADENYLOSUCCINASE DEFICIENCY	0.23648485400000002	2.9270044155878803
SAY-BARBER-MILLER SYNDROME	0.23548559400000002	2.914636441982601
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.23225810000000002	2.874689320509513
PITT-HOPKINS SYNDROME	0.22731774400000004	2.81354187879396
PITT-HOPKINS-LIKE SYNDROME	0.22695584000000002	2.8090625449672832
NARCOLEPSY 7; NRCLP7	0.2261903	2.7995873548127834
PHELAN-MCDERMID SYNDROME	0.225907304	2.7960846757718936
DYSTONIA 11, MYOCLONIC	0.22549955000000002	2.7910378504116795
POPOV-CHANG SYNDROME; POPCHAS	0.22520261400000002	2.7873626341411826
TUBEROUS SCLEROSIS COMPLEX	0.22452100000000003	2.7789262072242753
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.22247001000000002	2.753540831861815
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.220953754	2.7347739301677145
CLEFT VELUM	0.2208333	2.7332830550274605
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2204082	2.728021535923719
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.21947030400000003	2.716413072688429
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.219279264	2.714048545260579
ALCOHOL DEPENDENCE	0.2172414	2.6888256321417217
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.21607024400000002	2.674330078936686
CHROMOSOME 16P13.3 DELETION SYNDROME	0.215530554	2.6676502641987465
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.21472004	2.6576184248789403
SCHIZOPHRENIA 10	0.21449279999999998	2.6548058452479495
PAROXYSMAL HEMICRANIA	0.20990245	2.5979904742344058
STIFF-PERSON SYNDROME; SPS	0.20937055000000002	2.5914070773600706
NARCOLEPSY TYPE 1	0.2089371	2.5860422091984225
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.20877193000000002	2.583997878193095
KEPPEN-LUBINSKY SYNDROME	0.20740741000000001	2.567109033103853
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.20648184000000003	2.5556531304060184
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.20570884999999997	2.546085730613026
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.20570884999999997	2.546085730613026
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.20479756999999998	2.534806697141238
VELOCARDIOFACIAL SYNDROME	0.2047392	2.5340842439065043
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.20444444	2.5304359602767263
BROOKE-SPIEGLER SYNDROME	0.203704	2.521271436152581
APNEA, OBSTRUCTIVE SLEEP	0.2036865	2.52105483633062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.2034824	2.5185286635499256
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.20271475400000002	2.509027407153994
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.20216920000000002	2.5022750129099993
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20216920000000002	2.5022750129099993
CARPENTER SYNDROME	0.20204918000000002	2.5007895094453296
HSD10 DISEASE	0.20170466400000003	2.496525389201753
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.20054555400000001	2.482178930937022
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.20054555400000001	2.482178930937022
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	2.4754265366930266
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.2	2.4754265366930266
PORPHYRIA CUTANEA TARDA, TYPE I	0.2	2.4754265366930266
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.2	2.4754265366930266
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.2	2.4754265366930266
ACUTE PROMYELOCYTIC LEUKEMIA	0.2	2.4754265366930266
LINEAR VERRUCOUS NEVUS SYNDROME	0.2	2.4754265366930266
CRANIOSYNOSTOSIS 4; CRS4	0.2	2.4754265366930266
ROMANO-WARD SYNDROME	0.2	2.4754265366930266
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.2	2.4754265366930266
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.2	2.4754265366930266
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.2	2.4754265366930266
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.199729394	2.4720772103260846
PEDIATRIC-ONSET GRAVES DISEASE	0.19800696399999998	2.4507584656781036
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.19792841400000002	2.449786241905818
PROGRESSIVE NON-FLUENT APHASIA	0.19787205	2.4490886171992465
HEREDITARY COPROPORPHYRIA	0.19663756000000002	2.433809170672836
TURNER SYNDROME	0.19660314	2.433383149765871
MONOSOMY X	0.19660314	2.433383149765871
MOSAIC MONOSOMY X	0.19660314	2.433383149765871
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.19660314	2.433383149765871
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.19535468000000003	2.4179307946958724
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.19457093000000003	2.408230216955207
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.1938224	2.3989655618276524
8Q22.1 MICRODELETION SYNDROME	0.193053694	2.389451185671076
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.19216655	2.378470886673736
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.18998064000000003	2.3514155885696235
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.187620754	2.3222069664297713
GITELMAN SYNDROME	0.1870752	2.315454572185776
KOOLEN-DE VRIES SYNDROME; KDVS	0.18683294399999997	2.3124561375304102
GM2 GANGLIOSIDOSIS, AB VARIANT	0.18674431000000002	2.3113591027521445
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.18645467	2.3077741900417053
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.18527559999999998	2.293180684208612
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.18500004	2.2897700415263564
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.18500004	2.2897700415263564
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.184875444	2.2882279003025277
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.184564554	2.2843799735225647
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.18445289	2.2829978933785986
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.18381190000000003	2.2750642750998247
RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1	0.182857	2.2632453511003834
WITTEVEEN-KOLK SYNDROME	0.181992764	2.2525485874585565
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.18180294400000002	2.2501991601325813
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.1813081	2.2440744102869647
KOOLEN-DE VRIES SYNDROME	0.180350264	2.232219147025965
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.18021894	2.2305937324534413
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.18021894	2.2305937324534413
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.17700351000000003	2.190795928709048
PFAPA SYNDROME	0.17543893000000002	2.1714309144551516
INSULINOMA	0.17526790999999997	2.1693141772236246
2Q32Q33 MICRODELETION SYNDROME	0.174990314	2.165878334699226
AURICULOCONDYLAR SYNDROME	0.174143154	2.1553929229751017
MULTIPLE SYSTEM ATROPHY	0.173611	2.1488063823090644
TRIGEMINAL NEURALGIA	0.17328064	2.1447174727557554
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.17286091	2.1395224188545248
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.17275576	2.1382209633528584
XIA-GIBBS SYNDROME	0.17197395399999998	2.128544446758129
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.17195189400000002	2.128271407211132
PEMPHIGUS VULGARIS	0.17071558	2.1129693847947064
WAARDENBURG SYNDROME	0.17035704000000002	2.108531687642377
268650 RUDIGER SYNDROME	0.17020057000000002	2.1065950376913953
ROIFMAN SYNDROME; RFMN	0.16926173400000002	2.0949749399513813
CHROMOSOME 16P13.2 DELETION SYNDROME	0.16909544400000004	2.0929167465574485
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.16871618000000002	2.0882225457073864
BRACHYDACTYLY, TYPE E	0.16871618000000002	2.0882225457073864
17Q24.2 MICRODELETION SYNDROME	0.16868845	2.0878793278180736
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.16836796399999998	2.0839126300728803
MCLEOD SYNDROME; MCLDS	0.16835655	2.0837713574804315
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.167857	2.0775883608484067
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.166739764	2.063760182637663
BRACHYDACTYLY, TYPE B1	0.166667	2.0628595729550834
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	0.166667	2.0628595729550834
EXOSTOSES-ANETODERMIA-BRACHYDACTYLY TYPE E SYNDROME	0.166667	2.0628595729550834
247150 LIP PRINTS	0.166667	2.0628595729550834
BRACHYDACTYLY TYPE B	0.166667	2.0628595729550834
PARAGANGLIOMAS 4	0.166667	2.0628595729550834
ACUTE ADRENAL INSUFFICIENCY	0.166667	2.0628595729550834
XANTHOMA DISSEMINATUM	0.166667	2.0628595729550834
SPINOCEREBELLAR ATAXIA TYPE 1	0.166667	2.0628595729550834
SOLAR URTICARIA	0.166667	2.0628595729550834
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.166667	2.0628595729550834
PARAGANGLIOMAS 3	0.166667	2.0628595729550834
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.166667	2.0628595729550834
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.166667	2.0628595729550834
PHLEBECTASIA OF LIPS	0.166667	2.0628595729550834
BRACHYDACTYLY TYPE E	0.166667	2.0628595729550834
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.166667	2.0628595729550834
GRANULOMATOSIS WITH POLYANGIITIS	0.166667	2.0628595729550834
PARAGANGLIOMAS 1	0.166667	2.0628595729550834
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.166667	2.0628595729550834
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.166667	2.0628595729550834
BRACHYDACTYLY TYPE B2	0.166667	2.0628595729550834
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	2.0628595729550834
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	2.0628595729550834
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.166667	2.0628595729550834
HOLT-ORAM SYNDROME	0.166667	2.0628595729550834
SCALP-EAR-NIPPLE SYNDROME	0.166667	2.0628595729550834
EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	0.166667	2.0628595729550834
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.166667	2.0628595729550834
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY;;APICAL DYSTROPHY;;SORSBY SYNDROME	0.166667	2.0628595729550834
ADDISON DISEASE	0.166667	2.0628595729550834
PITYRIASIS RUBRA PILARIS	0.166667	2.0628595729550834
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.16542486	2.047485441363644
MELAS	0.16541866	2.047408703141006
PERRY SYNDROME	0.16532722	2.0462769381284303
CARIBBEAN PARKINSONISM	0.16459617999999998	2.0372287590515095
MYOTONIC DYSTROPHY 1	0.16430498000000002	2.033624538014085
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.16300838	2.017576347776704
SPINOCEREBELLAR ATAXIA TYPE 7	0.16216540399999999	2.007142721975727
LEPTIN DEFICIENCY OR DYSFUNCTION	0.16208779999999998	2.0061822069709594
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.16009839999999997	1.9815591392104739
AUTOIMMUNE HYPOPARATHYROIDISM	0.15893896	1.967208596491957
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.15893896	1.967208596491957
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.1571427	1.944976048137956
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.156618924	1.9384932030895414
CHRONIC HICCUP	0.15454781999999997	1.9128588740802859
LENNOX-GASTAUT SYNDROME	0.15430775	1.9098874958369667
DRAVET SYNDROME	0.15188942	1.8799555045545622
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.15032022	1.8605333079476691
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.14745177399999998	1.8250301712103136
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.14730143999999998	1.8231694673454777
49,XYYYY SYNDROME	0.14485067000000001	1.7928359618788223
KUFOR-RAKEB SYNDROME	0.14423214	1.7851803340001187
DE BARSY SYNDROME	0.143402554	1.7749124380057733
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.143402554	1.7749124380057733
WRINKLY SKIN SYNDROME	0.143402554	1.7749124380057733
3Q27.3 MICRODELETION SYNDROME	0.1432077	1.7725007041938694
EHLERS-DANLOS SYNDROME, TYPE VI	0.14285699999999998	1.7681600437617782
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.14285699999999998	1.7681600437617782
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.14285699999999998	1.7681600437617782
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.14285699999999998	1.7681600437617782
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.14285699999999998	1.7681600437617782
ACROOTOOCULAR SYNDROME	0.14285699999999998	1.7681600437617782
JUVENILE PRIMARY LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617782
PRIMARY PROGRESSIVE FREEZING GAIT	0.14285699999999998	1.7681600437617782
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	1.7681600437617782
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	1.7681600437617782
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.14285699999999998	1.7681600437617782
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	1.7681600437617782
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.14285699999999998	1.7681600437617782
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	1.7681600437617782
RESTRICTIVE DERMOPATHY, LETHAL	0.14285699999999998	1.7681600437617782
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.14285699999999998	1.7681600437617782
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.14285699999999998	1.7681600437617782
SPINOCEREBELLAR ATAXIA TYPE 6	0.14285699999999998	1.7681600437617782
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.141939794	1.756807663401708
HUNTINGTON DISEASE-LIKE 1	0.14042569	1.7380673972971425
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.13892525	1.7194962523335644
ADRENOCORTICAL CARCINOMA	0.13663752	1.6911807145796205
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.13647167000000002	1.689127967124068
USHER SYNDROME	0.13582966000000002	1.6811817241699567
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.13498865	1.670772431811835
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.13293112	1.6453061100016257
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.1326971	1.6424096134110409
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.13138522000000002	1.626172300586257
SYDENHAM CHOREA	0.13129341	1.6250359560345877
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.13115090000000001	1.623272090855867
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.130438554	1.6144552898973314
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.12992611	1.608112702516486
CREUTZFELDT-JAKOB DISEASE; CJD	0.12961786	1.6042974513668078
SMITH-MAGENIS SYNDROME	0.12927388400000003	1.6000400147748803
49,XXXYY SYNDROME	0.12899125	1.5965418162560217
TONNE-KALSCHEUER SYNDROME; TOKAS	0.12819491400000002	1.586685459923402
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.12790654	1.5831162166629404
LUSCAN-LUMISH SYNDROME; LLS	0.127062314	1.5726671194461095
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.12591117000000002	1.5584192574203344
BRUNNER SYNDROME; BRNRS	0.12551649	1.5535342506928245
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.12522982	1.5499860980664553
LYSINURIC PROTEIN INTOLERANCE; LPI	0.125	1.5471415854331414
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.125	1.5471415854331414
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.125	1.5471415854331414
NON-FUNCTIONING PARAGANGLIOMA	0.125	1.5471415854331414
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.125	1.5471415854331414
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.12481703400000001	1.5448769909745788
SMITH-FINEMAN-MYERS SYNDROME	0.12407411	1.535681722052848
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.12393006399999999	1.5338988455983253
CHILDHOOD APRAXIA OF SPEECH	0.12316631	1.5244457610027982
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.1229513	1.5217845537045265
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.1229513	1.5217845537045265
DIASTEMA, DENTAL MEDIAL	0.1222223	1.5127616239782804
FG SYNDROME TYPE 1	0.12175119400000001	1.506930682508304
NON-24-HOUR SLEEP-WAKE SYNDROME	0.12003584	1.4856995184511912
MOHR-TRANEBJAERG SYNDROME	0.11965903000000001	1.4810356910847347
NOONAN SYNDROME 7; NS7	0.11913691	1.4745733425680438
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.11890293399999999	1.4716773905712972
ROLANDIC EPILEPSY	0.11662073	1.4434302488525625
MACULAR CORNEAL DYSTROPHY	0.11565645	1.4314952273485508
48,XYYY SYNDROME	0.115104494	1.4246635947011161
WIEDEMANN-STEINER SYNDROME	0.11507355	1.4242805967073588
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.11482948400000001	1.4212597594418366
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.11478283400000001	1.4206823662021528
MUCOLIPIDOSIS III ALPHA/BETA	0.11464456999999999	1.4189710543288059
ADULT-ONSET DYSTONIA-PARKINSONISM	0.11463909400000001	1.4189032771502317
DISTAL MONOSOMY 12Q	0.11433558400000002	1.415146693609473
GM2-GANGLIOSIDOSIS, AB VARIANT	0.114181954	1.4132451947153122
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.11347775	1.4045291683710852
SOMATOMAMMOTROPINOMA	0.11316602	1.4006708447996687
ACROMEGALY	0.11316602	1.4006708447996687
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.11316017999999999	1.400598562344797
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.113045554	1.3991798211338224
KBG SYNDROME	0.11285975399999999	1.3968801498812344
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.11232785	1.3902967034983689
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.11215972400000002	1.3882157856888286
RING CHROMOSOME 22 SYNDROME	0.11212498400000001	1.387785804099405
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.11210831000000002	1.387579427789041
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.112059924	1.3869805478470187
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.11189494999999999	1.3849386427596966
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.11189494999999999	1.3849386427596966
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.11189494999999999	1.3849386427596966
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.11165655399999999	1.3819879838364892
15Q13.3 MICRODELETION SYNDROME	0.11128458399999999	1.3773840617922206
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.11111099999999999	1.3752355895924941
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.11111099999999999	1.3752355895924941
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.11111099999999999	1.3752355895924941
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.110422544	1.3667144783337664
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.10973714	1.3582311420839888
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.10840336	1.3417227700534367
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.106010034	1.31210025659665
TETRASOMY 9P	0.10589082400000001	1.310624778609454
DEMENTIA, LEWY BODY; DLB	0.1055556	1.306475666682772
BECKWITH-WIEDEMANN SYNDROME	0.10533855	1.303789210033826
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.105284894	1.303125102602562
EARLY-ONSET LAFORA BODY DISEASE	0.1046099	1.294770612304019
KUFOR-RAKEB SYNDROME	0.10459870000000002	1.2946319884179645
HUNTINGTON DISEASE-LIKE 1	0.10444444	1.2927226919302128
IDIOPATHIC HYPERSOMNIA	0.1036867	1.2833440434106442
NIEMANN-PICK DISEASE, TYPE C2	0.103502854	1.2810685570753197
HUNTINGTON DISEASE-LIKE 2	0.10330206	1.278583303095276
RAMOS-ARROYO SYNDROME	0.10325498000000001	1.2780005876885385
MYASTHENIA GRAVIS	0.1029573	1.2743161628313247
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.10256544000000001	1.269466059617982
22Q11.2 DELETION SYNDROME	0.10248147399999999	1.268426801295082
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.102474964	1.2683462261613128
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.10244824400000001	1.2680155091760106
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.100682934	1.2461660330785627
SPINOCEREBELLAR ATAXIA TYPE 29	0.10054555400000001	1.2444656625905084
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.10054555400000001	1.2444656625905084
PSEUDOAMINOPTERIN SYNDROME	0.10035113400000001	1.242059300454189
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.10033526400000001	1.2418628753585026
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.099204054	1.2278617390956397
POSTORGASMIC ILLNESS SYNDROME	0.09903460000000001	1.225764384453896
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.0981997	1.2154307163764708
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.09782610000000001	1.2108066196059284
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.09775640000000001	1.2099439334578908
TRISOMY 8P	0.09690986	1.1994661955560302
ERMINE PHENOTYPE	0.09688776000000002	1.1991926609237258
CHIARI MALFORMATION TYPE I	0.09545455000000001	1.1814536305904568
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.09537729400000002	1.180497422827863
RAYNAUD-CLAES SYNDROME; MRXSRC	0.09525585399999999	1.1789943438347825
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.09507361400000001	1.1767387351745482
AMISH INFANTILE EPILEPSY SYNDROME	0.09445241000000001	1.169050010843049
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.09424558000000001	1.1664900484901277
ABLEPHARON-MACROSTOMIA SYNDROME	0.0940171	1.1636621212146097
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0938597	1.1617139605302322
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.09290991000000001	1.149958283678804
HYPERTRICHOSIS CUBITI	0.09219245400000001	1.1410782355722557
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.09175435400000001	1.1356558137436297
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.09166454	1.134544173948797
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.09145210000000001	1.1319147758815218
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.0912088	1.1289034194996346
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0909091	1.1251939928344001
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0909091	1.1251939928344001
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.09074071000000002	1.1231098074618315
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.09057968000000001	1.121116717785813
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.090013394	1.114107720827024
SCHIZOPHRENIA 1; SCZD1	0.08949280000000001	1.1076642598148085
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.08925809400000001	1.1047592725112032
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.08856062	1.096126544269936
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08825228999999998	1.0923103029496428
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.08807264000000001	1.0900867510630585
GABRIELE-DE VRIES SYNDROME	0.08806046	1.0899359975869738
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08786423	1.0875072328404976
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.087859244	1.0874455204569378
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.08768959000000001	1.0853456903886571
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.087528834	1.083355992046994
KBG SYNDROME	0.087251924	1.0799286402356156
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.08713383400000001	1.0784670246370254
47,XYY SYNDROME	0.08701528	1.0769996660488697
NARCOLEPSY TYPE 2	0.08675089999999999	1.0737273997100152
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.08674443000000001	1.0736473196615535
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.08604805400000001	1.0650281815119726
PRADER-WILLI SYNDROME; PWS	0.085997884	1.064407220765243
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.085961674	1.0639590447907747
NASU-HAKOLA DISEASE	0.08565881	1.06021045687773
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.08538248000000001	1.056790283803308
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.08538079	1.0567693664490727
LAFORA DISEASE	0.08479032	1.0494610409134673
3Q29 MICRODELETION SYNDROME	0.084664874	1.047908379126857
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.08442411	1.0449284111534554
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.08439329	1.044546947924151
GLYCINE ENCEPHALOPATHY; GCE	0.08417805	1.0418828938853621
1P36 DELETION SYNDROME	0.08403786399999999	1.0401477931629977
RETT SYNDROME, CONGENITAL VARIANT	0.08399551	1.0396235720853222
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.08387885400000002	1.0381797052950001
PRIMROSE SYNDROME; PRIMS	0.08386609	1.0380217235734284
CONGENITAL ENTEROVIRUS INFECTION	0.08363451000000001	1.0351554271865915
POTOCKI-LUPSKI SYNDROME	0.08334688400000001	1.0315954420213773
SCLEROSTEOSIS	0.08333330000000001	1.031427311051005
MUCKLE-WELLS SYNDROME	0.08333330000000001	1.031427311051005
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	1.031427311051005
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.08333330000000001	1.031427311051005
ALKAPTONURIA	0.08333330000000001	1.031427311051005
DIPROSOPUS	0.08333330000000001	1.031427311051005
9P13 MICRODELETION SYNDROME	0.08317707999999999	1.0294937553831938
FRAXE INTELLECTUAL DISABILITY	0.08251990999999999	1.021359875097601
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08250585	1.0211858526120716
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.08239476400000001	1.0198109264507962
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.08228929	1.0185054607581405
GLASS SYNDROME	0.08226905400000001	1.0182549971011579
PHENYLKETONURIA	0.08224077999999999	1.0179050460516652
MEND SYNDROME	0.082207994	1.0174992493795054
METACHROMATIC LEUKODYSTROPHY	0.0820367	1.015379120813624
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.08155609	1.0094305470746237
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.08136754	1.0070968387071564
JACOBSEN SYNDROME	0.080513114	0.9965214947369541
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.079782904	0.987483588680161
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.079676354	0.9861648051927377
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.07909439400000001	0.9789618090562686
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0790923	0.9789358913404292
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.07850679400000002	0.9716890058914645
ATKIN-FLAITZ SYNDROME	0.07820027	0.9678951176727978
CLARK-BARAITSER SYNDROME	0.07820027	0.9678951176727978
MUCOPOLYSACCHARIDOSIS TYPE 1	0.07820027	0.9678951176727978
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.07778558000000001	0.9627624445202918
ATHYREOSIS	0.07767692400000001	0.9614175947914371
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	0.9520874151234567
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07692310000000001	0.9520874151234567
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	0.9520874151234567
DDOST-CDG	0.07692310000000001	0.9520874151234567
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	0.9520874151234567
ETHYLMALONIC ENCEPHALOPATHY	0.07692310000000001	0.9520874151234567
DIGEORGE SYNDROME; DGS	0.076464534	0.9464116828973308
CONGENITAL ANALBUMINEMIA	0.07573640000000001	0.9373994717679887
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.07550772400000001	0.9345691185744647
THYROID HEMIAGENESIS	0.07550772400000001	0.9345691185744647
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.07550772400000001	0.9345691185744647
THYROID ECTOPIA	0.07550772400000001	0.9345691185744647
FAMILIAL THYROID DYSHORMONOGENESIS	0.07550772400000001	0.9345691185744647
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.07550772400000001	0.9345691185744647
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.075212254	0.9309120471804812
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.07414335400000001	0.9176821300551252
CUSHING DISEASE	0.07411963	0.9173884949593427
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.073923664	0.9149629977758947
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.07392259999999999	0.9149498285067195
SCHINZEL-GIEDION SYNDROME	0.07373067000000001	0.9125742854307821
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.07373067000000001	0.9125742854307821
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.073654754	0.9116346630259842
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.073621454	0.9112225045076248
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.07320315399999999	0.9060451499061312
CRANIOPHARYNGIOMA	0.07286775399999999	0.9018938596040968
17P11.2 MICRODUPLICATION SYNDROME	0.07214499399999999	0.8929481631857956
NORRIE DISEASE	0.07201613000000001	0.8913531963596739
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.071978754	0.8908905886484967
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.07168092400000001	0.8872043072213802
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.07142860000000001	0.8840812595941575
ALZHEIMER DISEASE 4	0.07142860000000001	0.8840812595941575
POSTPOLIOMYELITIS SYNDROME	0.07142860000000001	0.8840812595941575
AREGENERATIVE ANEMIA	0.07111113999999999	0.8801520150524645
SCHAAF-YANG SYNDROME; SHFYNG	0.071088904	0.8798767971301149
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.070695334	0.8750055290198837
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.070657664	0.8745392824316975
MICROPHTHALMIA, SYNDROMIC 1	0.07047855	0.8723223646882314
DARIER-WHITE DISEASE; DAR	0.0704545	0.8720246946471941
16Q24.3 MICRODELETION SYNDROME	0.07010212	0.8676632406321947
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.069786794	0.8637604088916484
RABIES	0.06932783	0.8580797505667143
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.069264	0.8572897181875289
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.069206404	0.8565768448534921
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.06899329	0.8539391045987881
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.0687562	0.8510046102108654
FRONTONASAL DYSPLASIA 1; FND1	0.06871588	0.8505055642210678
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.06861319	0.849234556465803
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.068188054	0.8439725917852853
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.06795380000000001	0.841073198945653
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.067641964	0.8372135633981717
MYOCLONIC EPILEPSY OF LAFORA	0.0676038	0.8367412025064401
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.06704545	0.8298304304726273
EPISODIC ATAXIA TYPE 6	0.06704545	0.8298304304726273
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.06704545	0.8298304304726273
ARNOLD-CHIARI MALFORMATION TYPE I	0.06704545	0.8298304304726273
EPISODIC ATAXIA, TYPE 6	0.06704545	0.8298304304726273
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.06704545	0.8298304304726273
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.06704545	0.8298304304726273
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.06704545	0.8298304304726273
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.06704545	0.8298304304726273
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.06704545	0.8298304304726273
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.06704545	0.8298304304726273
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.06704545	0.8298304304726273
COFS SYNDROME	0.06701159000000001	0.8294113407599653
DESANTO-SHINAWI SYNDROME	0.066998704	0.829251849028206
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.06694444	0.8285802163002703
9Q33.3Q34.11 MICRODELETION SYNDROME	0.06681480000000001	0.8269756448191862
HEPATOCELLULAR CARCINOMA	0.0666667	0.8251425914687648
GLIOBLASTOMA	0.0666667	0.8251425914687648
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.0666667	0.8251425914687648
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.066656754	0.8250194885070952
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.066411304	0.8219815212899387
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.06584025399999999	0.8149135596710457
SMITH-LEMLI-OPITZ SYNDROME	0.06549264399999999	0.8106111445789463
ALG11-CDG	0.065228294	0.8073392495540725
OROFACIODIGITAL SYNDROME TYPE 14	0.065107254	0.8058411214140659
PORPHYRIA VARIEGATA	0.06492615	0.8035995731765597
CORNELIA DE LANGE SYNDROME	0.06489647	0.8032322198785145
MEIER-GORLIN SYNDROME 1; MGORS1	0.06468018	0.8005551698504078
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.0644928	0.79823594272818
EMANUEL SYNDROME	0.064355364	0.7965348791206953
NEUROLEPTIC MALIGNANT SYNDROME	0.06429791	0.7958237633394994
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.06428798	0.7957008584119527
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.06398344	0.7919315264245302
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.063873624	0.7905723192217629
ACUTE INTERMITTENT PORPHYRIA	0.06386335	0.7904451565605729
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.063736954	0.7888807364979137
MUCOLIPIDOSIS TYPE IV	0.06363462	0.787614135001884
6Q16 MICRODELETION SYNDROME	0.063624164	0.7874847197025456
MICROHYDRANENCEPHALY; MHAC	0.06349210000000001	0.7858501460518366
KLEEFSTRA SYNDROME	0.06346702	0.7855397275641351
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.06313021	0.7813709855050174
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.063045554	0.7803231869605659
PARKINSONIAN-PYRAMIDAL SYNDROME	0.06280198000000001	0.7773084392443236
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.06270057	0.7760532742188933
NANCE-HORAN SYNDROME	0.06259785000000001	0.7747818951496479
HADDAD SYNDROME	0.0625	0.7735707927165707
DYSTONIA 12; DYT12	0.062476750000000005	0.7732830243816802
RAPID-ONSET DYSTONIA-PARKINSONISM	0.062476750000000005	0.7732830243816802
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.06215023	0.7692416430178751
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.062048200000000005	0.7679788041701812
CENTRAL DIABETES INSIPIDUS	0.06203685	0.7678383237142238
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.061947140000000005	0.7667279711411903
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0618502	0.765528131898855
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.061840374	0.7654065141931072
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.06172844	0.7640210922233164
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.061656714	0.7631333300044622
COSTELLO SYNDROME; CSTLO	0.061483824	0.7609934475348178
SUSAC SYNDROME	0.0610913	0.7561351259053735
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.061087999999999996	0.7560942813675179
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.061014694	0.7551869632790239
PERRY SYNDROME	0.06073392	0.7517117862269566
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	0.7515357834001977
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.06037726	0.7472973580840719
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.060338294	0.746815070731928
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.060331524000000004	0.746731277543661
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.060294940000000005	0.7462784725215691
VAN BOGAERT-HOZAY SYNDROME	0.06025901	0.7458337621442522
1Q21.1 MICRODELETION SYNDROME	0.060224774	0.745410018629701
COFFIN-LOWRY SYNDROME	0.059956539999999996	0.7420900508214845
TURNPENNY-FRY SYNDROME; TPFS	0.059627124000000004	0.7380128252814282
SPINOCEREBELLAR ATAXIA 12	0.05937055	0.7348371748403008
BLEPHAROCHALASIS AND DOUBLE LIP	0.0592948	0.7338996070395283
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.05905466	0.7309273623969209
RETT SYNDROME; RTT	0.05833875	0.7220664493375014
TRISOMY 9P	0.058150334	0.7197343995058136
16P13.11 MICRODELETION SYNDROME	0.057928254	0.7169856858794698
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.057910833999999994	0.7167700762281237
USHER SYNDROME TYPE 3	0.057872360000000005	0.7162938784252602
AREDYLD SYNDROME	0.05760478	0.7129820052618185
DYSOSTOSIS, STANESCU TYPE	0.05760478	0.7129820052618185
TETRALOGY OF FALLOT	0.05760478	0.7129820052618185
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.05760478	0.7129820052618185
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	0.7095735904634459
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.057325444	0.7095246265265501
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.05707604	0.7064377201267632
ALEXANDER DISEASE	0.05690614	0.7043348452838425
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.056905250000000004	0.7043238296357542
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.056711410000000004	0.7019246462363914
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.056680180000000004	0.7015381083826867
13Q12.3 MICRODELETION SYNDROME	0.0563492	0.6974415250071134
DOORS SYNDROME	0.056290493999999996	0.6967149130557978
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.056217640000000006	0.6958131894312768
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.056101154	0.6943714267535106
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.0559079	0.6919794963539003
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.055861654	0.6914071034758207
2Q23.1 MICRODUPLICATION SYNDROME	0.055750844	0.690035593403166
XP22.13P22.2 DUPLICATION SYNDROME	0.05574732999999999	0.6899921001589161
FAMILIAL MEDIAN CLEFT OF THE UPPER AND LOWER LIPS	0.055555600000000004	0.6876190325095155
POSTERIOR URETHRAL VALVE	0.055555600000000004	0.6876190325095155
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.055555600000000004	0.6876190325095155
RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARYDIASTEMA	0.055555600000000004	0.6876190325095155
DEAFNESS-OLIGODONTIA SYNDROME	0.055555600000000004	0.6876190325095155
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.055555600000000004	0.6876190325095155
BENIGN OCCIPITAL EPILEPSY	0.055555600000000004	0.6876190325095155
CLASSICAL EHLERS-DANLOS SYNDROME	0.055555600000000004	0.6876190325095155
NAGER SYNDROME	0.055555600000000004	0.6876190325095155
ANOPHTHALMIA PLUS SYNDROME	0.055555600000000004	0.6876190325095155
CLEFT LIP AND ALVEOLUS	0.055555600000000004	0.6876190325095155
3MC SYNDROME	0.055555600000000004	0.6876190325095155
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.055555600000000004	0.6876190325095155
NIEMANN-PICK DISEASE TYPE B	0.05536342	0.6852403951504071
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.05526076	0.6839697587091226
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.055155454	0.6826663723747576
FILIPPI SYNDROME	0.055155454	0.6826663723747576
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.055155454	0.6826663723747576
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.055155454	0.6826663723747576
MIETENS SYNDROME	0.055155454	0.6826663723747576
COFFIN-SIRIS SYNDROME 8; CSS8	0.05490352	0.6795481518292815
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.0548395	0.6787557677948861
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.05482505	0.67857691822761
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.05482505	0.67857691822761
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0548008	0.678276772760036
KNIEST-LIKE DYSPLASIA, LETHAL	0.05468078	0.6767912692953665
LETHAL KNIEST-LIKE DYSPLASIA	0.05468078	0.6767912692953665
N-ACETYLASPARTATE DEFICIENCY; NACED	0.054639154	0.6762760587702846
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0546099	0.6759139781307625
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.0546099	0.6759139781307625
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.0546099	0.6759139781307625
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.0546099	0.6759139781307625
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.05441928	0.6735546490986404
15Q24 MICRODELETION SYNDROME	0.054010034	0.668489357056463
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.05375768	0.6653659381152598
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.053460549999999996	0.6616883206810218
CHAR SYNDROME	0.05323229399999999	0.6588631658832247
AICARDI SYNDROME	0.05312269	0.6575065826325863
CEREBROFACIOARTICULAR SYNDROME	0.052802893999999996	0.6535484251089448
COFFIN-SIRIS SYNDROME 1; CSS1	0.05271646399999999	0.6524786695311129
SEVERE CONGENITAL NEMALINE MYOPATHY	0.0526316	0.6514282965430634
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	0.6514282965430634
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	0.6514282965430634
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.0526316	0.6514282965430634
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	0.6514282965430634
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	0.6514282965430634
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.0526316	0.6514282965430634
1Q21.1 MICRODUPLICATION SYNDROME	0.052545084	0.6503574765318207
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.05253729	0.6502610091596859
PARKINSON DISEASE, LATE-ONSET; PD	0.05249942	0.649792287144963
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.05242669	0.6488920982848945
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.05242669	0.6488920982848945
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.05185929399999999	0.6418693627088271
MONOSOMY 18P	0.051545233999999995	0.637982200418258
GANGLIOCYTOMA	0.0514889	0.6372849470256678
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.051377123999999996	0.6359014806428407
RENPENNING SYNDROME 1; RENS1	0.05131497	0.6351321923380328
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.05114946	0.6330836531075924
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.050846470000000005	0.6293335056758294
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.050828894	0.6291159651917847
AMYOTROPHIC LATERAL SCLEROSIS	0.050723950000000004	0.6278170593794512
HAMAMY SYNDROME; HMMS	0.05059527	0.6262243699457428
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.05059527	0.6262243699457428
KLEEFSTRA SYNDROME	0.050554054	0.6257142340450611
HISTIDINEMIA	0.05043863	0.6242856158822048
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.05019384	0.6212558175726195
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.05010048400000001	0.620100337973822
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.05	0.6188566341732566
MENINGIOMA	0.049802	0.6164059619019305
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.049673023999999996	0.6148096088369478
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.049576060000000005	0.6136094725434285
USHER SYNDROME TYPE 1	0.049408904000000003	0.6115405605525911
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.04939146	0.6113246538500607
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.049339454	0.6106809686877244
OCULOCEREBRORENAL SYNDROME OF LOWE	0.04909711	0.6076814448446827
MICROTRIPLICATION 11Q24.1	0.04898807	0.6063318422968778
USHER SYNDROME TYPE 2	0.04886335000000001	0.604788166308596
MARSHALL SYNDROME	0.04865564	0.6022173120789134
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.04860162	0.6015486993713526
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.048378109999999995	0.5987822864452713
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.04817627	0.5962840859844407
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.04806555	0.5949136898537274
YELLOW FEVER	0.048023750000000004	0.5943963257075586
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.048022553999999995	0.594381522656869
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.047619	0.5893866812539261
RING CHROMOSOME 1 SYNDROME	0.04752688000000001	0.5882464997911254
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.047414074	0.5868502849616343
PGM3-CDG	0.04740591999999999	0.5867493618217332
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.047222259999999995	0.5844761776330881
LISSENCEPHALY, X-LINKED, 2	0.047170290000000004	0.5838329380475284
PACHYDERMOPERIOSTOSIS	0.047011870000000004	0.581872152687814
48,XXYY SYNDROME	0.046519614	0.5757794348615821
WOLFRAM SYNDROME	0.046195959999999994	0.5717735263600479
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.046073034	0.5702520549478002
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.04601637	0.5695507171014244
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.046000054	0.569348771804561
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.046000054	0.569348771804561
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.045902194	0.5681375456001571
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.045867254	0.5677050885841968
MAJOR AFFECTIVE DISORDER 2	0.0454545	0.5625963775605658
FACIOMANDIBULAR MYOCLONUS, NOCTURNAL	0.0454545	0.5625963775605658
LITHIUM TRANSPORT	0.0454545	0.5625963775605658
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.045261194000000005	0.560203803550056
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.045197554	0.5594161228260802
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.044757594	0.5539706795306628
CONGENITAL HYPOTHYROIDISM	0.044744634	0.5538102718910851
OGDEN SYNDROME; OGDNS	0.044734764	0.5536881095914994
SLC39A8-CDG	0.04472331	0.553546341913743
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.044594134	0.5519475134222237
LYME DISEASE	0.04454545	0.5513449450946619
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.04449460399999999	0.5507156174062383
YUNIS-VARON SYNDROME	0.044444410000000004	0.5500943596083245
ALLAN-HERNDON-DUDLEY SYNDROME	0.044444410000000004	0.5500943596083245
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.04422715000000001	0.547405303761515
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.04418211	0.5468478377054515
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.04414605	0.5464015183008858
DISTAL TRISOMY 18Q	0.044023854	0.5448890821954971
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.044023854	0.5448890821954971
ABLEPHARON MACROSTOMIA SYNDROME	0.044023854	0.5448890821954971
TARP SYNDROME	0.044023854	0.5448890821954971
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.044017060000000004	0.5448049919560457
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.044011804	0.5447399377466614
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.043859760000000005	0.5428580689849366
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.0438359	0.5425627505991091
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.043623973999999996	0.5399397143780331
LASSA FEVER	0.043478300000000004	0.538136687951502
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	0.538136687951502
HYDATIDIFORM MOLE	0.043478300000000004	0.538136687951502
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	0.538136687951502
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.043478300000000004	0.538136687951502
VIRAL HEMORRHAGIC FEVER	0.043478300000000004	0.538136687951502
KEUTEL SYNDROME; KTLS	0.043478300000000004	0.538136687951502
FRASER SYNDROME	0.043478300000000004	0.538136687951502
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.043478300000000004	0.538136687951502
RINGED HAIR DISEASE	0.043478300000000004	0.538136687951502
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	0.538136687951502
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	0.538136687951502
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	0.538136687951502
OCULOTRICHOANAL SYNDROME	0.043478300000000004	0.538136687951502
WERNER SYNDROME	0.043478300000000004	0.538136687951502
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	0.538136687951502
ASHERMAN SYNDROME	0.043478300000000004	0.538136687951502
FAMILIAL THROMBOCYTOSIS	0.043478300000000004	0.538136687951502
BRADDOCK SYNDROME	0.043478300000000004	0.538136687951502
C SYNDROME	0.043478300000000004	0.538136687951502
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	0.538136687951502
JOHANSON-BLIZZARD SYNDROME	0.043478300000000004	0.538136687951502
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	0.538136687951502
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.043411370000000005	0.5373082864609978
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.04320984	0.534813922911299
JUVENILE MYOCLONIC EPILEPSY	0.043200840000000004	0.5347025287171479
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	0.5337231262079053
OGDEN SYNDROME	0.043048633999999995	0.5328186548599283
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.043028354	0.5325676466091076
16P13.11 MICRODUPLICATION SYNDROME	0.042791624	0.5296376079889509
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.042697094	0.528467597636383
8P INVERTED DUPLICATION/DELETION SYNDROME	0.042641439999999996	0.5277787606940173
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.0424828	0.5258152523651125
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.042435763999999994	0.5252330815522129
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.042324794	0.5238595911383289
JAWAD SYNDROME	0.042321894	0.5238236974535468
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0422414	0.5228274125353239
SHPRINTZEN OMPHALOCELE SYNDROME	0.04215154	0.5217152033923879
HARTNUP DISEASE	0.042053814	0.5205056357237636
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.041956474	0.519300845628355
4Q21 MICRODELETION SYNDROME	0.04195338	0.5192625507798323
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.04189021	0.5184806873082178
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.041666699999999994	0.5157142743821365
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	0.5157142743821365
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	0.5157142743821365
BARATELA-SCOTT SYNDROME	0.041365613999999995	0.5119876930110028
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.041279503999999995	0.5109218981156296
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.04108196	0.5084768698168072
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.041075274	0.5083941163076856
INFANTILE MYOFIBROMATOSIS	0.0408333	0.5053991720037369
611426 TENTED EYEBROWS	0.0408333	0.5053991720037369
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0408086	0.5050934568264551
CORNELIA DE LANGE SYNDROME 1	0.04079400999999999	0.5049128744606033
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.040769614	0.5046109219316576
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.04072704	0.5040839778847918
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.04065564	0.5032002506111923
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.040630700000000006	0.5028915649220668
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.0406015	0.5025301526477095
WILSON DISEASE	0.0406015	0.5025301526477095
CHROMOSOME 10Q26 DELETION SYNDROME	0.040529263999999995	0.5016360780911866
ACROCEPHALOPOLYDACTYLY	0.04051068	0.5014060614573972
MAL DE MELEDA	0.04051068	0.5014060614573972
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.040308434000000004	0.49890283588069717
MUCOPOLYSACCHARIDOSIS, TYPE II	0.040104970000000004	0.4963845349563886
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.04006544	0.4958952669014112
DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO; DSPD	0.04	0.49508530733860523
BUERGER DISEASE	0.04	0.49508530733860523
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.04	0.49508530733860523
TYPHOID	0.04	0.49508530733860523
MERCURY POISONING	0.04	0.49508530733860523
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.039973369999999994	0.4947557042952445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.039969264	0.49470488378844624
NOVELTY SEEKING PERSONALITY TRAIT	0.039968699999999996	0.49469790308561273
ZELLWEGER SYNDROME	0.03976288000000001	0.4921504416367021
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.039749610000000005	0.49198619708599245
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0397012	0.49138702009278584
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.039638999999999994	0.4906171624398743
MEHMO SYNDROME	0.03962027	0.4903853387447131
MILD CANAVAN DISEASE	0.039504479999999995	0.4889521905512946
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.039325453999999996	0.4867363619955045
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.0391926	0.48509201040997557
SPINOCEREBELLAR ATAXIA TYPE 10	0.03915746	0.48465707796747853
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.03908618	0.48377483594980114
CLEIDOCRANIAL DYSPLASIA; CCD	0.03908618	0.48377483594980114
GORLIN SYNDROME	0.03908618	0.48377483594980114
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.03902825	0.48305782865344804
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.03896951	0.48233079587962124
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.03896951	0.48233079587962124
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.03895456	0.4821457577460035
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.038909554	0.48158871251245144
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.038842864	0.4807632815337911
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.038718393999999996	0.4792226998286802
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.038718393999999996	0.4792226998286802
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.038587064	0.4775972109933607
2Q37 MICRODELETION SYNDROME	0.038476843999999996	0.47623300342898917
CYCLIC NEUTROPENIA	0.0384615	0.47604308870509415
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	0.47604308870509415
LIP, HAMARTOMATOUS	0.0384615	0.47604308870509415
LIP, MEDIAN NODULE OF UPPER	0.0384615	0.47604308870509415
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	0.47604308870509415
JUVENILE ABSENCE EPILEPSY	0.0384615	0.47604308870509415
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	0.47604308870509415
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	0.47604308870509415
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	0.47604308870509415
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	0.47604308870509415
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	0.47604308870509415
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	0.47604308870509415
BAZEX SYNDROME; BZX	0.0384615	0.47604308870509415
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.038429054000000004	0.4756415002580465
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.038402784	0.4753163529824519
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.03811733999999999	0.4717833747207527
248100 MACROSOMIA ADIPOSA CONGENITA	0.0380987	0.471552664967533
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	0.4712556137831299
TETRASOMY 12P	0.03801637	0.4705336556337033
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.037994933999999994	0.4702683394175005
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.037948784	0.46969713474415864
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.0378835	0.4688891060140513
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.0378835	0.4688891060140513
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.0378835	0.4688891060140513
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03776348	0.46740360254938185
BAKER-GORDON SYNDROME; BAGOS	0.037632554	0.4657831140756664
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.03759781	0.46535308297771216
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.037582554	0.46516425744149315
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.037582554	0.46516425744149315
SILVER-RUSSELL SYNDROME; SRS	0.037582554	0.46516425744149315
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.037170654	0.4600661164891739
HELSMOORTEL-VAN DER AA SYNDROME	0.037088734	0.45905218177974444
SMITH-MAGENIS SYNDROME	0.03707336	0.45886189574186886
BRACHYDACTYLY, TYPE A1, D	0.037037	0.4584118631974981
DIABETIC EMBRYOPATHY	0.037037	0.4584118631974981
KAPOSIFORM LYMPHANGIOMATOSIS	0.037037	0.4584118631974981
CERVICAL VERTEBRAE, AGENESIS OF	0.037037	0.4584118631974981
FIBROSCLEROSIS, MULTIFOCAL	0.037037	0.4584118631974981
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.037037	0.4584118631974981
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.037037	0.4584118631974981
PROTEUS SYNDROME	0.037037	0.4584118631974981
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.037037	0.4584118631974981
SYNPOLYDACTYLY 1	0.037037	0.4584118631974981
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.037037	0.4584118631974981
PAROTIDOMEGALY, HEREDITARY BILATERAL	0.037037	0.4584118631974981
MALAKOPLAKIA	0.037037	0.4584118631974981
KIKUCHI-FUJIMOTO DISEASE	0.037037	0.4584118631974981
BRACHYDACTYLY-SYNDACTYLY, ZHAO TYPE	0.037037	0.4584118631974981
BRACHYDACTYLY TYPE A4	0.037037	0.4584118631974981
OCULODENTODIGITAL DYSPLASIA; ODDD	0.037037	0.4584118631974981
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.037037	0.4584118631974981
CLEIDORHIZOMELIC SYNDROME	0.037037	0.4584118631974981
CARCINOMA OF ESOPHAGUS	0.037037	0.4584118631974981
BRACHYDACTYLY, TYPE A2; BDA2	0.037037	0.4584118631974981
BRACHYDACTYLY, TYPE A4	0.037037	0.4584118631974981
CLEIDORHIZOMELIC SYNDROME	0.037037	0.4584118631974981
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.037037	0.4584118631974981
BRANCHIAL CLEFT ANOMALIESBRANCHIAL CYSTS, INCLUDED	0.037037	0.4584118631974981
HYPOPARATHYROIDISM, X-LINKED	0.037037	0.4584118631974981
BRACHYDACTYLY, TYPE A3	0.037037	0.4584118631974981
HYPERPROLINEMIA, TYPE I	0.036996304	0.4579081634058118
HURLER-SCHEIE SYNDROME	0.03697476	0.4576415104592792
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0368414	0.45599089604461235
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.03680556	0.4555472996092369
PITUITARY APOPLEXY	0.03680355	0.4555224215725431
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.0367747	0.4551653412946252
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.036724233999999994	0.45454071691662135
WHITE-SUTTON SYNDROME; WHSUS	0.03662937399999999	0.45336662211026785
KEIPERT SYNDROME; KPTS	0.03653198	0.45216116364969444
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.03649369399999999	0.45168729274777525
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.036340774000000006	0.44979458161781993
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036259854	0.4487930240410739
YOU-HOOVER-FONG SYNDROME; YHFS	0.036259854	0.4487930240410739
TRANSKETOLASE DEFICIENCY	0.036223533999999995	0.44834348658201034
DISTAL MONOSOMY 10Q	0.03614925399999999	0.4474241131662825
THUMBS, CONGENITAL CLASPED	0.0361093	0.44692959720704745
LYNCH SYNDROME	0.03603924	0.4460624552912439
FAMILIAL COLORECTAL CANCER TYPE X	0.03603924	0.4460624552912439
COG1-CDG	0.035948139999999996	0.4449348985037802
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.035945753999999996	0.4449053666651975
OCULOFACIOCARDIODENTAL SYNDROME	0.035844134	0.4436476024419037
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03579167	0.4429982485527984
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.035714300000000004	0.44204062979707875
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.035714300000000004	0.44204062979707875
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.03567798	0.4415910923380153
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.035664554	0.4414249169546071
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.035616579999999995	0.4408311363912505
RABSON-MENDENHALL SYNDROME	0.035598424	0.44060641717024945
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.03549958	0.4393830118672852
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.035459484	0.43888673835520886
CUSHING SYNDROME	0.035376540000000005	0.43786012946191155
17Q21.31 MICRODUPLICATION SYNDROME	0.035354123999999994	0.43758268365567893
MARTSOLF SYNDROME	0.03529858	0.43689520819790867
XQ28 (MECP2) DUPLICATION	0.035292633999999996	0.43682161376697265
CHARGE SYNDROME	0.035279043999999996	0.4366534085338044
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.035242383999999995	0.4361996628496285
MAN1B1-CDG	0.035221964	0.4359469218002322
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.03519641	0.435630636551639
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.035034764	0.4336299225618876
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.035028354	0.43355058514138656
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.035028354	0.43355058514138656
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.035028354	0.43355058514138656
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.035028354	0.43355058514138656
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.035028354	0.43355058514138656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.035028354	0.43355058514138656
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.035007144	0.43328806615717025
RODRIGUES BLINDNESS	0.03494004	0.432457511045579
MYOCLONIC-ASTASTIC EPILEPSY	0.034723604	0.4297786539561006
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.034672514	0.4291463062473024
TYSHCHENKO SYNDROME	0.034659154	0.42898094775465123
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.0344828	0.4267981908973914
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0344828	0.4267981908973914
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0344828	0.4267981908973914
NASODIGITOACOUSTIC SYNDROME	0.0344828	0.4267981908973914
LATHOSTEROLOSIS	0.0344828	0.4267981908973914
DIAMOND-BLACKFAN ANEMIA 8	0.0344828	0.4267981908973914
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0344828	0.4267981908973914
ISOTRETINOIN-LIKE SYNDROME	0.034427299999999994	0.426111260033459
MEIER-GORLIN SYNDROME 5; MGORS5	0.034427299999999994	0.426111260033459
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.03437055	0.4254088577536725
OCULODENTODIGITAL DYSPLASIA	0.034307279999999996	0.42462575656878954
22Q11.2 MICRODUPLICATION SYNDROME	0.034107394	0.42215174102522246
SAETHRE-CHOTZEN SYNDROME	0.03399358	0.4207430500459866
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.03398416	0.4206264574561084
CHOREOACANTHOCYTOSIS	0.03389067	0.4194693193215312
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.033440584	0.41389854518056113
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.03335805	0.41287701091166407
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.03329918	0.4121483691105884
WEILL-MARCHESANI SYNDROME 1; WMS1	0.03329918	0.4121483691105884
WEILL-MARCHESANI SYNDROME 2; WMS2	0.03329918	0.4121483691105884
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.0332735	0.41183052434327705
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.033165534	0.41049421483597404
JOUBERT SYNDROME 1	0.033062694000000004	0.40922135051080655
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.033062694000000004	0.40922135051080655
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.03301584	0.4086414323360554
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	0.40601517806048165
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.032803653999999995	0.40601517806048165
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.03274593	0.4053007204534613
ALSTRÖM SYNDROME	0.032706693999999994	0.40481509127549287
CHERUBISM	0.03261998	0.40374182059197894
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.032547964	0.4028504690046465
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.032540484	0.40275788805217416
ALLAN-HERNDON-DUDLEY SYNDROME	0.0324531	0.4016763246897623
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.03243109400000001	0.40140395350793
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.03242833	0.4013697431131928
COSTELLO SYNDROME	0.03236687	0.400609044538467
SCHWARTZ-JAMPEL SYNDROME	0.03226168	0.39930709395149333
SECKEL SYNDROME	0.0322581	0.3992627838164865
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	0.3992627838164865
PRIMARY BILIARY CHOLANGITIS	0.0322581	0.3992627838164865
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	0.3992627838164865
FLUSHING OF EARS AND SOMNOLENCE	0.0322581	0.3992627838164865
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	0.3992627838164865
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	0.3992627838164865
OBESITY-HYPOVENTILATION SYNDROME	0.0322581	0.3992627838164865
DENT DISEASE	0.0322581	0.3992627838164865
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0322581	0.3992627838164865
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0322581	0.3992627838164865
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	0.3992627838164865
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0322581	0.3992627838164865
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.0322581	0.3992627838164865
FETAL AKINESIA DEFORMATION SEQUENCE	0.0322581	0.3992627838164865
DEND SYNDROME	0.0322581	0.3992627838164865
DYSTONIA, JUVENILE-ONSET	0.0322581	0.3992627838164865
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0322581	0.3992627838164865
SECKEL SYNDROME 2; SCKL2	0.0322581	0.3992627838164865
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0322581	0.3992627838164865
HYPER-BETA-ALANINEMIA	0.0322581	0.3992627838164865
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.032173954000000005	0.3982212976097037
WHIPPLE DISEASE	0.03209902	0.3972938295492009
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.0319766	0.3957786209660912
OBESITY DUE TO SIM1 DEFICIENCY	0.031952244	0.3954771635224526
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.031795554	0.3935377906022805
CHROMOSOME 18P DELETION SYNDROME	0.031795554	0.3935377906022805
RETT SYNDROME	0.03174403	0.39290007121789766
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.031601434	0.3911351416057662
CLASSIC PHENYLKETONURIA	0.031581224	0.3908849997542334
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.03157324	0.39078618072688864
FRAGILE X SYNDROME	0.03151734	0.3900942990098829
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.031383629999999996	0.38843935259877677
NEPHRONOPHTHISIS 11; NPHP11	0.031263054	0.3869469674483353
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.03125	0.38678539635828535
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.03125	0.38678539635828535
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.03125	0.38678539635828535
MELNICK-NEEDLES SYNDROME	0.03125	0.38678539635828535
TOOTH MALFORMATION	0.03125	0.38678539635828535
ODONTO-ONYCHO DYSPLASIA-ALOPECIA SYNDROME	0.03125	0.38678539635828535
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.03125	0.38678539635828535
GIGANTIFORM CEMENTOMA, FAMILIAL	0.03125	0.38678539635828535
MELNICK-NEEDLES SYNDROME	0.03125	0.38678539635828535
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.03122452	0.38647002701751065
MONILETHRIX	0.03117284	0.3858303768004292
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.03116819	0.38577282313345107
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.03116819	0.38577282313345107
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.031110724	0.38506155882666304
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.03105588	0.38438274736177114
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.030974964	0.38338123929355583
HUNTINGTON DISEASE; HD	0.03076024	0.3807235718552315
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.03076024	0.3807235718552315
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.03076024	0.3807235718552315
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.030567954	0.3783436225200587
SHUKLA-VERNON SYNDROME; SHUVER	0.030540714	0.3780064694257611
TEMPLE-BARAITSER SYNDROME	0.03045544	0.3769510218133113
20Q11.2 MICRODUPLICATION SYNDROME	0.030394924	0.3762020072518387
SIALURIA	0.030376904	0.3759789713208827
DUBOWITZ SYNDROME	0.03036438	0.37582396011115493
HARTNUP DISORDER	0.030137654000000003	0.37301774232636364
INTELLECTUAL DISABILITY, WOLFF TYPE	0.02989154	0.36997155669310533
MENTAL RETARDATION, X-LINKED 21	0.02976955	0.3684616702770494
19P13.3 MICRODUPLICATION SYNDROME	0.029744824	0.36815563329431805
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.02967996	0.3673528029599377
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.02964381	0.3669053696134305
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.029580774000000004	0.36612516467759565
ATYPICAL TERATOID RHABDOID TUMOR	0.02943871	0.3643668197000518
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.02943871	0.3643668197000518
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.029365060000000002	0.3634552438779146
MONOSOMY 18Q	0.029305614	0.3627194728484133
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.029281164000000002	0.3624168519543026
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.02919419	0.36134036321629087
15Q11Q13 MICRODUPLICATION SYNDROME	0.029181284	0.36118062394187805
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.029116954	0.36038440299635077
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.029105564	0.36024342745508614
16P11.2P12.2 MICRODELETION SYNDROME	0.029103614	0.3602192920463534
HYPERCALCEMIA, INFANTILE, 1	0.0288333	0.35687357980215517
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.028799494000000002	0.35645515845465797
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.028737334	0.3556857958870538
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.028737334	0.3556857958870538
ADIPOSIS DOLOROSA	0.028665130000000004	0.3547921173987769
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.028587844	0.35383553832220255
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	0.3536320087523556
DYSOSTEOSCLEROSIS	0.0285714	0.3536320087523556
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	0.3536320087523556
ACHONDROPLASIA	0.0285714	0.3536320087523556
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	0.3536320087523556
SCHEIE SYNDROME	0.0285714	0.3536320087523556
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0285714	0.3536320087523556
HALLERMANN-STREIFF SYNDROME; HSS	0.0285714	0.3536320087523556
MARSHALL-SMITH SYNDROME; MRSHSS	0.0285714	0.3536320087523556
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.028403360000000002	0.3515521553762262
LEIGH SYNDROME; LS	0.028398754	0.3514951463030861
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	0.3505619104987529
DUPLICATION OF THE PITUITARY GLAND	0.028323354000000002	0.3505619104987529
WOLFRAM-LIKE SYNDROME	0.02813016	0.3481707227271035
FRAGILE X MENTAL RETARDATION SYNDROME	0.02811972	0.3480415054618881
1Q41Q42 MICRODELETION SYNDROME	0.02811627	0.34799880435413016
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.02810493	0.3478584476694997
XQ25 MICRODUPLICATION SYNDROME	0.027832814	0.3444904318322059
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.34380951625475775
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	0.34380951625475775
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.34380951625475775
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	0.34380951625475775
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	0.34380951625475775
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	0.34380951625475775
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	0.34380951625475775
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.34380951625475775
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.34380951625475775
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	0.34380951625475775
OROFACIAL CLEFT 3	0.027777800000000002	0.34380951625475775
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.34380951625475775
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	0.34380951625475775
CLEFT CHIN	0.027777800000000002	0.34380951625475775
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.34380951625475775
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.34380951625475775
MENKES DISEASE	0.027777800000000002	0.34380951625475775
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	0.34380951625475775
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	0.34380951625475775
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	0.34380951625475775
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.027777800000000002	0.34380951625475775
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.34380951625475775
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.34380951625475775
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	0.34380951625475775
DIMPLES, FACIAL	0.027777800000000002	0.34380951625475775
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.34380951625475775
DWARFISM, LEVI TYPE	0.027777800000000002	0.34380951625475775
NASAL BONES, ABSENCE OF	0.027777800000000002	0.34380951625475775
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.34380951625475775
ADAMS-OLIVER SYNDROME 2; AOS2	0.027521514	0.34063743042784317
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.02746664	0.3399582476489707
COFFIN-SIRIS SYNDROME 2; CSS2	0.027408604	0.33923992837655315
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.02727275	0.33755844539297364
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.027269684000000002	0.33752049710416615
PROGRESSIVE SUPRANUCLEAR PALSY	0.02717174	0.3363082312206168
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.02717174	0.3363082312206168
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.02711961	0.3356630112938278
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.027098464000000003	0.3354012844461033
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.027081624	0.3351928535317137
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.027051323999999998	0.3348178264114047
OSTEOGENESIS IMPERFECTA, TYPE V	0.027006139999999998	0.334258578048235
SALT-AND-PEPPER SYNDROME	0.026970064000000002	0.3338120606095464
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.02691445	0.3331237187524881
HOLMES-GANG SYNDROME	0.026863334	0.3324910492382401
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.026861354	0.3324665425155268
BAND HETEROTOPIA; BH	0.026659834	0.32997230273715494
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.026583474	0.3290271848854455
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.02658292	0.3290203279539389
PETTIGREW SYNDROME	0.026566984000000002	0.3288230859674952
RICHARDS-RUNDLE SYNDROME; RRNS	0.026561493999999998	0.328755135509063
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.3285014785518481
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.3285014785518481
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.026524254	0.3282942110879308
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.026424510000000002	0.3270596663655512
HURLER SYNDROME	0.026342504000000003	0.326044667222711
ALZHEIMER DISEASE 10	0.0263158	0.3257141482715317
HUNTINGTON DISEASE-LIKE 2	0.0263158	0.3257141482715317
NIPAH VIRUS DISEASE	0.0263158	0.3257141482715317
7Q11.23 DUPLICATION SYNDROME	0.0263158	0.3257141482715317
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0263158	0.3257141482715317
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0263158	0.3257141482715317
WILLIAMS-BEUREN SYNDROME (WBS)	0.0263158	0.3257141482715317
ALZHEIMER DISEASE 3; AD	0.0263158	0.3257141482715317
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.0263158	0.3257141482715317
HYPERLYSINEMIA, TYPE I	0.0263158	0.3257141482715317
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.02618362	0.3240781388734313
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02617284	0.3239447133831035
HEART AND BRAIN MALFORMATION SYNDROME	0.026089454	0.3229126337971601
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.02594221	0.321090175272316
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.025899619999999998	0.3205630331913272
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.02572202	0.3183648544267438
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.025597234	0.31682036154770493
LETTERER-SIWE DISEASE	0.02557931	0.3165985138214865
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.025545554	0.3161807113306235
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.025512194	0.315767810184303
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02546448	0.31517724767544414
COFFIN-SIRIS SYNDROME 5	0.025359424000000002	0.3138769556242501
SARCOSINEMIA	0.025335834	0.3135849790642471
AGEL AMYLOIDOSIS	0.02527774	0.3128659419181339
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.025140554	0.31116797259382
PRIMARY HYPEROXALURIA TYPE 1	0.02504074	0.30993256147215265
KLEEFSTRA SYNDROME 2; KLEFS2	0.025031504	0.3098182462746882
SCHIZOPHRENIA 19; SCZD19	0.025	0.3094283170866283
ACATALASEMIA	0.025	0.3094283170866283
MYOPATHY AND DIABETES MELLITUS	0.025	0.3094283170866283
SCHIZOPHRENIA 4	0.025	0.3094283170866283
SCHIZOPHRENIA 15; SCZD15	0.025	0.3094283170866283
MADRAS MOTOR NEURON DISEASE	0.025	0.3094283170866283
HYPERPROLINEMIA TYPE 1	0.025	0.3094283170866283
CYSTINOSIS, NEPHROPATHIC; CTNS	0.024953649999999997	0.30885463698674964
CYSTINOSIS	0.024953649999999997	0.30885463698674964
NEPHROPATHIC INFANTILE CYSTINOSIS	0.024953649999999997	0.30885463698674964
TOXIC EPIDERMAL NECROLYSIS	0.024953649999999997	0.30885463698674964
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.02488188	0.3079663301740574
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.02488188	0.3079663301740574
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.024800864000000002	0.3069635843925738
TRISOMY 18P	0.02469528	0.3056567572153228
ALG13-CDG	0.02458615	0.3043060407255762
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02454545	0.3038022914253592
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02454545	0.3038022914253592
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.024456779999999997	0.3027048110703163
COFFIN-SIRIS SYNDROME 7; CSS7	0.024426503999999998	0.30233008100119174
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.024355704	0.3014537800072024
SULFOCYSTEINURIA	0.024355054	0.3014457348709582
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.024355054	0.3014457348709582
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.024355054	0.3014457348709582
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.024355054	0.3014457348709582
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.024255310000000002	0.30021119014857867
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.024255310000000002	0.30021119014857867
OCULOSKELETODENTAL SYNDROME; OCSKD	0.024118794	0.2985215135031627
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.024107484000000002	0.2983815281325128
RECOMBINANT 8 SYNDROME	0.024050324	0.29767405122832585
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.02397014	0.2966816032212349
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.02386231	0.2953469770039769
ENCEPHALITIS LETHARGICA	0.02384003	0.2950712144877893
DISTAL 16P11.2 MICRODELETION SYNDROME	0.023832544	0.2949785592725208
HYPOTONIA-CYSTINURIA SYNDROME	0.023824934	0.29488436929279965
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.0238095	0.29469334062696306
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.0238095	0.29469334062696306
CLUSTER HEADACHE, FAMILIAL	0.0238095	0.29469334062696306
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0238095	0.29469334062696306
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0238095	0.29469334062696306
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.02377625	0.2942818009652378
6Q TERMINAL DELETION SYNDROME	0.023750054	0.2939575695974618
RUBINSTEIN-TAYBI SYNDROME	0.023745314000000003	0.2938989019885422
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.023712344000000003	0.29349082792396836
RECOMBINANT CHROMOSOME 8 SYNDROME	0.023646964	0.2926816109891233
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.023553934000000002	0.29153016633558065
COFFIN-LOWRY SYNDROME; CLS	0.02353357	0.2912781184056145
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.023476593999999996	0.29057291889384135
MENTAL RETARDATION, X-LINKED 91; MRX91	0.023473464	0.2905341784685421
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.023452164	0.2902705455423844
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0234458	0.29019177746998676
OCCIPITAL HORN SYNDROME	0.023428034	0.28997188533073237
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.02341424	0.2898011551624966
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.02333679	0.28884254623616223
CORNELIA DE LANGE SYNDROME 3	0.023309974000000004	0.2885106410461225
TEMPLE SYNDROME	0.02327938	0.2881319750488045
NEPHROGENIC DIABETES INSIPIDUS	0.023122953999999998	0.2861958696916608
NOONAN SYNDROME	0.02302633	0.2849999416232537
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0230025	0.2847049945514067
CHROMOSOME 2Q37 DELETION SYNDROME	0.022902963999999998	0.2834730242726253
CLEIDOCRANIAL DYSPLASIA	0.02288248	0.2832194910867372
HYPOCHONDROPLASIA	0.02288248	0.2832194910867372
MENTAL RETARDATION, X-LINKED 104; MRX104	0.022828794	0.28255501234149266
2Q31.1 MICRODELETION SYNDROME	0.022794964	0.2821362939428111
TAY-SACHS DISEASE; TSD	0.0227273	0.28129880763691706
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0227273	0.28129880763691706
CAUDAL REGRESSION SEQUENCE	0.0227273	0.28129880763691706
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0227273	0.28129880763691706
GAUCHER DISEASE, PERINATAL LETHAL	0.0227273	0.28129880763691706
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.0227273	0.28129880763691706
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.022676694	0.2806724504603376
MEGAEPIPHYSEAL DWARFISM	0.02255794	0.2792026164456454
NEPHROSIALIDOSIS	0.02255794	0.2792026164456454
DISTAL MONOSOMY 15Q	0.022427854	0.27759252476338414
COFFIN-SIRIS SYNDROME	0.022300544	0.2760167920014522
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.02224623	0.2753445404168825
FONTAINE PROGEROID SYNDROME; FPS	0.02220887	0.27488213073982826
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.022138034	0.27400538416906234
HENNEKAM-BEEMER SYNDROME	0.02211882	0.2737675699416822
ACRODERMATITIS ENTEROPATHICA	0.02208935	0.2734028158415005
TRISOMY 20P	0.02208885	0.2733966272751588
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.021988340000000002	0.2721526016691437
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.021988340000000002	0.2721526016691437
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.021988340000000002	0.2721526016691437
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.021965954	0.2718755271768916
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.021850403999999997	0.27044534949531723
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.021833164000000002	0.27023196772785435
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.021822154	0.27009569549700935
RIDDLE SYNDROME	0.021779494	0.2695676870167327
WILSON-TURNER SYNDROME	0.021779494	0.2695676870167327
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.021779494	0.2695676870167327
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.021779494	0.2695676870167327
PORPHYRIA	0.02173918	0.26906871528973153
QAZI-MARKOUIZOS SYNDROME	0.02169311	0.2684985007870043
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.02159248	0.2672529899250672
INFANT BOTULISM	0.021532080000000002	0.2665054111109859
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.02141875	0.2651027106639688
TRISOMY 17P	0.021411054	0.2650074562508368
VASCULAR EHLERS-DANLOS SYNDROME	0.021378854	0.2646089125784293
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.021378854	0.2646089125784293
CHROMOSOME 16Q22 DELETION SYNDROME	0.021378854	0.2646089125784293
KAGAMI-OGATA SYNDROME	0.021378854	0.2646089125784293
EARLY MYOCLONIC ENCEPHALOPATHY	0.021378854	0.2646089125784293
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.021378854	0.2646089125784293
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.021378854	0.2646089125784293
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.021378854	0.2646089125784293
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.021378854	0.2646089125784293
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.021341464	0.2641461315873945
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.0212766	0.2633433012530142
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.0212766	0.2633433012530142
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.0212766	0.2633433012530142
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0212766	0.2633433012530142
HUNTINGTON DISEASE-LIKE 3	0.0212766	0.2633433012530142
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.021243074	0.26292834550266836
XQ25 DUPLICATION SYNDROME	0.021121404	0.26142241976907116
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.021118994	0.261392590879304
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.020953753999999998	0.2593473934746882
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.020953753999999998	0.2593473934746882
ENDOCARDIAL FIBROELASTOSIS	0.02093144	0.2590712101359894
FABRY DISEASE	0.02090412	0.2587330668710771
CRANDALL SYNDROME	0.0208333	0.2578565183344341
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.2578565183344341
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.2578565183344341
DERMOIDS OF CORNEA	0.0208333	0.2578565183344341
PUPIL, EGG-SHAPED	0.0208333	0.2578565183344341
POLYARTERITIS NODOSA	0.0208333	0.2578565183344341
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.2578565183344341
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.2578565183344341
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.2578565183344341
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.2578565183344341
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.2578565183344341
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0208333	0.2578565183344341
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.2578565183344341
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.2578565183344341
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.2578565183344341
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.0208333	0.2578565183344341
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.0208333	0.2578565183344341
STICKLER SYNDROME, TYPE III	0.0208333	0.2578565183344341
IMINOGLYCINURIA	0.0208333	0.2578565183344341
UNIQUE GREEN PHENOMENON	0.0208333	0.2578565183344341
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	0.2578565183344341
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.2578565183344341
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0208333	0.2578565183344341
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.2578565183344341
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0208333	0.2578565183344341
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.2578565183344341
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.2578565183344341
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0208333	0.2578565183344341
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.0208333	0.2578565183344341
RIBOFLAVIN DEFICIENCY	0.0208333	0.2578565183344341
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.2578565183344341
GAUCHER DISEASE, TYPE I	0.0208333	0.2578565183344341
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0208333	0.2578565183344341
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.2578565183344341
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.2578565183344341
GLAUCOMA - SLEEP APNEA	0.0208333	0.2578565183344341
TRANSALDOLASE DEFICIENCY	0.0208333	0.2578565183344341
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.2578565183344341
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0208333	0.2578565183344341
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.0208333	0.2578565183344341
APNEA, CENTRAL SLEEP	0.0208333	0.2578565183344341
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.2578565183344341
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.2578565183344341
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.2578565183344341
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.0208333	0.2578565183344341
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.2578565183344341
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.2578565183344341
CROUZON SYNDROME	0.0208333	0.2578565183344341
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.0208333	0.2578565183344341
OSTEOPETROSIS AND RELATED DISORDERS	0.0208333	0.2578565183344341
CLEFT LIP/PALATE	0.0208333	0.2578565183344341
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.0208333	0.2578565183344341
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0208333	0.2578565183344341
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0208333	0.2578565183344341
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.2578565183344341
GLYCINE ENCEPHALOPATHY	0.0208333	0.2578565183344341
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.2578565183344341
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.0208333	0.2578565183344341
DISTAL MONOSOMY 6P	0.020802894	0.25748017923806066
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.02077497	0.2571345601850076
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.020545554	0.25429504791329777
NEPHRONOPHTHISIS 1	0.020408199999999998	0.25259499923069306
APPARENT MINERALOCORTICOID EXCESS	0.020408199999999998	0.25259499923069306
NEPHRONOPHTHISIS 4	0.020408199999999998	0.25259499923069306
SENIOR-LOKEN SYNDROME 3	0.020408199999999998	0.25259499923069306
SENIOR-LOKEN SYNDROME 4; SLSN4	0.020408199999999998	0.25259499923069306
OCHOA SYNDROME	0.020408199999999998	0.25259499923069306
SENIOR-LOKEN SYNDROME 1	0.020408199999999998	0.25259499923069306
HELIX SYNDROME; HELIX	0.020408199999999998	0.25259499923069306
ERDHEIM-CHESTER DISEASE	0.020408199999999998	0.25259499923069306
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.020408199999999998	0.25259499923069306
TERATOMA, PINEAL	0.020408199999999998	0.25259499923069306
FAMILIAL COLD URTICARIA	0.020408199999999998	0.25259499923069306
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.020408199999999998	0.25259499923069306
FAMILIAL HYPERALDOSTERONISM TYPE III	0.020408199999999998	0.25259499923069306
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.020408199999999998	0.25259499923069306
PANHYPOPHYSITIS	0.020408199999999998	0.25259499923069306
PRIMARY PARATHYROID HYPERPLASIA	0.020408199999999998	0.25259499923069306
PARATHYROID CARCINOMA	0.020408199999999998	0.25259499923069306
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.020408199999999998	0.25259499923069306
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.020408199999999998	0.25259499923069306
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.020258654	0.25074404854641164
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.020258654	0.25074404854641164
MENTAL RETARDATION, X-LINKED 98; MRX98	0.020258654	0.25074404854641164
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.020258654	0.25074404854641164
ISOLATED COMPLEX I DEFICIENCY	0.020258654	0.25074404854641164
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.020258654	0.25074404854641164
COFFIN-SIRIS SYNDROME 6; CSS6	0.020208933999999998	0.25012865750938973
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.020198494	0.24999944024417436
GORLIN-CHAUDHRY-MOSS SYNDROME	0.02012011	0.24902927107591363
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.020060014	0.24828545491016812
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.020039670000000002	0.24803365452285572
SCARF SYNDROME	0.020039670000000002	0.24803365452285572
STRIATE PALMOPLANTAR KERATODERMA	0.02	0.24754265366930261
DARIER DISEASE	0.02	0.24754265366930261
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.02	0.24754265366930261
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	0.24754265366930261
WERNER SYNDROME; WRN	0.02	0.24754265366930261
GYRATE ATROPHY OF CHOROID AND RETINA	0.02	0.24754265366930261
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.02	0.24754265366930261
CATATRICHY	0.02	0.24754265366930261
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.02	0.24754265366930261
HAIR WHORL	0.02	0.24754265366930261
MIDPHALANGEAL HAIR	0.02	0.24754265366930261
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.02	0.24754265366930261
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02	0.24754265366930261
HAIRY NOSE TIP	0.02	0.24754265366930261
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02	0.24754265366930261
INHERITED EPIDERMOLYSIS BULLOSA	0.02	0.24754265366930261
JUVENILE HYALINE FIBROMATOSIS	0.02	0.24754265366930261
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02	0.24754265366930261
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.02	0.24754265366930261
MANITOBA OCULOTRICHOANAL SYNDROME	0.02	0.24754265366930261
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	0.24754265366930261
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	0.24754265366930261
NEVUS COMEDONICUS SYNDROME	0.02	0.24754265366930261
FAMILIAL MELANOMA	0.02	0.24754265366930261
TRICHODENTOOSSEOUS SYNDROME	0.02	0.24754265366930261
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.02	0.24754265366930261
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02	0.24754265366930261
KNOBLOCH SYNDROME	0.02	0.24754265366930261
DISSECTING CELLULITIS OF THE SCALP	0.02	0.24754265366930261
SCALP-EAR-NIPPLE SYNDROME; SENS	0.02	0.24754265366930261
RINGED HAIR	0.02	0.24754265366930261
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02	0.24754265366930261
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	0.24754265366930261
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	0.24754265366930261
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01997806	0.2472710993782274
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.019799544	0.24506158316010596
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.019735463999999998	0.24426845649774945
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.019656654000000003	0.24329301467096565
HADZISELIMOVIC SYNDROME	0.019656654000000003	0.24329301467096565
MEHMO SYNDROME; MEHMO	0.019570594	0.24222783863222663
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.019524734000000002	0.2416602233273629
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.01951446	0.24153306066617297
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019413454	0.24028289600234687
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.019413454	0.24028289600234687
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.01931055	0.2390092395406876
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.01929058	0.2387620682009988
CK SYNDROME	0.019242684000000003	0.2381692530539916
SAGLIKER SYNDROME	0.01923343	0.23805471506813877
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.01923214	0.23803874856697713
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0192308	0.23802216320918126
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.0192308	0.23802216320918126
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.0192308	0.23802216320918126
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.0192308	0.23802216320918126
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.0192308	0.23802216320918126
HYPOTONIA-CYSTINURIA SYNDROME	0.0192308	0.23802216320918126
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.0192308	0.23802216320918126
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.0192308	0.23802216320918126
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.0192308	0.23802216320918126
SECONDARY SHORT BOWEL SYNDROME	0.0192308	0.23802216320918126
ASPARTYLGLUCOSAMINURIA	0.019183310000000002	0.2374343731780435
MUENKE SYNDROME	0.019170314	0.2372735199616892
RIFT VALLEY FEVER	0.01903825	0.23563894631098004
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.01897775	0.2348901297836304
CEREBROTENDINOUS XANTHOMATOSIS	0.01893724	0.23438873213862324
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.23353050175835172
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.23353050175835172
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.23353050175835172
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.23353050175835172
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.23353050175835172
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.23353050175835172
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.23353050175835172
MONOPHALANGY OF GREAT TOE	0.0188679	0.23353050175835172
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.23353050175835172
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0188679	0.23353050175835172
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.23353050175835172
RAYNAUD DISEASE	0.0188679	0.23353050175835172
PUBIC BONE DYSPLASIA	0.0188679	0.23353050175835172
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.23353050175835172
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.23353050175835172
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.23353050175835172
CARPAL DISPLACEMENT	0.0188679	0.23353050175835172
HHHH SYNDROME	0.0188679	0.23353050175835172
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.23353050175835172
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.23353050175835172
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.23353050175835172
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.23353050175835172
TRACHEOBRONCHOMEGALY	0.0188679	0.23353050175835172
VAN DEN BOSCH SYNDROME	0.0188679	0.23353050175835172
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.23353050175835172
THROMBOCYTOPENIA 3	0.0188679	0.23353050175835172
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.23353050175835172
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.23353050175835172
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.23353050175835172
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.23353050175835172
VESICOURETERAL REFLUX 1	0.0188679	0.23353050175835172
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.23353050175835172
TOE, MISSHAPEN	0.0188679	0.23353050175835172
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.23353050175835172
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.23353050175835172
KNUCKLE PADS	0.0188679	0.23353050175835172
SPINAL ARACHNOIDITIS	0.0188679	0.23353050175835172
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.23353050175835172
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.23353050175835172
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.018840454	0.23319079897472136
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.018804809999999998	0.23274962845735192
GAPO SYNDROME; GAPOS	0.01871829	0.2316787589375785
DUBOWITZ SYNDROME	0.01862476	0.23052112571769404
ALPHA-MANNOSIDOSIS	0.018571924	0.22986716753523048
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.018563084	0.22975775368230866
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.018551924	0.22961962488156118
MAPLE SYRUP URINE DISEASE; MSUD	0.01854138	0.22948912039454672
RING CHROMOSOME 7 SYNDROME	0.018518510000000002	0.2292060553700759
WARBURG MICRO SYNDROME 2; WARBM2	0.018518510000000002	0.2292060553700759
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.018515294	0.22916625051136585
MYHRE SYNDROME	0.018408914000000002	0.22784957113649884
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.01840145	0.22775718821814944
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.018368064	0.22734396526637926
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.01817417	0.2249441135018515
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.018089454	0.2238955723294391
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.018089454	0.2238955723294391
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.018089454	0.2238955723294391
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.018089454	0.2238955723294391
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.018089454	0.2238955723294391
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.018089454	0.2238955723294391
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.018089454	0.2238955723294391
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.018089454	0.2238955723294391
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.018089454	0.2238955723294391
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.018089454	0.2238955723294391
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.018089454	0.2238955723294391
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.018042314	0.22331211429474052
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.018038044000000003	0.22325926393818216
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.017957924	0.22226760806758286
MALAN OVERGROWTH SYNDROME	0.01790326	0.22159102448657395
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.017877484	0.22127199151452492
HALL-RIGGS SYNDROME	0.01785995	0.22105497087005305
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.01777454	0.2199978399675583
LISSENCEPHALY 5; LIS5	0.017716709999999997	0.2192820703844735
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.017716709999999997	0.2192820703844735
BETA-THALASSEMIA MAJOR	0.01771259	0.21923107659781765
CRANIOFRONTONASAL SYNDROME; CFNS	0.017696144	0.2190275222737054
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.017566263999999998	0.2174199802807769
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.017566263999999998	0.2174199802807769
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.017566263999999998	0.2174199802807769
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.0175439	0.21714317808544395
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0175439	0.21714317808544395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0175439	0.21714317808544395
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.0175439	0.21714317808544395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0175439	0.21714317808544395
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.0175439	0.21714317808544395
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.0175439	0.21714317808544395
ADRENOLEUKODYSTROPHY	0.017512680000000003	0.21675676400306618
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.01749249	0.21650686969418698
MYOCLONIC EPILEPSY OF INFANCY	0.017460784	0.21611444032532506
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.017460784	0.21611444032532506
CENTRAL CONGENITAL HYPOTHYROIDISM	0.01739359	0.2152827712717923
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.017370550000000002	0.21499760213476524
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.017333094	0.21453400425297336
PITT-HOPKINS SYNDROME	0.01728192	0.2139006168650297
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.017279324	0.21386848582858345
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.2133990954486957
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.2133990954486957
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.2133990954486957
CARDIAC ARRHYTHMIA	0.0172414	0.2133990954486957
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.2133990954486957
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.2133990954486957
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.2133990954486957
CERVICAL RIB	0.0172414	0.2133990954486957
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.2133990954486957
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.2133990954486957
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.2133990954486957
MYOPATHY, CONGENITAL	0.0172414	0.2133990954486957
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.2133990954486957
MOTION SICKNESS	0.0172414	0.2133990954486957
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.2133990954486957
PALMOMENTAL REFLEX	0.0172414	0.2133990954486957
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.2133990954486957
SICKLE CELL ANEMIA	0.0172414	0.2133990954486957
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.2133990954486957
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.2133990954486957
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.2133990954486957
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.2133990954486957
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.2133990954486957
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.2133990954486957
RHEUMATOID ARTHRITIS	0.0172414	0.2133990954486957
JUMPING FRENCHMAN OF MAINE	0.0172414	0.2133990954486957
269800 SENILE PLAQUE FORMATION	0.0172414	0.2133990954486957
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.2133990954486957
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.2133990954486957
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.2133990954486957
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.2133990954486957
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.2133990954486957
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.2133990954486957
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.2133990954486957
TRANSSEXUALITY	0.0172414	0.2133990954486957
ERYTHERMALGIA, PRIMARY	0.0172414	0.2133990954486957
MOSAIC TRISOMY 15	0.0172414	0.2133990954486957
DIASTEMATOMYELIA	0.0172414	0.2133990954486957
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.2133990954486957
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.2133990954486957
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.2133990954486957
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.2133990954486957
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.017207554	0.21298017901589117
CRANIOFRONTONASAL DYSPLASIA	0.01715059	0.21227512802971024
HEART-HAND SYNDROME TYPE 2	0.01715059	0.21227512802971024
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.017102	0.21167372315262067
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.01708913	0.21151442945498447
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.01708913	0.21151442945498447
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.017078864	0.21138736581085604
CARDIOFACIOCUTANEOUS SYNDROME	0.017056274000000003	0.2111077663835366
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.017056104	0.21110566227098035
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.01703874	0.2108907457390647
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.017027694	0.21075402793144313
WIEACKER-WOLFF SYNDROME	0.017000453999999998	0.2104168748371455
BILATERAL POLYMICROGYRIA	0.017000453999999998	0.2104168748371455
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.016974310000000003	0.21009328708026906
HYPOPHOSPHATASIA	0.01693283	0.20957988361655888
SOTOS SYNDROME	0.016899634	0.20916901231999857
GABRIELE-DE VRIES SYNDROME; GADEVS	0.016887594	0.20901999164248966
CHROMOSOME 19P13.13 DELETION SYNDROME	0.016799254	0.20792659574123235
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.016714094	0.20687255912190844
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.0167077	0.20679341973553036
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.01669385	0.2066219964478644
ACROOSTEOLYSIS DOMINANT TYPE	0.01669385	0.2066219964478644
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.01666666	0.20628546221020094
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.016642334	0.20598437608054299
ADIPOSIS DOLOROSA	0.016616930000000002	0.20566994740185227
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.016585854	0.20528531562658087
NIJMEGEN BREAKAGE SYNDROME	0.01657558	0.20515815296539094
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.016553654	0.20488677195417332
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.01651055	0.2043532680269852
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.016492640000000003	0.20413159358062438
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.0164549	0.2036644805931504
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0164549	0.2036644805931504
GENITOPATELLAR SYNDROME; GTPTS	0.016437603999999998	0.20345040570625716
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.016410413999999998	0.20311387146859372
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.016376670000000003	0.20269621750332295
AMISH LETHAL MICROCEPHALY	0.01628802	0.20159898469093376
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0162537	0.2011742014972372
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.016128999999999998	0.1996307730516091
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.01612699	0.19960589501491535
SILVER-RUSSELL SYNDROME	0.01612699	0.19960589501491535
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.01612699	0.19960589501491535
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.01609678	0.1992319818365479
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.01585044	0.19618299897130306
LEPRECHAUNISM	0.01573862	0.19479898799463796
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.015727404	0.19466016607446027
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.01572366	0.19461382608969335
COHEN SYNDROME	0.015705234000000002	0.19438576504286784
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.015686343999999998	0.19415196100647714
MONOSOMY 9P	0.015646964	0.1936645495214023
45,X/46,XY MIXED GONADAL DYSGENESIS	0.01563998	0.193578107626741
ACROMICRIC DYSPLASIA	0.015604739999999999	0.19314193747097566
MENTAL RETARDATION, X-LINKED 9	0.015587804	0.19293231835184851
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.01554339	0.1923826003808451
FRIED SYNDROME	0.015529873999999999	0.19221531105549536
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.01551929	0.19208431148317356
CHIME SYNDROME	0.01544561	0.19117236434705587
TRISOMY X	0.015380584	0.19036752891718084
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.015346694000000001	0.18994806789053825
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.015299293999999998	0.18936139180134196
TENORIO SYNDROME; TNORS	0.015235409999999998	0.18857069105699145
2P15P16.1 MICRODELETION SYNDROME	0.015221484	0.18839832710724158
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.015190224	0.18801141793955645
X SMALL RINGS	0.015176894	0.18784643076088586
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.015159680000000002	0.1876333707988727
DYSTONIA 28, CHILDHOOD-ONSET	0.015110123999999999	0.1870200096116109
BRANCHIOOCULOFACIAL SYNDROME	0.01510141	0.18691215527740715
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.014903434	0.1844617800572655
PROPIONIC ACIDEMIA	0.014903434	0.1844617800572655
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.014903434	0.1844617800572655
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.014903434	0.1844617800572655
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.014903434	0.1844617800572655
NIEMANN-PICK DISEASE, TYPE A	0.014903434	0.1844617800572655
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.014890644	0.18430347653024395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.014831254	0.18356839862017296
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.014831254	0.18356839862017296
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.014831254	0.18356839862017296
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.014831254	0.18356839862017296
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.014831254	0.18356839862017296
PROLIDASE DEFICIENCY	0.01480114	0.1831956736465431
LANDAU-KLEFFNER SYNDROME	0.014781964000000002	0.18295832975020498
19P13.12 MICRODELETION SYNDROME	0.014630054	0.18107811952425978
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.014630054	0.18107811952425978
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.014630054	0.18107811952425978
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.014564569999999999	0.18026761536761574
GLYCEROL KINASE DEFICIENCY; GKD	0.014544894	0.18002408290493588
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.014544894	0.18002408290493588
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.014544894	0.18002408290493588
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.01451115	0.17960642893966505
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.014504474	0.17952379920187023
GOLDBERG-SHPRINTZEN SYNDROME	0.014504474	0.17952379920187023
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.014504474	0.17952379920187023
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.014503344000000001	0.17950981304193792
BENIGN FAMILIAL INFANTILE EPILEPSY	0.0144928	0.17937930855492346
LEGIONELLOSIS	0.0144928	0.17937930855492346
KETAMINE-INDUCED BILIARY DILATATION	0.0144928	0.17937930855492346
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.0144928	0.17937930855492346
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.0144928	0.17937930855492346
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.014484130000000001	0.17927199881455783
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.014484130000000001	0.17927199881455783
KAPUR-TORIELLO SYNDROME	0.014484130000000001	0.17927199881455783
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.014484130000000001	0.17927199881455783
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.01445003	0.17884993859005166
LEGIUS SYNDROME	0.014393050000000001	0.1781446895697478
AUTISM, SUSCEPTIBILITY TO, 18	0.01428863	0.1768522693749404
ORAL SENSIBILITY, DISTURBANCE OF	0.0142857	0.1768160043761778
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0142857	0.1768160043761778
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0142857	0.1768160043761778
SUPRABULBAR PARESIS, CONGENITAL	0.0142857	0.1768160043761778
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.0142857	0.1768160043761778
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0142857	0.1768160043761778
TEMTAMY SYNDROME	0.014128304	0.17486789320033114
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.01411882	0.17475050847396117
2Q24 MICRODELETION SYNDROME	0.01411882	0.17475050847396117
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.014097759999999999	0.17448984605964737
MICROPHTHALMIA, LENZ TYPE	0.0140845	0.17432572528026463
KERATODERMA HEREDITARIUM MUTILANS	0.0140845	0.17432572528026463
HARLEQUIN ICHTHYOSIS	0.0140845	0.17432572528026463
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.0140845	0.17432572528026463
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.0140845	0.17432572528026463
17Q12 MICRODUPLICATION SYNDROME	0.0140845	0.17432572528026463
LESCH-NYHAN SYNDROME; LNS	0.0140845	0.17432572528026463
FRANK-TER HAAR SYNDROME	0.01398611	0.1731079391955385
CRANIOFACIOFRONTODIGITAL SYNDROME	0.01398611	0.1731079391955385
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.01395892	0.17277140495787507
SOTOS SYNDROME 2	0.013935119999999999	0.1724768292000086
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.013916000000000001	0.17224017842310077
ALAZAMI SYNDROME; ALAZS	0.013875024	0.1717330130342631
BOHRING-OPITZ SYNDROME	0.013825854	0.17112442942021713
BOHRING-OPITZ SYNDROME	0.013825854	0.17112442942021713
15Q14 MICRODELETION SYNDROME	0.013760643999999999	0.17031731659792834
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.013705834	0.16963892595554764
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.013688254	0.16942133596297232
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.013603144000000001	0.16836791820028263
MACS SYNDROME	0.01358275	0.168115498956336
CARPENTER-WAZIRI SYNDROME	0.01358275	0.168115498956336
FOUNTAIN SYNDROME	0.01358275	0.168115498956336
TRISOMY 13	0.013580249999999999	0.16808455612462733
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.013555560000000001	0.16777896471867262
ACROMICRIC DYSPLASIA	0.013555560000000001	0.16777896471867262
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.01355446	0.1677653498727208
HERMANSKY-PUDLAK SYNDROME	0.01355446	0.1677653498727208
X-LINKED RECESSIVE OCULAR ALBINISM	0.01355446	0.1677653498727208
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.01355446	0.1677653498727208
RETINAL CONE DYSTROPHY 3B	0.01355446	0.1677653498727208
OCULOCUTANEOUS ALBINISM	0.01355446	0.1677653498727208
OCULAR ALBINISM	0.01355446	0.1677653498727208
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.01355446	0.1677653498727208
CONE-ROD DYSTROPHY, X-LINKED, 3	0.01355446	0.1677653498727208
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.013508524000000001	0.16719679390577313
PERIPHERAL HYPOTHYROIDISM	0.013494704	0.16702574193208763
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.013494704	0.16702574193208763
PRIMARY CONGENITAL HYPOTHYROIDISM	0.013494704	0.16702574193208763
PERMANENT CONGENITAL HYPOTHYROIDISM	0.013494704	0.16702574193208763
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.013494704	0.16702574193208763
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.013429804	0.16622246602093074
EPIDERMAL NEVUS SYNDROME	0.013244604	0.16393022104795302
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.013244604	0.16393022104795302
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.013215089999999999	0.16356492235393322
CONO-SPONDYLAR DYSPLASIA	0.01314663	0.1627175838504232
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.013143364000000001	0.16267716013507902
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.013143364000000001	0.16267716013507902
MOEBIUS SYNDROME	0.013140009999999999	0.16263564723205864
STICKLER SYNDROME	0.01305759	0.16161552395628748
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.013052284	0.16154985089026902
10Q22.3Q23.3 MICRODELETION SYNDROME	0.013052284	0.16154985089026902
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.013052284	0.16154985089026902
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.013024053999999998	0.16120044443461476
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.013024053999999998	0.16120044443461476
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.013024053999999998	0.16120044443461476
GAUCHER DISEASE, TYPE II	0.013024053999999998	0.16120044443461476
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.013024053999999998	0.16120044443461476
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.013024053999999998	0.16120044443461476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.013024053999999998	0.16120044443461476
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.013007694	0.1609979545439133
JOUBERT SYNDROME 10	0.012997494000000002	0.16087170779054197
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.012990159999999999	0.1607809338994414
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.01294915	0.1602733476880925
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.012904033999999998	0.15971494096994526
HYPOPHOSPHATASIA, INFANTILE	0.01288425	0.15947007177693562
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.01282051	0.15868115333969154
CAFFEY DISEASE	0.01282051	0.15868115333969154
MENKES DISEASE	0.01282051	0.15868115333969154
SCLERODERMA	0.01282051	0.15868115333969154
FAMILIAL DYSAUTONOMIA	0.01282051	0.15868115333969154
2Q33.1 DELETION SYNDROME	0.01282051	0.15868115333969154
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.012812524	0.1585823095580814
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.012812524	0.1585823095580814
CORNEODERMATOOSSEOUS SYNDROME	0.01276747	0.15802467022216055
MARFAN SYNDROME	0.012710860000000001	0.1573240007409496
NOONAN SYNDROME 5; NS5	0.012638954	0.15643401063821236
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.012638954	0.15643401063821236
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.012593754000000002	0.15587456424091975
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.012593754000000002	0.15587456424091975
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.012593754000000002	0.15587456424091975
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.012570650000000001	0.15558860296740096
SIFRIM-HITZ-WEISS SYNDROME	0.01254258	0.15524117685297606
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.012531274	0.15510124099085684
RECESSIVE X-LINKED ICHTHYOSIS	0.01250673	0.15479745664627387
CYCLIC VOMITING SYNDROME	0.01250673	0.15479745664627387
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.01250673	0.15479745664627387
TUBEROUS SCLEROSIS 2; TSC2	0.01250673	0.15479745664627387
TUBEROUS SCLEROSIS-1	0.01250673	0.15479745664627387
HURLER SYNDROME	0.012482484	0.15449736068723058
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.012482484	0.15449736068723058
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.012482484	0.15449736068723058
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.012478499999999998	0.15444805019061963
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.01246214	0.15424556029991815
SCARF SYNDROME	0.01246214	0.15424556029991815
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.01246214	0.15424556029991815
MILROY DISEASE	0.012461970000000001	0.154243456187362
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.012451940000000002	0.15411931354654682
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.012451940000000002	0.15411931354654682
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.012380203999999999	0.15323142755636573
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.01229416	0.15216644955174968
MOEBIUS SYNDROME; MBS	0.0122706	0.15187484430572723
20Q13.33 MICRODELETION SYNDROME	0.01226697	0.15182991531408627
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.012235594	0.15144157039900988
FLOATING-HARBOR SYNDROME	0.012198874000000002	0.15098708208687303
3P25.3 MICRODELETION SYNDROME	0.01217589	0.15070260606927624
STURGE-WEBER SYNDROME	0.01217589	0.15070260606927624
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.01214675	0.15034193642288007
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.0120934	0.14968161639421723
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0120934	0.14968161639421723
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.0120934	0.14968161639421723
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.012079124	0.14950492044802807
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.01204918	0.14913429958695437
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.012048200000000002	0.14912216999692463
MIXED CONNECTIVE TISSUE DISEASE	0.012048200000000002	0.14912216999692463
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.012048200000000002	0.14912216999692463
PORPHYRIA VARIEGATA	0.012048200000000002	0.14912216999692463
SHEEHAN SYNDROME	0.012048200000000002	0.14912216999692463
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.012048200000000002	0.14912216999692463
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.012048200000000002	0.14912216999692463
CLASSIC HOMOCYSTINURIA	0.012048200000000002	0.14912216999692463
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.012048200000000002	0.14912216999692463
WERNICKE-KORSAKOFF SYNDROME	0.012048200000000002	0.14912216999692463
DEMENTIA, FAMILIAL DANISH	0.012048200000000002	0.14912216999692463
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.011960354000000001	0.14803488839921294
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.011960354000000001	0.14803488839921294
KID SYNDROME	0.01195286	0.147942134166883
ATKIN-FLAITZ SYNDROME	0.01193693	0.14774496644323543
SCHEIE SYNDROME	0.01193693	0.14774496644323543
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.01193693	0.14774496644323543
VICI SYNDROME	0.011840514	0.14655161281842644
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.011840514	0.14655161281842644
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.011840514	0.14655161281842644
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.01178159	0.14582230265218596
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.01178159	0.14582230265218596
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.0117284	0.14516396296475245
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.011690820000000001	0.14469883031850783
ALAZAMI-YUAN SYNDROME	0.011656654	0.14427595320324457
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.011656654	0.14427595320324457
MACDERMOT-WINTER SYNDROME	0.011656654	0.14427595320324457
TREACHER-COLLINS SYNDROME	0.011656654	0.14427595320324457
CRANIOSYNOSTOSIS 6; CRS6	0.011656654	0.14427595320324457
LIG4 SYNDROME	0.011656654	0.14427595320324457
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.011656654	0.14427595320324457
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.011656654	0.14427595320324457
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.011656654	0.14427595320324457
HYPERTELORISM, TEEBI TYPE; TBHS	0.01163752	0.14403912914647915
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.011603744	0.1436210791129624
BARDET-BIEDL SYNDROME 1; BBS1	0.011603744	0.1436210791129624
SIALIDOSIS TYPE 1	0.01153357	0.14275252620403295
ASPARTYLGLUCOSAMINURIA; AGU	0.01153357	0.14275252620403295
ZIMMERMANN-LABAND SYNDROME 1	0.01153357	0.14275252620403295
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.01153357	0.14275252620403295
MOSAIC TRISOMY 1	0.01153357	0.14275252620403295
FOUNTAIN SYNDROME	0.01153357	0.14275252620403295
MUCOPOLYSACCHARIDOSIS TYPE 6	0.01153357	0.14275252620403295
DUANE RETRACTION SYNDROME	0.011523304	0.1426254625599045
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.011486684	0.142172211961036
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.011486534	0.14217035539113346
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.011481974	0.14211391566609688
WIEDEMANN-STEINER SYNDROME; WDSTS	0.011457734	0.14181389396984967
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.01145599	0.1417923082504497
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.01145599	0.1417923082504497
BOWEN-CONRADI SYNDROME	0.01145599	0.1417923082504497
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.011450749999999999	0.14172745207518836
20Q11.2 MICRODELETION SYNDROME	0.011366664	0.1406867084963665
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.011305544	0.1399302181467531
AICARDI-GOUTIERES SYNDROME 5	0.011305544	0.1399302181467531
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.011305544	0.1399302181467531
FOLATE MALABSORPTION, HEREDITARY	0.011305544	0.1399302181467531
ARGININOSUCCINIC ACIDURIA	0.011305544	0.1399302181467531
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.011305544	0.1399302181467531
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.011263844	0.13941409171385263
ALSTROM SYNDROME; ALMS	0.011263844	0.13941409171385263
BEHÇET DISEASE	0.01125686	0.1393276498191913
JUVENILE HUNTINGTON DISEASE	0.01115585	0.13807743564683447
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.01113831	0.13786034073956652
EAR-PATELLA-SHORT STATURE SYNDROME	0.011118114	0.13761037216789124
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.0111111	0.13752355895924942
TRISOMY 4P	0.0111111	0.13752355895924942
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0111111	0.13752355895924942
CHROMOSOME 18Q DELETION SYNDROME	0.0111111	0.13752355895924942
TEEBI-SHALTOUT SYNDROME; TBSH	0.0111111	0.13752355895924942
WARBURG MICRO SYNDROME 3; WARBM3	0.0111111	0.13752355895924942
UNILATERAL POLYMICROGYRIA	0.01109745	0.1373546110981201
ADENYLOSUCCINATE LYASE DEFICIENCY	0.01109745	0.1373546110981201
GOLDENHAR SYNDROME	0.01109083	0.13727267447975558
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.011058189999999999	0.13686868486896725
LOWRY-WOOD SYNDROME	0.011058189999999999	0.13686868486896725
LAMB-SHAFFER SYNDROME	0.011027224	0.1364854145782911
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.010998094	0.13612486870322177
PELVISCAPULAR DYSPLASIA	0.01097775	0.13587306831590934
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.01097775	0.13587306831590934
EMERY-NELSON SYNDROME	0.01097775	0.13587306831590934
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.01097775	0.13587306831590934
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.010947004	0.13549252099442352
LOCKED-IN SYNDROME	0.01094113	0.13541981771704087
FRYNS SYNDROME	0.01094098	0.13541796114713833
MUCOLIPIDOSIS TYPE II	0.01094098	0.13541796114713833
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.010854853999999999	0.1343519682176422
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.010854853999999999	0.1343519682176422
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.010854853999999999	0.1343519682176422
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.010854853999999999	0.1343519682176422
VICI SYNDROME; VICIS	0.010854853999999999	0.1343519682176422
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.010854853999999999	0.1343519682176422
CREE MENTAL RETARDATION SYNDROME	0.010854853999999999	0.1343519682176422
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.010854853999999999	0.1343519682176422
HYDROXYKYNURENINURIA	0.010854853999999999	0.1343519682176422
WARSAW BREAKAGE SYNDROME; WABS	0.010854853999999999	0.1343519682176422
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.010854853999999999	0.1343519682176422
GABA-TRANSAMINASE DEFICIENCY	0.010854853999999999	0.1343519682176422
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.010854853999999999	0.1343519682176422
MARINESCO-SJOGREN SYNDROME; MSS	0.010854853999999999	0.1343519682176422
ARIMA SYNDROME	0.010854853999999999	0.1343519682176422
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.010854853999999999	0.1343519682176422
HYDROCEPHALUS, NORMAL-PRESSURE	0.010854853999999999	0.1343519682176422
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.010854853999999999	0.1343519682176422
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.010854853999999999	0.1343519682176422
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.010854853999999999	0.1343519682176422
ROSSELLI-GULIENETTI SYNDROME	0.010854853999999999	0.1343519682176422
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.010854853999999999	0.1343519682176422
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.010854853999999999	0.1343519682176422
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.010854853999999999	0.1343519682176422
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.010854853999999999	0.1343519682176422
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.010854853999999999	0.1343519682176422
C SYNDROME	0.010854853999999999	0.1343519682176422
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.010854853999999999	0.1343519682176422
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.010854853999999999	0.1343519682176422
ADAMS-OLIVER SYNDROME 3; AOS3	0.010854853999999999	0.1343519682176422
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.010854853999999999	0.1343519682176422
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.010854853999999999	0.1343519682176422
CHROMOSOME 4Q21 DELETION SYNDROME	0.010854853999999999	0.1343519682176422
SEPTOOPTIC DYSPLASIA	0.010854853999999999	0.1343519682176422
PYRUVATE CARBOXYLASE DEFICIENCY	0.010854853999999999	0.1343519682176422
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.010854853999999999	0.1343519682176422
HARTSFIELD SYNDROME; HRTFDS	0.010854853999999999	0.1343519682176422
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.010854853999999999	0.1343519682176422
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.010854853999999999	0.1343519682176422
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.010854853999999999	0.1343519682176422
MEVALONIC ACIDURIA; MEVA	0.010854853999999999	0.1343519682176422
REVESZ SYNDROME	0.010854853999999999	0.1343519682176422
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.010854853999999999	0.1343519682176422
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.010854853999999999	0.1343519682176422
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.010854853999999999	0.1343519682176422
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.010840454	0.1341737375070003
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01077995	0.13342487147111995
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.01077995	0.13342487147111995
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01077995	0.13342487147111995
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.01077995	0.13342487147111995
KABUKI SYNDROME 1	0.010766974	0.13326426579741932
XERODERMA PIGMENTOSUM	0.01071829	0.13266169746985748
ELSAHY-WATERS SYNDROME; ESWS	0.010594734	0.13113242846401926
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.010594734	0.13113242846401926
LEUKOCYTE ADHESION DEFICIENCY	0.01057582	0.1308983273764442
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.01057256	0.1308579779238961
MEIER-GORLIN SYNDROME 6; MGORS6	0.01057256	0.1308579779238961
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.01057256	0.1308579779238961
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.01045254	0.12937247445922662
CHITAYAT SYNDROME	0.01045254	0.12937247445922662
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.010408434	0.1288265686450897
JABERI-ELAHI SYNDROME; JABELS	0.010408434	0.1288265686450897
HOLOPROSENCEPHALY	0.010333354000000001	0.12789729352321516
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.010319493999999999	0.1277257464642223
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.010309299999999999	0.12759957397364707
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.010309299999999999	0.12759957397364707
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.010309299999999999	0.12759957397364707
PIERSON SYNDROME	0.010309299999999999	0.12759957397364707
FUCOSIDOSIS	0.010251964	0.12688991869410793
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.010228414	0.1265984372194123
STÜVE-WIEDEMANN SYNDROME	0.01022142	0.12651187155342417
FREEMAN-SHELDON SYNDROME	0.01022142	0.12651187155342417
MEIER-GORLIN SYNDROME 3; MGORS3	0.0101692	0.1258655376846936
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.010122164	0.12528336687179414
PIERPONT SYNDROME	0.010122164	0.12528336687179414
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.010058614	0.12449680008975994
DOWN SYNDROME	0.01004918	0.12438003422002412
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.009961134	0.12329027719577576
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.009961134	0.12329027719577576
CHROMOSOME 17P13.1 DELETION SYNDROME	0.009961134	0.12329027719577576
SPINOCEREBELLAR ATAXIA 14	0.00990892	0.12264401758984131
IRIDOGONIODYSGENESIS, TYPE 2	0.00986288	0.12207417440109458
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00986288	0.12207417440109458
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.009791154	0.12118641218224036
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.009787800000000001	0.12114489927922002
17Q12 MICRODELETION SYNDROME	0.009757004	0.12076373310110002
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.00970641	0.12013752445011279
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.009636984	0.11927822963643053
COWDEN SYNDROME	0.009636984	0.11927822963643053
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.009636984	0.11927822963643053
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.009634684000000001	0.11924976223125858
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.009634684000000001	0.11924976223125858
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00957661	0.118530972627799
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00957661	0.118530972627799
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00957661	0.118530972627799
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00957661	0.118530972627799
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.009554564	0.11825810636065934
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.009554564	0.11825810636065934
FANCONI ANEMIA	0.009554564	0.11825810636065934
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.009554564	0.11825810636065934
OKAMOTO SYNDROME	0.009554564	0.11825810636065934
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.009554564	0.11825810636065934
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.009554564	0.11825810636065934
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.009554564	0.11825810636065934
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.009554564	0.11825810636065934
RAHMAN SYNDROME	0.009554564	0.11825810636065934
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.009554564	0.11825810636065934
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.009554564	0.11825810636065934
OCULOECTODERMAL SYNDROME; OES	0.009554564	0.11825810636065934
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.009543604	0.11812245298644856
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.009474124	0.11726248980760141
FETAL HYDANTOIN SYNDROME	0.009474124	0.11726248980760141
LATERAL MENINGOCELE SYNDROME	0.009474124	0.11726248980760141
WOLF-HIRSCHHORN SYNDROME	0.009474124	0.11726248980760141
RITSCHER-SCHINZEL SYNDROME 1	0.009474124	0.11726248980760141
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.009474124	0.11726248980760141
DISTAL TRISOMY 17Q	0.009474124	0.11726248980760141
BARAITSER-WINTER SYNDROME 1; BRWS1	0.009474124	0.11726248980760141
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.009456589999999999	0.11704546916312952
AICARDI-GOUTIERES SYNDROME 7	0.009426164	0.11666888252410243
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.009426164	0.11666888252410243
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.009426164	0.11666888252410243
KRABBE DISEASE	0.009426164	0.11666888252410243
COG4-CDG	0.009426164	0.11666888252410243
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.009426164	0.11666888252410243
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.009426164	0.11666888252410243
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.009426164	0.11666888252410243
INFANTILE DYSTONIA-PARKINSONISM	0.009426164	0.11666888252410243
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.009426164	0.11666888252410243
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.009426164	0.11666888252410243
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.009426164	0.11666888252410243
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.009426164	0.11666888252410243
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00941558	0.11653788295178061
LARYNGOTRACHEAL ANGIOMA	0.00941558	0.11653788295178061
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00937055	0.11598054066704419
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00937055	0.11598054066704419
PLAGUE	0.00937055	0.11598054066704419
ACTH-INDEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704419
ACTH-DEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704419
AUTOIMMUNE HEPATITIS	0.00937055	0.11598054066704419
CUTANEOUS MASTOCYTOSIS	0.00937055	0.11598054066704419
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00937055	0.11598054066704419
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00937055	0.11598054066704419
DYSTONIA 26, MYOCLONIC; DYT26	0.00937055	0.11598054066704419
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.00937055	0.11598054066704419
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00937055	0.11598054066704419
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00937055	0.11598054066704419
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.009317484000000001	0.11532373574406343
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.009317484000000001	0.11532373574406343
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.11532373574406343
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.009317484000000001	0.11532373574406343
FETAL ALCOHOL SYNDROME	0.009317484000000001	0.11532373574406343
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.009317484000000001	0.11532373574406343
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.009317484000000001	0.11532373574406343
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.11532373574406343
INFANTILE REFSUM DISEASE	0.009317484000000001	0.11532373574406343
WEAVER SYNDROME	0.009317484000000001	0.11532373574406343
HEREDITARY FOLATE MALABSORPTION	0.009317484000000001	0.11532373574406343
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.009317484000000001	0.11532373574406343
MENTAL RETARDATION, X-LINKED 90	0.009317484000000001	0.11532373574406343
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.009317484000000001	0.11532373574406343
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.009317484000000001	0.11532373574406343
ARGININEMIA	0.009317484000000001	0.11532373574406343
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.0092456	0.11443401793824523
SPINOCEREBELLAR ATAXIA TYPE 27	0.009183779999999999	0.11366886359575339
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.009183779999999999	0.11366886359575339
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00908913	0.11249736798726344
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.00908913	0.11249736798726344
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00908913	0.11249736798726344
SVEINSSON CHORIORETINAL ATROPHY	0.00900901	0.11150571211666421
BRANCHIOGENIC DEAFNESS SYNDROME	0.00900901	0.11150571211666421
HYPEREKPLEXIA 2; HKPX2	0.00900901	0.11150571211666421
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00900901	0.11150571211666421
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00900901	0.11150571211666421
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00900901	0.11150571211666421
EDICT SYNDROME	0.00900901	0.11150571211666421
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00900901	0.11150571211666421
NEUROTROPHIC KERATOPATHY	0.00900901	0.11150571211666421
ALAND ISLAND EYE DISEASE	0.00900901	0.11150571211666421
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00900901	0.11150571211666421
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00900901	0.11150571211666421
MEGALOCORNEA	0.00900901	0.11150571211666421
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00900901	0.11150571211666421
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00900901	0.11150571211666421
SANJAD-SAKATI SYNDROME	0.00900901	0.11150571211666421
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.00900901	0.11150571211666421
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00900901	0.11150571211666421
ÅLAND ISLANDS EYE DISEASE	0.00900901	0.11150571211666421
%300843 BORNHOLM EYE DISEASE; BED;;MYOPIA, HIGH, WITH NONPROGRESSIVE CONE DYSFUNCTION	0.00900901	0.11150571211666421
BABESIOSIS	0.00898989	0.11126906133975636
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.008974934	0.11108394894334245
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.008974934	0.11108394894334245
11P15.4 MICRODUPLICATION SYNDROME	0.008974934	0.11108394894334245
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.008974934	0.11108394894334245
THAUVIN-ROBINET-FAIVRE SYNDROME	0.008948914	0.11076189595091868
8P23.1 DUPLICATION SYNDROME	0.008948914	0.11076189595091868
TEMPLE-BARAITSER SYNDROME; TMBTS	0.008948914	0.11076189595091868
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.008948914	0.11076189595091868
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.008948914	0.11076189595091868
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.008948914	0.11076189595091868
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.008948914	0.11076189595091868
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.008948914	0.11076189595091868
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.008948914	0.11076189595091868
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00892857	0.11051009556360626
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00892857	0.11051009556360626
MAYER-ROKITANSKY-KÜSTER-HAUSER SYNDROME TYPE 2	0.00892857	0.11051009556360626
SPONDYLO-OCULAR SYNDROME	0.00892857	0.11051009556360626
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.11051009556360626
PTERYGIUM COLLI, ISOLATED	0.00892857	0.11051009556360626
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00892857	0.11051009556360626
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.11051009556360626
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00892857	0.11051009556360626
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00892857	0.11051009556360626
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00892857	0.11051009556360626
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00892857	0.11051009556360626
THORACOMELIC DYSPLASIA	0.00892857	0.11051009556360626
JUNG SYNDROME	0.00892857	0.11051009556360626
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00892857	0.11051009556360626
ISOLATED KLIPPEL-FEIL SYNDROME	0.00892857	0.11051009556360626
FLOATING-HARBOR SYNDROME	0.00892857	0.11051009556360626
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00892857	0.11051009556360626
WILDERVANCK SYNDROME	0.00892857	0.11051009556360626
CEREBROFACIOTHORACIC DYSPLASIA	0.00892857	0.11051009556360626
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00892857	0.11051009556360626
RING CHROMOSOME 6 SYNDROME	0.00892857	0.11051009556360626
RING CHROMOSOME 8 SYNDROME	0.00892857	0.11051009556360626
SPONDYLOOCULAR SYNDROME; SOS	0.00892857	0.11051009556360626
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00892857	0.11051009556360626
EDINBURGH MALFORMATION SYNDROME	0.00892857	0.11051009556360626
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00892857	0.11051009556360626
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00892857	0.11051009556360626
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.008887593999999999	0.11000293017476859
ZTTK SYNDROME; ZTTKS	0.008887593999999999	0.11000293017476859
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00888061	0.10991648828010728
5Q14.3 MICRODELETION SYNDROME	0.00888061	0.10991648828010728
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00888061	0.10991648828010728
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00888061	0.10991648828010728
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.1085713415000683
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.1085713415000683
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.1085713415000683
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.1085713415000683
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00877193	0.1085713415000683
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00877193	0.1085713415000683
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.1085713415000683
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.1085713415000683
CRYPTOCOCCOSIS	0.00877193	0.1085713415000683
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.1085713415000683
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.1085713415000683
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00877193	0.1085713415000683
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.1085713415000683
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.1085713415000683
PELIZAEUS-MERZBACHER DISEASE	0.00877193	0.1085713415000683
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.1085713415000683
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.1085713415000683
HISTIDINEMIA	0.00877193	0.1085713415000683
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.1085713415000683
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.1085713415000683
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	0.1085713415000683
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.1085713415000683
CORTICOBASAL SYNDROME	0.00877193	0.1085713415000683
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.1085713415000683
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.1085713415000683
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.1085713415000683
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00877193	0.1085713415000683
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.1085713415000683
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.1085713415000683
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.1085713415000683
NEUROFERRITINOPATHY	0.00877193	0.1085713415000683
NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.1085713415000683
HUNTINGTON DISEASE	0.00877193	0.1085713415000683
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.1085713415000683
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00877193	0.1085713415000683
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.1085713415000683
BREATH-HOLDING SPELLS	0.00877193	0.1085713415000683
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.1085713415000683
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.1085713415000683
METACHROMATIC LEUKODYSTROPHY	0.00877193	0.1085713415000683
DIENCEPHALIC SYNDROME	0.00877193	0.1085713415000683
PINEOBLASTOMA	0.00877193	0.1085713415000683
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.1085713415000683
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00877193	0.1085713415000683
LESCH-NYHAN SYNDROME	0.00877193	0.1085713415000683
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00877193	0.1085713415000683
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.1085713415000683
ANGELMAN SYNDROME	0.00877193	0.1085713415000683
NANCE-HORAN SYNDROME	0.00877193	0.1085713415000683
KEIPERT SYNDROME	0.00877193	0.1085713415000683
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00877193	0.1085713415000683
RHEUMATIC FEVER	0.00877193	0.1085713415000683
ISOLATED CEREBELLAR AGENESIS	0.00877193	0.1085713415000683
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.1085713415000683
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.1085713415000683
SNEDDON SYNDROME	0.00877193	0.1085713415000683
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.1085713415000683
TETRASOMY X	0.008767574	0.10851742671009912
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.008767574	0.10851742671009912
DISTAL MONOSOMY 9P	0.008767574	0.10851742671009912
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.008767574	0.10851742671009912
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.008545554	0.1057694557117162
GAUCHER DISEASE	0.00849302	0.10511923542332302
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.008453974	0.10463595790056444
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.008453974	0.10463595790056444
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00842938	0.10433155469934731
MENTAL RETARDATION, X-LINKED 102	0.00842938	0.10433155469934731
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00842938	0.10433155469934731
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00842938	0.10433155469934731
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00840336	0.10400950170692355
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00840336	0.10400950170692355
XYLT1-CDG	0.00840336	0.10400950170692355
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00840336	0.10400950170692355
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00840336	0.10400950170692355
ATYPICAL RETT SYNDROME	0.00840336	0.10400950170692355
THREE M SYNDROME 2; 3M2	0.00840336	0.10400950170692355
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.00840336	0.10400950170692355
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00840336	0.10400950170692355
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.00840336	0.10400950170692355
NEU-LAXOVA SYNDROME	0.00840336	0.10400950170692355
FEINGOLD SYNDROME 1; FGLDS1	0.00840336	0.10400950170692355
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00840336	0.10400950170692355
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.00840336	0.10400950170692355
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00840336	0.10400950170692355
SPONASTRIME DYSPLASIA	0.00840336	0.10400950170692355
MEIER-GORLIN SYNDROME 8; MGORS8	0.00840336	0.10400950170692355
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.008284174	0.10253432077091207
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.008270314	0.10236277371191925
BARDET-BIEDL SYNDROME 4; BBS4	0.00822202	0.10176503246610398
AYME-GRIPP SYNDROME; AYGRP	0.00822202	0.10176503246610398
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00822202	0.10176503246610398
19P13.13 MICRODELETION SYNDROME	0.008179234	0.10123546446710924
MARDEN-WALKER SYNDROME	0.008179234	0.10123546446710924
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.008150293999999999	0.10087727024724975
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.008127704000000001	0.1005976708199303
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.008127704000000001	0.1005976708199303
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.008059214	0.09974996100243975
AARSKOG-SCOTT SYNDROME	0.008059214	0.09974996100243975
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.008	0.09901706146772105
LIPOID PROTEINOSIS	0.008	0.09901706146772105
PROGNATHISM, MANDIBULAR	0.008	0.09901706146772105
BLACKFAN-DIAMOND ANEMIA	0.008	0.09901706146772105
CHEILITIS GLANDULARIS	0.008	0.09901706146772105
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.008	0.09901706146772105
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.008	0.09901706146772105
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.008	0.09901706146772105
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.008	0.09901706146772105
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.008	0.09901706146772105
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.008	0.09901706146772105
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.008	0.09901706146772105
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.008	0.09901706146772105
NOONAN SYNDROME 4; NS4	0.008	0.09901706146772105
NAKAJO-NISHIMURA SYNDROME	0.008	0.09901706146772105
FRYNS-SMEETS-THIRY SYNDROME	0.008	0.09901706146772105
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.008	0.09901706146772105
MENTAL RETARDATION, X-LINKED 19	0.008	0.09901706146772105
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.09843489065482157
WEBB-DATTANI SYNDROME; WEDAS	0.007952964	0.09843489065482157
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.007952964	0.09843489065482157
300270 ADRENOMYODYSTROPHY	0.007952964	0.09843489065482157
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.007952964	0.09843489065482157
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.09843489065482157
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00790842	0.0978835636565693
SEVERE CANAVAN DISEASE	0.007791934	0.0964418009788032
NIEMANN-PICK DISEASE TYPE C	0.007791934	0.0964418009788032
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.007791934	0.0964418009788032
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.007791934	0.0964418009788032
INFANTILE SYSTEMIC HYALINOSIS	0.00775195	0.09594691370558753
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00773862	0.09578192652691693
CAMURATI-ENGELMANN DISEASE	0.00773862	0.09578192652691693
14Q12 MICRODELETION SYNDROME	0.00772476	0.09561037946792411
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.007640864	0.09457198754431212
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0076047400000000005	0.09412487600325463
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0076047400000000005	0.09412487600325463
15Q26 OVERGROWTH SYNDROME	0.0076047400000000005	0.09412487600325463
MESOMELIA-SYNOSTOSES SYNDROME	0.0076047400000000005	0.09412487600325463
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.007587804	0.09391525688412745
MACROCEPHALY/AUTISM SYNDROME	0.007587804	0.09391525688412745
TIMOTHY SYNDROME; TS	0.007587804	0.09391525688412745
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.007587804	0.09391525688412745
AUSTRALIA ANTIGEN	0.007587804	0.09391525688412745
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.007587804	0.09391525688412745
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.007587804	0.09391525688412745
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.007587804	0.09391525688412745
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.007587804	0.09391525688412745
MENTAL RETARDATION, X-LINKED 88	0.007587804	0.09391525688412745
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.007582150000000001	0.09384527657593515
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.007454094	0.09226031047302133
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.007454094	0.09226031047302133
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.007454094	0.09226031047302133
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00740741	0.09168249641082644
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00740741	0.09168249641082644
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00740741	0.09168249641082644
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.00740741	0.09168249641082644
CRANIOFACIAL DYSSYNOSTOSIS	0.00740741	0.09168249641082644
DISTAL MONOSOMY 10P	0.00740741	0.09168249641082644
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00740741	0.09168249641082644
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.09168249641082644
TRISOMY XQ28	0.00740741	0.09168249641082644
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.00740741	0.09168249641082644
COG8-CDG	0.00740741	0.09168249641082644
NEONATAL ADRENOLEUKODYSTROPHY	0.00740741	0.09168249641082644
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00740741	0.09168249641082644
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.09168249641082644
DPM1-CDG	0.00740741	0.09168249641082644
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.09168249641082644
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00740741	0.09168249641082644
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.09168249641082644
CROME SYNDROME	0.00740741	0.09168249641082644
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00740741	0.09168249641082644
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00740741	0.09168249641082644
ADRENOMYODYSTROPHY	0.00740741	0.09168249641082644
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.09168249641082644
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00740741	0.09168249641082644
HEREDITARY METHEMOGLOBINEMIA	0.00740741	0.09168249641082644
MONOSOMY 5P	0.00740741	0.09168249641082644
LOWRY-MACLEAN SYNDROME	0.00740741	0.09168249641082644
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.09168249641082644
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.09168249641082644
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00740741	0.09168249641082644
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00740741	0.09168249641082644
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.09168249641082644
SECKEL SYNDROME 7; SCKL7	0.00740741	0.09168249641082644
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00740741	0.09168249641082644
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00740741	0.09168249641082644
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.007260204	0.08986050821702428
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.007256964	0.08982040630712985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.007256964	0.08982040630712985
WYBURN-MASON SYNDROME	0.007256964	0.08982040630712985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.007256964	0.08982040630712985
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.007256964	0.08982040630712985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.007256964	0.08982040630712985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.007256964	0.08982040630712985
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.007256964	0.08982040630712985
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.007256964	0.08982040630712985
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.007256964	0.08982040630712985
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.007256964	0.08982040630712985
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.007256964	0.08982040630712985
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.007256964	0.08982040630712985
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.007256964	0.08982040630712985
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.007256964	0.08982040630712985
MEDULLOBLASTOMA	0.007256964	0.08982040630712985
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.007256964	0.08982040630712985
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.007256964	0.08982040630712985
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.007256964	0.08982040630712985
AICARDI-GOUTIÈRES SYNDROME	0.007256964	0.08982040630712985
CITRULLINEMIA, CLASSIC	0.007256964	0.08982040630712985
MENTAL RETARDATION, X-LINKED 107; MRX107	0.007256964	0.08982040630712985
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.007256964	0.08982040630712985
NARP SYNDROME	0.007256964	0.08982040630712985
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.007256964	0.08982040630712985
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.007256964	0.08982040630712985
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.007256964	0.08982040630712985
JOUBERT SYNDROME 14	0.007256964	0.08982040630712985
MACHADO-JOSEPH DISEASE TYPE 2	0.00724638	0.08968940673480806
PREECLAMPSIA	0.00724638	0.08968940673480806
BRONCHOPULMONARY DYSPLASIA	0.00724638	0.08968940673480806
MACHADO-JOSEPH DISEASE TYPE 3	0.00724638	0.08968940673480806
MACHADO-JOSEPH DISEASE TYPE 1	0.00724638	0.08968940673480806
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00724638	0.08968940673480806
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00724638	0.08968940673480806
NEURALGIC AMYOTROPHY	0.00724638	0.08968940673480806
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00724638	0.08968940673480806
HEREDITARY HYPEREKPLEXIA	0.00724638	0.08968940673480806
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00724638	0.08968940673480806
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00704225	0.08716286264013232
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00704225	0.08716286264013232
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00704225	0.08716286264013232
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00704225	0.08716286264013232
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00704225	0.08716286264013232
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00704225	0.08716286264013232
HYPERLEXIA	0.00704225	0.08716286264013232
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0069085399999999995	0.08550791622902619
OROFACIODIGITAL SYNDROME IX; OFD9	0.006718394	0.08315445395779604
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.006718394	0.08315445395779604
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.006718394	0.08315445395779604
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.006718394	0.08315445395779604
GALLOWAY-MOWAT SYNDROME	0.006718394	0.08315445395779604
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.006718394	0.08315445395779604
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.006718394	0.08315445395779604
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.006718394	0.08315445395779604
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.006718394	0.08315445395779604
CEDNIK SYNDROME	0.006718394	0.08315445395779604
PELGER-HUET ANOMALY; PHA	0.006718394	0.08315445395779604
3Q29 MICRODUPLICATION SYNDROME	0.006718394	0.08315445395779604
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.006718394	0.08315445395779604
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.006718394	0.08315445395779604
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.006718394	0.08315445395779604
POLYMYOCLONUS, INFANTILE	0.00671141	0.08306801206313472
RHABDOID TUMOR	0.00671141	0.08306801206313472
MENTAL RETARDATION, X-LINKED 82	0.00671141	0.08306801206313472
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.00671141	0.08306801206313472
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00671141	0.08306801206313472
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00671141	0.08306801206313472
GRAFT VERSUS HOST DISEASE	0.00671141	0.08306801206313472
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00671141	0.08306801206313472
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00671141	0.08306801206313472
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00671141	0.08306801206313472
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.00671141	0.08306801206313472
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.00671141	0.08306801206313472
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00671141	0.08306801206313472
BEHCET SYNDROME	0.00671141	0.08306801206313472
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00671141	0.08306801206313472
PTEN HAMARTOMA TUMOR SYNDROME	0.00671141	0.08306801206313472
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00671141	0.08306801206313472
46,XY SEX REVERSAL 9; SRXY9	0.00671141	0.08306801206313472
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.00671141	0.08306801206313472
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00671141	0.08306801206313472
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00671141	0.08306801206313472
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00671141	0.08306801206313472
BETA-THALASSEMIA	0.00671141	0.08306801206313472
9Q21.13 MICRODELETION SYNDROME	0.00671141	0.08306801206313472
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00671141	0.08306801206313472
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00671141	0.08306801206313472
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00671141	0.08306801206313472
KAWASAKI DISEASE	0.00671141	0.08306801206313472
3C SYNDROME	0.006643314000000001	0.0822251788359215
OROFACIODIGITAL SYNDROME TYPE 6	0.006643314000000001	0.0822251788359215
PETERS-PLUS SYNDROME; PTRPLS	0.006643314000000001	0.0822251788359215
PETERS PLUS SYNDROME	0.006643314000000001	0.0822251788359215
CORNEODERMATOOSSEOUS SYNDROME	0.006594630000000001	0.08162261050835966
SSR4-CDG	0.006404794	0.07927298514826138
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.006404794	0.07927298514826138
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.006404794	0.07927298514826138
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.006404794	0.07927298514826138
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.006404794	0.07927298514826138
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.006404794	0.07927298514826138
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.006404794	0.07927298514826138
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.006404794	0.07927298514826138
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.006404794	0.07927298514826138
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.006404793999999999	0.07927298514826137
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.006284774	0.0777874816835919
MATERNAL PHENYLKETONURIA	0.006284774	0.0777874816835919
COFFIN-SIRIS SYNDROME 3; CSS3	0.0062483239999999995	0.07733633519727957
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0062483239999999995	0.07733633519727957
COFFIN-SIRIS SYNDROME 4; CSS4	0.0062483239999999995	0.07733633519727957
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.0062483239999999995	0.07733633519727957
GENITOPATELLAR SYNDROME	0.0062483239999999995	0.07733633519727957
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.00617284	0.0764020597138009
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.00617284	0.0764020597138009
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00617284	0.0764020597138009
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.00617284	0.0764020597138009
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.00617284	0.0764020597138009
BRITTLE CORNEA SYNDROME	0.00617284	0.0764020597138009
ERYTHEMA OF ACRAL REGIONS	0.00617284	0.0764020597138009
TEETH, FUSED	0.00617284	0.0764020597138009
HYPOGONADOTROPIC HYPOGONADISM-RETINITIS PIGMENTOSA SYNDROME	0.00617284	0.0764020597138009
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00617284	0.0764020597138009
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00617284	0.0764020597138009
JUVENILE PAGET DISEASE	0.00617284	0.0764020597138009
SEVERE COMBINED IMMUNODEFICIENCY	0.00617284	0.0764020597138009
ISOLATED HEMIHYPERPLASIA	0.00617284	0.0764020597138009
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00617284	0.0764020597138009
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.00617284	0.0764020597138009
8Q21.11 MICRODELETION SYNDROME	0.00617284	0.0764020597138009
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00617284	0.0764020597138009
TOOTH SIZE	0.00617284	0.0764020597138009
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.00617284	0.0764020597138009
EPILEPSY-TELANGIECTASIA SYNDROME	0.00617284	0.0764020597138009
LEGG-CALVÉ-PERTHES DISEASE	0.00617284	0.0764020597138009
PREMATURE OVARIAN FAILURE 2B	0.00617284	0.0764020597138009
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00617284	0.0764020597138009
PARAMOLAR TUBERCLE OF BOLK	0.00617284	0.0764020597138009
MULTIPLE OSTEOCHONDROMAS	0.00617284	0.0764020597138009
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00617284	0.0764020597138009
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00617284	0.0764020597138009
ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE	0.00617284	0.0764020597138009
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.00617284	0.0764020597138009
DEAFNESS-CRANIOFACIAL SYNDROME	0.00617284	0.0764020597138009
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00617284	0.0764020597138009
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00617284	0.0764020597138009
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.00617284	0.0764020597138009
BUSCHKE-OLLENDORFF SYNDROME	0.00617284	0.0764020597138009
MOLAR I REINCLUSION	0.00617284	0.0764020597138009
DENS EVAGINATUS	0.00617284	0.0764020597138009
125300 DENS IN DENTE AND PALATAL INVAGINATIONS	0.00617284	0.0764020597138009
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00617284	0.0764020597138009
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00617284	0.0764020597138009
SPLIT LOWER LIP	0.00617284	0.0764020597138009
INCISORS, FUSED MANDIBULAR	0.00617284	0.0764020597138009
TEETH, ODD SHAPES OFLOBODONTIA, INCLUDED	0.00617284	0.0764020597138009
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.00617284	0.0764020597138009
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.00617284	0.0764020597138009
FAMILIAL TUMORAL CALCINOSIS	0.00617284	0.0764020597138009
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00617284	0.0764020597138009
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	0.00617284	0.0764020597138009
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00617284	0.0764020597138009
LAMELLAR ICHTHYOSIS	0.00617284	0.0764020597138009
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00617284	0.0764020597138009
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00617284	0.0764020597138009
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00617284	0.0764020597138009
BANGSTAD SYNDROME	0.00617284	0.0764020597138009
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00617284	0.0764020597138009
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00617284	0.0764020597138009
VELO-FACIAL-SKELETAL SYNDROME	0.00617284	0.0764020597138009
NON-DISTAL TRISOMY 13Q	0.00617284	0.0764020597138009
CANINE TEETH, ABSENCE OF UPPER PERMANENT	0.00617284	0.0764020597138009
CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH	0.00617284	0.0764020597138009
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00617284	0.0764020597138009
CHOPS SYNDROME; CHOPS	0.006128303999999999	0.07585083173261009
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.006101114	0.07551429749494669
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.006101114	0.07551429749494669
LATHOSTEROLOSIS	0.006101114	0.07551429749494669
MOSAIC TRISOMY 9	0.006101114	0.07551429749494669
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.006101114	0.07551429749494669
XQ27.3Q28 DUPLICATION SYNDROME	0.006101114	0.07551429749494669
NOONAN SYNDROME 11; NS11	0.006101114	0.07551429749494669
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.006101114	0.07551429749494669
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.006101114	0.07551429749494669
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.006101114	0.07551429749494669
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.006101114	0.07551429749494669
JEUNE SYNDROME	0.006097760000000001	0.07547278459192636
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.006097760000000001	0.07547278459192636
INCONTINENTIA PIGMENTI	0.006010034	0.07438698825013668
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.006010034	0.07438698825013668
8Q12 MICRODUPLICATION SYNDROME	0.006010034	0.07438698825013668
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.006010034	0.07438698825013668
CHROMOSOME 15Q25 DELETION SYNDROME	0.006010034	0.07438698825013668
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006010034	0.07438698825013668
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.006010034	0.07438698825013668
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.006010034	0.07438698825013668
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.006010034	0.07438698825013668
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.006010034	0.07438698825013668
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.006010034	0.07438698825013668
8P23.1 MICRODELETION SYNDROME	0.006010034	0.07438698825013668
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.006010034	0.07438698825013668
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00585924	0.07252059090426624
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00585924	0.07252059090426624
CRISS-CROSS HEART	0.00585924	0.07252059090426624
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00573922	0.07103508743959676
LARON SYNDROME	0.00573922	0.07103508743959676
ATELOSTEOGENESIS TYPE II	0.00573922	0.07103508743959676
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00573922	0.07103508743959676
PALLISTER-KILLIAN SYNDROME	0.005702769999999999	0.07058394095328444
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00558275	0.06909843748861497
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00558275	0.06909843748861497
RIN2 SYNDROME	0.00558275	0.06909843748861497
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00558275	0.06909843748861497
CAMPOMELIA, CUMMING TYPE	0.00558275	0.06909843748861497
BASAL CELL NEVUS SYNDROME	0.00558275	0.06909843748861497
NOSE, ANOMALOUS SHAPE OF	0.00555556	0.06876190325095155
ZIMMERMANN-LABAND SYNDROME	0.00555556	0.06876190325095155
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00555556	0.06876190325095155
JOHNSON NEUROECTODERMAL SYNDROME	0.00555556	0.06876190325095155
KAPUR-TORIELLO SYNDROME	0.00555556	0.06876190325095155
260150 PALANT CLEFT PALATE SYNDROME	0.00555556	0.06876190325095155
CONGENITAL HYDROCEPHALUS	0.00555556	0.06876190325095155
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00555556	0.06876190325095155
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00555556	0.06876190325095155
3M SYNDROME	0.00555556	0.06876190325095155
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00555556	0.06876190325095155
OROFACIAL CLEFT 15	0.00555556	0.06876190325095155
RUIJS-AALFS SYNDROME; RJALS	0.00555556	0.06876190325095155
OROFACIODIGITAL SYNDROME III	0.00555556	0.06876190325095155
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.00555556	0.06876190325095155
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00555556	0.06876190325095155
OROFACIODIGITAL SYNDROME TYPE 3	0.00555556	0.06876190325095155
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00555556	0.06876190325095155
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.00555556	0.06876190325095155
DISTAL MONOSOMY 7Q36	0.00555556	0.06876190325095155
THAKKER-DONNAI SYNDROME	0.00555556	0.06876190325095155
BARBER-SAY SYNDROME; BBRSAY	0.00555556	0.06876190325095155
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00555556	0.06876190325095155
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00555556	0.06876190325095155
BEEMER-ERTBRUGGEN SYNDROME	0.00555556	0.06876190325095155
CHROMOSOME 13Q14 DELETION SYNDROME	0.00555556	0.06876190325095155
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00555556	0.06876190325095155
BARBER-SAY SYNDROME	0.00555556	0.06876190325095155
SCHIMKE IMMUNO-OSSEOUS DYSPLASIA	0.00555556	0.06876190325095155
CERNUNNOS-XLF DEFICIENCY	0.00555556	0.06876190325095155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.005471664	0.06772351132733956
DYSTONIA-APHONIA SYNDROME	0.005471664	0.06772351132733956
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00546448	0.06763459400614154
MICROTIA	0.00546448	0.06763459400614154
SPASTIC PARAPLEGIA TYPE 7	0.00546448	0.06763459400614154
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00546448	0.06763459400614154
ATTENTION DEFICIT-HYPERACTIVITY DISORDER	0.00546448	0.06763459400614154
NEUROFIBROMATOSIS TYPE 1	0.00546448	0.06763459400614154
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00546448	0.06763459400614154
SPINOCEREBELLAR ATAXIA TYPE 36	0.00546448	0.06763459400614154
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00546448	0.06763459400614154
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00546448	0.06763459400614154
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00546448	0.06763459400614154
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00546448	0.06763459400614154
IMMUNODEFICIENCY 61; IMD61	0.00546448	0.06763459400614154
MENTAL RETARDATION, X-LINKED 99	0.005284894	0.06541183425604878
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.005284894	0.06541183425604878
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.005284894	0.06541183425604878
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.005284894	0.06541183425604878
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.005284894	0.06541183425604878
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.005284894	0.06541183425604878
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.005284894	0.06541183425604878
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.005284894	0.06541183425604878
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.005284894	0.06541183425604878
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.005284894	0.06541183425604878
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.005284894	0.06541183425604878
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.0050910040000000005	0.06301203200005173
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.0050910040000000005	0.06301203200005173
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.0050910040000000005	0.06301203200005173
CHÉDIAK-HIGASHI SYNDROME	0.0050910040000000005	0.06301203200005173
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.0050910040000000005	0.06301203200005173
MUCOLIPIDOSIS IV; ML4	0.0050910040000000005	0.06301203200005173
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0050910040000000005	0.06301203200005173
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.0050910040000000005	0.06301203200005173
L1 SYNDROME	0.004989994	0.06176181782769491
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.004989994	0.06176181782769491
ACQUIRED METHEMOGLOBINEMIA	0.00492611	0.06097111708334441
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00492611	0.06097111708334441
GENIOSPASM 1; GSM1	0.00492611	0.06097111708334441
CHILDHOOD-ONSET BENIGN CHOREA WITH STRIATAL INVOLVEMENT	0.00492611	0.06097111708334441
PANIC DISORDER 1	0.00492611	0.06097111708334441
MENTAL RETARDATION, X-LINKED 63	0.00492611	0.06097111708334441
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00492611	0.06097111708334441
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00492611	0.06097111708334441
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004763933999999999	0.058963843213270764
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00473934	0.058659440012053636
LOWE OCULOCEREBRORENAL SYNDROME	0.00473934	0.058659440012053636
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00473934	0.058659440012053636
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00473934	0.058659440012053636
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00473934	0.058659440012053636
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00473934	0.058659440012053636
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.00473934	0.058659440012053636
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00473934	0.058659440012053636
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00473934	0.058659440012053636
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.004594134000000001	0.0568622060836184
GALACTOSEMIA	0.004594134000000001	0.0568622060836184
PYRUVATE DEHYDROGENASE DEFICIENCY	0.004594134000000001	0.0568622060836184
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004594134000000001	0.0568622060836184
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.004594134000000001	0.0568622060836184
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.004594134000000001	0.0568622060836184
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.004594134000000001	0.0568622060836184
WEAVER SYNDROME	0.004594134000000001	0.0568622060836184
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.004594134000000001	0.0568622060836184
SHASHI-PENA SYNDROME; SHAPNS	0.004594134000000001	0.0568622060836184
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.004594134000000001	0.0568622060836184
CANAVAN DISEASE	0.004594134000000001	0.0568622060836184
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.004594134000000001	0.0568622060836184
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004594134000000001	0.0568622060836184
JOUBERT SYNDROME	0.004594134000000001	0.0568622060836184
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004594134000000001	0.0568622060836184
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004594134000000001	0.0568622060836184
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.004594134000000001	0.0568622060836184
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.004594134000000001	0.0568622060836184
PEHO SYNDROME; PEHO	0.004594134000000001	0.0568622060836184
METHYLMALONIC ACIDURIA, CBLA TYPE	0.004594134000000001	0.0568622060836184
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.004594134000000001	0.0568622060836184
METHYLMALONIC ACIDURIA, CBLB TYPE	0.004594134000000001	0.0568622060836184
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00454545	0.05625963775605659
ALACRIMA, CONGENITAL	0.00454545	0.05625963775605659
CORNEAL DYSTROPHY, MEESMANN	0.00454545	0.05625963775605659
CHRONIC GRAFT VERSUS HOST DISEASE	0.00454545	0.05625963775605659
NEOVASCULAR GLAUCOMA	0.00454545	0.05625963775605659
RETINAL CONE DYSTROPHY 1; RCD1	0.00454545	0.05625963775605659
ISOLATED CONGENITAL ALACRIMA	0.00454545	0.05625963775605659
MACULAR DYSTROPHY, PATTERNED, 1; MDPT1	0.00454545	0.05625963775605659
MACULAR DYSTROPHY, CORNEAL, 1	0.00454545	0.05625963775605659
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00454545	0.05625963775605659
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00454545	0.05625963775605659
LEUKONYCHIA TOTALIS	0.00454545	0.05625963775605659
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00454545	0.05625963775605659
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00454545	0.05625963775605659
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.00454545	0.05625963775605659
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00454545	0.05625963775605659
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00454545	0.05625963775605659
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00454545	0.05625963775605659
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00454545	0.05625963775605659
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00454545	0.05625963775605659
CORNEAL FLECK DYSTROPHY	0.00454545	0.05625963775605659
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00454545	0.05625963775605659
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1	0.00454545	0.05625963775605659
XERODERMA PIGMENTOSUM VARIANT	0.00454545	0.05625963775605659
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00454545	0.05625963775605659
BOUCHER-NEUHAUSER SYNDROME	0.00454545	0.05625963775605659
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.00454545	0.05625963775605659
BLAU SYNDROME	0.00454545	0.05625963775605659
REACTIVE ARTHRITIS	0.00454545	0.05625963775605659
COGAN SYNDROME	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 51; RP51	0.00454545	0.05625963775605659
CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2	0.00454545	0.05625963775605659
CONE DYSTROPHY 4	0.00454545	0.05625963775605659
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00454545	0.05625963775605659
BLUE CONE MONOCHROMATISM	0.00454545	0.05625963775605659
AMOEBIC KERATITIS	0.00454545	0.05625963775605659
MICROPHTHALMIA, ISOLATED 5	0.00454545	0.05625963775605659
BILATERAL ACUTE DEPIGMENTATION OF THE IRIS	0.00454545	0.05625963775605659
VERNAL KERATOCONJUNCTIVITIS	0.00454545	0.05625963775605659
RETINAL CONE DYSTROPHY 4	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 11; CORD11	0.00454545	0.05625963775605659
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 10	0.00454545	0.05625963775605659
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00454545	0.05625963775605659
HEMORRHAGIC FEVER-RENAL SYNDROME	0.00454545	0.05625963775605659
BRADYOPSIA	0.00454545	0.05625963775605659
OLIGOCONE TRICHROMACY	0.00454545	0.05625963775605659
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA	0.00454545	0.05625963775605659
BIRDSHOT CHORIORETINOPATHY	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 8; CORD8	0.00454545	0.05625963775605659
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00454545	0.05625963775605659
LEBER CONGENITAL AMAUROSIS 16	0.00454545	0.05625963775605659
MICROTIA-EYE COLOBOMA-IMPERFORATION OF THE NASOLACRIMAL DUCT SYNDROME	0.00454545	0.05625963775605659
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00454545	0.05625963775605659
ACHROMATOPSIA 7; ACHM7	0.00454545	0.05625963775605659
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.00454545	0.05625963775605659
STEVENS-JOHNSON SYNDROME	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 79	0.00454545	0.05625963775605659
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 5	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 6	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00454545	0.05625963775605659
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00454545	0.05625963775605659
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 21; CORD21	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 16	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 72; RP72	0.00454545	0.05625963775605659
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00454545	0.05625963775605659
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.00454545	0.05625963775605659
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00454545	0.05625963775605659
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.00454545	0.05625963775605659
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00454545	0.05625963775605659
ACHROMATOPSIA	0.00454545	0.05625963775605659
%615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 17; CORD17	0.00454545	0.05625963775605659
RETINITIS PUNCTATA ALBESCENS	0.00454545	0.05625963775605659
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00454545	0.05625963775605659
ALPORT SYNDROME	0.00454545	0.05625963775605659
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00454545	0.05625963775605659
IDIOPATHIC ANTERIOR UVEITIS	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 4	0.00454545	0.05625963775605659
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.00454545	0.05625963775605659
CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II	0.00454545	0.05625963775605659
IDIOPATHIC PANUVEITIS	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 6; CORD6	0.00454545	0.05625963775605659
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00454545	0.05625963775605659
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00454545	0.05625963775605659
IRVAN SYNDROME	0.00454545	0.05625963775605659
TYROSINEMIA TYPE 2	0.00454545	0.05625963775605659
ALACRIMA	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 5; CORD5	0.00454545	0.05625963775605659
SJÖGREN-LARSSON SYNDROME	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 17	0.00454545	0.05625963775605659
BLUE CONE MONOCHROMACY; BCM	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00454545	0.05625963775605659
FLOTCH SYNDROME	0.00454545	0.05625963775605659
PROGRESSIVE CONE DYSTROPHY	0.00454545	0.05625963775605659
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 2	0.00454545	0.05625963775605659
CONE DYSTROPHY 3	0.00454545	0.05625963775605659
ALBINISM, OCULAR, TYPE I	0.00454545	0.05625963775605659
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00454545	0.05625963775605659
CONE ROD DYSTROPHY	0.00454545	0.05625963775605659
JALILI SYNDROME	0.00454545	0.05625963775605659
HIDROTIC ECTODERMAL DYSPLASIA	0.00454545	0.05625963775605659
SJOGREN-LARSSON SYNDROME; SLS	0.00454545	0.05625963775605659
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00454545	0.05625963775605659
EEC SYNDROME	0.00454545	0.05625963775605659
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00454545	0.05625963775605659
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	0.00454545	0.05625963775605659
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.00454545	0.05625963775605659
ECTODERMAL DYSPLASIA SYNDROME	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 25; RP25	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00454545	0.05625963775605659
SCRUB TYPHUS	0.00454545	0.05625963775605659
DE SANCTIS-CACCHIONE SYNDROME	0.00454545	0.05625963775605659
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00444444	0.05500942358369977
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00444444	0.05500942358369977
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00444444	0.05500942358369977
SPINOCEREBELLAR ATAXIA TYPE 28	0.00444444	0.05500942358369977
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00444444	0.05500942358369977
ACERULOPLASMINEMIA	0.00444444	0.05500942358369977
GIANT CELL ARTERITIS	0.00444444	0.05500942358369977
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00444444	0.05500942358369977
SPINOCEREBELLAR ATAXIA 42	0.00444444	0.05500942358369977
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00444444	0.05500942358369977
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00444444	0.05500942358369977
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.05500942358369977
CADASIL	0.00444444	0.05500942358369977
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00444444	0.05500942358369977
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.00444444	0.05500942358369977
WOLFRAM SYNDROME 2; WFS2	0.00444444	0.05500942358369977
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00444444	0.05500942358369977
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00444444	0.05500942358369977
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00444444	0.05500942358369977
TRIMETHYLAMINURIA	0.00444444	0.05500942358369977
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.05500942358369977
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00444444	0.05500942358369977
PRIMARY SCLEROSING CHOLANGITIS	0.00444444	0.05500942358369977
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00444444	0.05500942358369977
SPINOCEREBELLAR ATAXIA TYPE 8	0.00444444	0.05500942358369977
CENTRAL NEUROCYTOMA	0.00444444	0.05500942358369977
GLUCAGONOMA	0.00444444	0.05500942358369977
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00444444	0.05500942358369977
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00444444	0.05500942358369977
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004235594	0.052424508931288805
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.004235594	0.052424508931288805
JOUBERT SYNDROME 35; JBTS35	0.004235594	0.052424508931288805
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004235594	0.052424508931288805
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.004235594	0.052424508931288805
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.004235594	0.052424508931288805
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.004235594	0.052424508931288805
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.004235594	0.052424508931288805
SLC35A2-CDG	0.004235594	0.052424508931288805
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004235594	0.052424508931288805
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.004235594	0.052424508931288805
SRD5A3-CDG	0.004235594	0.052424508931288805
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.004235594	0.052424508931288805
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.004235594	0.052424508931288805
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.004235594	0.052424508931288805
MONOSOMY 13Q34	0.004235594	0.052424508931288805
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.004235594	0.052424508931288805
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.004235594	0.052424508931288805
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.004235594	0.052424508931288805
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.004235594	0.052424508931288805
HOLOPROSENCEPHALY 5; HPE5	0.004235594	0.052424508931288805
SPINOCEREBELLAR ATAXIA TYPE 13	0.004235594	0.052424508931288805
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.004235594	0.052424508931288805
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.004235594	0.052424508931288805
FREE SIALIC ACID STORAGE DISEASE	0.004235594	0.052424508931288805
SYNDROMIC DIARRHEA	0.004235594	0.052424508931288805
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.004235594	0.052424508931288805
RING CHROMOSOME 12 SYNDROME	0.004235594	0.052424508931288805
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.004235594	0.052424508931288805
7P22.1 MICRODUPLICATION SYNDROME	0.004235594	0.052424508931288805
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.004235594	0.052424508931288805
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.004235594	0.052424508931288805
ROIFMAN-CHITAYAT SYNDROME	0.004235594	0.052424508931288805
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.004235594	0.052424508931288805
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.004235594	0.052424508931288805
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004235594	0.052424508931288805
TRANSALDOLASE DEFICIENCY	0.004235594	0.052424508931288805
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.004235594	0.052424508931288805
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.004235594	0.052424508931288805
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.004235594	0.052424508931288805
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004235594	0.052424508931288805
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.004079124	0.05048785898030701
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.004079124	0.05048785898030701
THYROID HYPOPLASIA	0.004079124	0.05048785898030701
INFANTILE SIALIC ACID STORAGE DISEASE	0.004079124	0.05048785898030701
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.004079124	0.05048785898030701
SIALIDOSIS TYPE 2	0.004079124	0.05048785898030701
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004079124	0.05048785898030701
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.004079124	0.05048785898030701
TETRASOMY 5P	0.004079124	0.05048785898030701
SIMPSON-GOLABI-BEHMEL SYNDROME	0.004079124	0.05048785898030701
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.004079124	0.05048785898030701
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.004079124	0.05048785898030701
MULTIPLE SULFATASE DEFICIENCY	0.004079124	0.05048785898030701
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.004079124	0.05048785898030701
MENTAL RETARDATION, X-LINKED 103	0.004079124	0.05048785898030701
ADENOCARCINOMA OF THE ESOPHAGUS	0.00404858	0.050109811839623264
POTASSIUM-AGGRAVATED MYOTONIA	0.00404858	0.050109811839623264
CONGENITAL ADRENAL HYPERPLASIA	0.00404858	0.050109811839623264
INCLUSION BODY MYOSITIS	0.00404858	0.050109811839623264
SYSTEMIC SCLEROSIS	0.00404858	0.050109811839623264
HYPERKALEMIC PERIODIC PARALYSIS	0.00404858	0.050109811839623264
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.00404858	0.050109811839623264
ISOLATED POLYCYSTIC LIVER DISEASE	0.00404858	0.050109811839623264
APERT SYNDROME	0.00404858	0.050109811839623264
PRADER-WILLI SYNDROME (TYPE 1)	0.00404858	0.050109811839623264
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00404858	0.050109811839623264
AORTIC ARCH DEFECTS	0.00404858	0.050109811839623264
HYPOGLOSSIA WITH SITUS INVERSUS	0.00404858	0.050109811839623264
LIVER FAILURE, INFANTILE, TRANSIENT	0.00404858	0.050109811839623264
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00404858	0.050109811839623264
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00404858	0.050109811839623264
OHDO SYNDROME	0.00404858	0.050109811839623264
DERMATOMYOSITIS	0.00404858	0.050109811839623264
HYPOADRENOCORTICISM, FAMILIAL	0.00404858	0.050109811839623264
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00404858	0.050109811839623264
NEMALINE MYOPATHY 4	0.00404858	0.050109811839623264
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.00404858	0.050109811839623264
GMS SYNDROME	0.00404858	0.050109811839623264
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00404858	0.050109811839623264
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00404858	0.050109811839623264
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00404858	0.050109811839623264
COHEN SYNDROME	0.00404858	0.050109811839623264
%608572 BURN-MCKEOWN SYNDROME	0.00404858	0.050109811839623264
NEMALINE MYOPATHY 3; NEM3	0.00404858	0.050109811839623264
ACROCARDIOFACIAL SYNDROME	0.00404858	0.050109811839623264
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00404858	0.050109811839623264
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.00404858	0.050109811839623264
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00404858	0.050109811839623264
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00404858	0.050109811839623264
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00404858	0.050109811839623264
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00404858	0.050109811839623264
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00404858	0.050109811839623264
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00404858	0.050109811839623264
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00404858	0.050109811839623264
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00404858	0.050109811839623264
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00404858	0.050109811839623264
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00404858	0.050109811839623264
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00404858	0.050109811839623264
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.00404858	0.050109811839623264
16P11.2-P12.2 MICRODELETION SYNDROME	0.00404858	0.050109811839623264
2P15-16.1 MICRODELETION SYNDROME	0.00404858	0.050109811839623264
PIERRE ROBIN SYNDROME	0.00404858	0.050109811839623264
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00404858	0.050109811839623264
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.00404858	0.050109811839623264
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00404858	0.050109811839623264
PRADER-WILLI SYNDROME (TYPE 2)	0.00404858	0.050109811839623264
601095 HARROD SYNDROME	0.00369004	0.04567211468729367
CROUZON DISEASE	0.00369004	0.04567211468729367
SÉZARY SYNDROME	0.00369004	0.04567211468729367
KENNERKNECHT SYNDROME	0.00369004	0.04567211468729367
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00369004	0.04567211468729367
MENTAL RETARDATION, X-LINKED 14	0.00369004	0.04567211468729367
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00369004	0.04567211468729367
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.00369004	0.04567211468729367
BETA-MANNOSIDOSIS	0.00369004	0.04567211468729367
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00369004	0.04567211468729367
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00369004	0.04567211468729367
EPILEPSY-TELANGIECTASIA	0.00369004	0.04567211468729367
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.00369004	0.04567211468729367
DIAMOND-BLACKFAN ANEMIA 4	0.00369004	0.04567211468729367
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00369004	0.04567211468729367
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00369004	0.04567211468729367
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00369004	0.04567211468729367
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00369004	0.04567211468729367
JUVENILE POLYPOSIS OF INFANCY	0.00369004	0.04567211468729367
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00369004	0.04567211468729367
JUVENILE POLYPOSIS SYNDROME	0.00369004	0.04567211468729367
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.00369004	0.04567211468729367
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00369004	0.04567211468729367
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.00369004	0.04567211468729367
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00369004	0.04567211468729367
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00369004	0.04567211468729367
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00369004	0.04567211468729367
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00369004	0.04567211468729367
ISOLATED BILIARY ATRESIA	0.00369004	0.04567211468729367
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00369004	0.04567211468729367
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00369004	0.04567211468729367
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00369004	0.04567211468729367
DILATED CARDIOMYOPATHY WITH ATAXIA	0.00369004	0.04567211468729367
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00369004	0.04567211468729367
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.00369004	0.04567211468729367
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00369004	0.04567211468729367
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00369004	0.04567211468729367
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00369004	0.04567211468729367
HAIRY ELBOWS	0.00369004	0.04567211468729367
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00369004	0.04567211468729367
MCDONOUGH SYNDROME	0.00369004	0.04567211468729367
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00369004	0.04567211468729367
VERVERI-BRADY SYNDROME; VERBRAS	0.00369004	0.04567211468729367
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00369004	0.04567211468729367
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00369004	0.04567211468729367
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00369004	0.04567211468729367
ISOLATED AGAMMAGLOBULINEMIA	0.00369004	0.04567211468729367
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00369004	0.04567211468729367
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00369004	0.04567211468729367
ZECHI-CEIDE SYNDROME	0.00369004	0.04567211468729367
IMMUNODEFICIENCY 55; IMD55	0.00369004	0.04567211468729367
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.00369004	0.04567211468729367
LICHTENSTEIN SYNDROME	0.00369004	0.04567211468729367
MENTAL RETARDATION, X-LINKED 100	0.00369004	0.04567211468729367
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00369004	0.04567211468729367
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00369004	0.04567211468729367
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00369004	0.04567211468729367
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00369004	0.04567211468729367
UROFACIAL SYNDROME	0.00369004	0.04567211468729367
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00369004	0.04567211468729367
MUCOLIPIDOSIS III GAMMA	0.00353357	0.04373546473631189
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00353357	0.04373546473631189
X-LINKED ACROGIGANTISM	0.00353357	0.04373546473631189
HURLER-SCHEIE SYNDROME	0.00353357	0.04373546473631189
FRYNS SYNDROME; FRNS	0.00353357	0.04373546473631189
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00353357	0.04373546473631189
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00353357	0.04373546473631189
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.00353357	0.04373546473631189
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00353357	0.04373546473631189
GALACTOSIALIDOSIS	0.00353357	0.04373546473631189
MORQUIO SYNDROME A	0.00353357	0.04373546473631189
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.00353357	0.04373546473631189
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.00353357	0.04373546473631189
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00353357	0.04373546473631189
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00353357	0.04373546473631189
NEURAMINIDASE DEFICIENCY	0.00353357	0.04373546473631189
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00353357	0.04373546473631189
SANDHOFF DISEASE	0.00353357	0.04373546473631189
GM1 GANGLIOSIDOSIS	0.00353357	0.04373546473631189
GRFOMA	0.00353357	0.04373546473631189
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00353357	0.04373546473631189
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.04373546473631189
NF1-MICRODELETION SYNDROME	0.00353357	0.04373546473631189
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00353357	0.04373546473631189
FRANK-TER HAAR SYNDROME; FTHS	0.00353357	0.04373546473631189
ALAGILLE SYNDROME	0.00353357	0.04373546473631189
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00353357	0.04373546473631189
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00353357	0.04373546473631189
FRONTOMETAPHYSEAL DYSPLASIA	0.00353357	0.04373546473631189
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00353357	0.04373546473631189
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.00353357	0.04373546473631189
CRANIODIAPHYSEAL DYSPLASIA	0.00353357	0.04373546473631189
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00353357	0.04373546473631189
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.00353357	0.04373546473631189
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.00353357	0.04373546473631189
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00353357	0.04373546473631189
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.00353357	0.04373546473631189
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00353357	0.04373546473631189
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00353357	0.04373546473631189
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.00353357	0.04373546473631189
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00353357	0.04373546473631189
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00353357	0.04373546473631189
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00353357	0.04373546473631189
PITUITARY GIGANTISM	0.00353357	0.04373546473631189
BECKWITH-WIEDEMANN SYNDROME	0.00353357	0.04373546473631189
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.00353357	0.04373546473631189
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00353357	0.04373546473631189
MUCOLIPIDOSIS TYPE III	0.00353357	0.04373546473631189
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.0027147539999999998	0.0336008704609677
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0027147539999999998	0.0336008704609677
EMANUEL SYNDROME	0.0027147539999999998	0.0336008704609677
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.0027147539999999998	0.0336008704609677
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0027147539999999998	0.0336008704609677
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0027147539999999998	0.0336008704609677
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0027147539999999998	0.0336008704609677
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.0027147539999999998	0.0336008704609677
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0027147539999999998	0.0336008704609677
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0027147539999999998	0.0336008704609677
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0027147539999999998	0.0336008704609677
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0027147539999999998	0.0336008704609677
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0027147539999999998	0.0336008704609677
OROFACIODIGITAL SYNDROME TYPE 4	0.0027147539999999998	0.0336008704609677
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0027147539999999998	0.0336008704609677
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0027147539999999998	0.0336008704609677
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.0027147539999999998	0.0336008704609677
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.0027147539999999998	0.0336008704609677
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0027147539999999998	0.0336008704609677
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.0027147539999999998	0.0336008704609677
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.0027147539999999998	0.0336008704609677
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0027147539999999998	0.0336008704609677
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0027147539999999998	0.0336008704609677
PEHO SYNDROME	0.0027147539999999998	0.0336008704609677
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.0027147539999999998	0.0336008704609677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0027147539999999998	0.0336008704609677
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.0027147539999999998	0.0336008704609677
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0027147539999999998	0.0336008704609677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0027147539999999998	0.0336008704609677
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0027147539999999998	0.0336008704609677
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.0027147539999999998	0.0336008704609677
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0027147539999999998	0.0336008704609677
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0027147539999999998	0.0336008704609677
AU-KLINE SYNDROME; AUKS	0.0027147539999999998	0.0336008704609677
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0027147539999999998	0.0336008704609677
JOUBERT SYNDROME WITH RENAL DEFECT	0.0027147539999999998	0.0336008704609677
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.0027147539999999998	0.0336008704609677
JOUBERT SYNDROME WITH OCULAR DEFECT	0.0027147539999999998	0.0336008704609677
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0027147539999999998	0.0336008704609677
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.0027147539999999998	0.0336008704609677
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0027147539999999998	0.0336008704609677
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0027147539999999998	0.0336008704609677
RFT1-CDG	0.0027147539999999998	0.0336008704609677
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0027147539999999998	0.0336008704609677
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0027147539999999998	0.0336008704609677
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.0027147539999999998	0.0336008704609677
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0027147539999999998	0.0336008704609677
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0027147539999999998	0.0336008704609677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.0027147539999999998	0.0336008704609677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.0027147539999999998	0.0336008704609677
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.0027147539999999998	0.0336008704609677
LYSOSOMAL ACID LIPASE DEFICIENCY	0.0027147539999999998	0.0336008704609677
8P11.2 DELETION SYNDROME	0.0027147539999999998	0.0336008704609677
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0027147539999999998	0.0336008704609677
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.0027147539999999998	0.0336008704609677
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.0027147539999999998	0.0336008704609677
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0027147539999999998	0.0336008704609677
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0027147539999999998	0.0336008704609677
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.0027147539999999998	0.0336008704609677
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.0027147539999999998	0.0336008704609677
STT3B-CDG	0.0027147539999999998	0.0336008704609677
STT3A-CDG	0.0027147539999999998	0.0336008704609677
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.0027147539999999998	0.0336008704609677
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0027147539999999998	0.0336008704609677
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0027147539999999998	0.0336008704609677
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.0027147539999999998	0.0336008704609677
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0027147539999999998	0.0336008704609677
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0027147539999999998	0.0336008704609677
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.0027147539999999998	0.0336008704609677
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0027147539999999998	0.0336008704609677
PMM2-CDG	0.0027147539999999998	0.0336008704609677
GALACTOSE EPIMERASE DEFICIENCY	0.0027147539999999998	0.0336008704609677
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.0027147539999999998	0.0336008704609677
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.0027147539999999998	0.0336008704609677
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0027147539999999998	0.0336008704609677
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0027147539999999998	0.0336008704609677
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0027147539999999998	0.0336008704609677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0027147539999999998	0.0336008704609677
HAREL-YOON SYNDROME; HAYOS	0.0027147539999999998	0.0336008704609677
PONTINE TEGMENTAL CAP DYSPLASIA	0.0027147539999999998	0.0336008704609677
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.0027147539999999998	0.0336008704609677
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.0027147539999999998	0.0336008704609677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0027147539999999998	0.0336008704609677
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0027147539999999998	0.0336008704609677
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0027147539999999998	0.0336008704609677
MONOSOMY 9Q22.3	0.0027147539999999998	0.0336008704609677
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0027147539999999998	0.0336008704609677
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0027147539999999998	0.0336008704609677
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0027147539999999998	0.0336008704609677
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0027147539999999998	0.0336008704609677
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0027147539999999998	0.0336008704609677
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0027147539999999998	0.0336008704609677
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0027147539999999998	0.0336008704609677
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.0027147539999999998	0.0336008704609677
PEHO-LIKE SYNDROME; PEHOL	0.0027147539999999998	0.0336008704609677
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0027147539999999998	0.0336008704609677
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.0025947339999999996	0.03211536699629821
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.03211536699629821
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.0025947339999999996	0.03211536699629821
%300712 CRANIOFACIOSKELETAL SYNDROME	0.0025947339999999996	0.03211536699629821
TEMTAMY SYNDROME; TEMTYS	0.0025947339999999996	0.03211536699629821
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0025947339999999996	0.03211536699629821
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.03211536699629821
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0025947339999999996	0.03211536699629821
TRISOMY 8Q	0.0025947339999999996	0.03211536699629821
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0025947339999999996	0.03211536699629821
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.0025947339999999996	0.03211536699629821
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0025947339999999996	0.03211536699629821
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.0025947339999999996	0.03211536699629821
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0025947339999999996	0.03211536699629821
ROBERTS SYNDROME	0.0025947339999999996	0.03211536699629821
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0025947339999999996	0.03211536699629821
GRACILE BONE DYSPLASIA; GCLEB	0.0025947339999999996	0.03211536699629821
ADAMS-OLIVER SYNDROME 1; AOS1	0.0025947339999999996	0.03211536699629821
AL-RAQAD SYNDROME; ARS	0.0025947339999999996	0.03211536699629821
RAINE SYNDROME	0.0025947339999999996	0.03211536699629821
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0025947339999999996	0.03211536699629821
RUVALCABA SYNDROME	0.0025947339999999996	0.03211536699629821
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.0025947339999999996	0.03211536699629821
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.03211536699629821
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.0025947339999999996	0.03211536699629821
CODAS SYNDROME	0.0025947339999999996	0.03211536699629821
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.03211536699629821
CINCA SYNDROME	0.0025947339999999996	0.03211536699629821
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.03211536699629821
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0025947339999999996	0.03211536699629821
MARINESCO-SJÖGREN SYNDROME	0.0025947339999999996	0.03211536699629821
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0025947339999999996	0.03211536699629821
OROFACIODIGITAL SYNDROME VI	0.0025947339999999996	0.03211536699629821
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.03211536699629821
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0025947339999999996	0.03211536699629821
PHENOBARBITAL EMBRYOPATHY	0.0025947339999999996	0.03211536699629821
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.0021691999999999996	0.02684847621697256
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.02684847621697256
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0021691999999999996	0.02684847621697256
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0021691999999999996	0.02684847621697256
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0021691999999999996	0.02684847621697256
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0021691999999999996	0.02684847621697256
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.0021691999999999996	0.02684847621697256
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0021691999999999996	0.02684847621697256
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.02684847621697256
KABUKI SYNDROME	0.0021691999999999996	0.02684847621697256
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0021691999999999996	0.02684847621697256
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0021691999999999996	0.02684847621697256
SMITH-KINGSMORE SYNDROME; SKS	0.0021691999999999996	0.02684847621697256
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0021691999999999996	0.02684847621697256
DOUBLE OUTLET RIGHT VENTRICLE	0.0021691999999999996	0.02684847621697256
SANDIFER SYNDROME	0.0021691999999999996	0.02684847621697256
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0021691999999999996	0.02684847621697256
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.0021691999999999996	0.02684847621697256
DESMOSTEROLOSIS	0.0021691999999999996	0.02684847621697256
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0021691999999999996	0.02684847621697256
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.0021691999999999996	0.02684847621697256
NEMALINE MYOPATHY 2; NEM2	0.0021691999999999996	0.02684847621697256
CITRULLINEMIA TYPE I	0.0021691999999999996	0.02684847621697256
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0021691999999999996	0.02684847621697256
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.02684847621697256
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0021691999999999996	0.02684847621697256
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0021691999999999996	0.02684847621697256
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.0021691999999999996	0.02684847621697256
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0021691999999999996	0.02684847621697256
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0021691999999999996	0.02684847621697256
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.0021691999999999996	0.02684847621697256
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0021691999999999996	0.02684847621697256
COMBINED SAPOSIN DEFICIENCY	0.0021691999999999996	0.02684847621697256
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.0021691999999999996	0.02684847621697256
FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.02684847621697256
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0021691999999999996	0.02684847621697256
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0021691999999999996	0.02684847621697256
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0021691999999999996	0.02684847621697256
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0021691999999999996	0.02684847621697256
ATRESIA OF SMALL INTESTINE	0.0021691999999999996	0.02684847621697256
ADENOCARCINOMA OF OVARY	0.0021691999999999996	0.02684847621697256
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0021691999999999996	0.02684847621697256
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0021691999999999996	0.02684847621697256
TEMPLE SYNDROME	0.0021691999999999996	0.02684847621697256
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0021691999999999996	0.02684847621697256
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0021691999999999996	0.02684847621697256
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.0021691999999999996	0.02684847621697256
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0021691999999999996	0.02684847621697256
RETINITIS PIGMENTOSA 59; RP59	0.0021691999999999996	0.02684847621697256
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.0021691999999999996	0.02684847621697256
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0021691999999999996	0.02684847621697256
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.02684847621697256
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0021691999999999996	0.02684847621697256
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0021691999999999996	0.02684847621697256
PEROXISOME BIOGENESIS DISORDER 11B	0.0021691999999999996	0.02684847621697256
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0021691999999999996	0.02684847621697256
NEONATAL MARFAN SYNDROME	0.0021691999999999996	0.02684847621697256
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0021691999999999996	0.02684847621697256
CRISPONI SYNDROME	0.0021691999999999996	0.02684847621697256
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.0021691999999999996	0.02684847621697256
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0021691999999999996	0.02684847621697256
CHIARI MALFORMATION TYPE II	0.0021691999999999996	0.02684847621697256
CHARGE SYNDROME	0.0021691999999999996	0.02684847621697256
COCKAYNE SYNDROME	0.0021691999999999996	0.02684847621697256
CLASSIC GALACTOSEMIA	0.0021691999999999996	0.02684847621697256
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0021691999999999996	0.02684847621697256
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0021691999999999996	0.02684847621697256
MEIER-GORLIN SYNDROME 2; MGORS2	0.0021691999999999996	0.02684847621697256
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.0021691999999999996	0.02684847621697256
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0021691999999999996	0.02684847621697256
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0021691999999999996	0.02684847621697256
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.0021691999999999996	0.02684847621697256
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.0021691999999999996	0.02684847621697256
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0021691999999999996	0.02684847621697256
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0021691999999999996	0.02684847621697256
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0021691999999999996	0.02684847621697256
PRIMARY DYSTONIA, DYT2 TYPE	0.0021691999999999996	0.02684847621697256
ADULT-ONSET NEMALINE MYOPATHY	0.0021691999999999996	0.02684847621697256
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.0021691999999999996	0.02684847621697256
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0021691999999999996	0.02684847621697256
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0021691999999999996	0.02684847621697256
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0021691999999999996	0.02684847621697256
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.0021691999999999996	0.02684847621697256
STUVE-WIEDEMANN SYNDROME	0.0021691999999999996	0.02684847621697256
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.0021691999999999996	0.02684847621697256
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0021691999999999996	0.02684847621697256
19Q13.11 MICRODELETION SYNDROME	0.0021691999999999996	0.02684847621697256
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0021691999999999996	0.02684847621697256
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0021691999999999996	0.02684847621697256
NATIVE AMERICAN MYOPATHY	0.0021691999999999996	0.02684847621697256
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0021691999999999996	0.02684847621697256
CEREBROCOSTOMANDIBULAR SYNDROME	0.0021691999999999996	0.02684847621697256
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.0021691999999999996	0.02684847621697256
TYPICAL NEMALINE MYOPATHY	0.0021691999999999996	0.02684847621697256
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.025362972752303075
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.025362972752303075
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.025362972752303075
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.025362972752303075
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00204918	0.025362972752303075
CRANIOSYNOSTOSIS 2	0.00204918	0.025362972752303075
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.025362972752303075
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00204918	0.025362972752303075
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.025362972752303075
LARSEN SYNDROME	0.00204918	0.025362972752303075
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.025362972752303075
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00204918	0.025362972752303075
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00204918	0.025362972752303075
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00204918	0.025362972752303075
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00204918	0.025362972752303075
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00204918	0.025362972752303075
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00204918	0.025362972752303075
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.025362972752303075
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00204918	0.025362972752303075
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00204918	0.025362972752303075
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.025362972752303075
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.025362972752303075
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00204918	0.025362972752303075
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00204918	0.025362972752303075
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.025362972752303075
MULTIPLE SYNOSTOSES SYNDROME 2	0.00204918	0.025362972752303075
PYCNODYSOSTOSIS	0.00204918	0.025362972752303075
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00204918	0.025362972752303075
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.025362972752303075
SATOYOSHI SYNDROME	0.00204918	0.025362972752303075
EIKEN SYNDROME	0.00204918	0.025362972752303075
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00204918	0.025362972752303075
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.025362972752303075
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.025362972752303075
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.025362972752303075
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.025362972752303075
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00204918	0.025362972752303075
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.025362972752303075
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.025362972752303075
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00204918	0.025362972752303075
OROFACIODIGITAL SYNDROME I; OFD1	0.00204918	0.025362972752303075
FOCAL DERMAL HYPOPLASIA; FDH	0.00204918	0.025362972752303075
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00204918	0.025362972752303075
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.025362972752303075
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.025362972752303075
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.025362972752303075
ADAMS-OLIVER SYNDROME 5; AOS5	0.00204918	0.025362972752303075
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.025362972752303075
POTOCKI-SHAFFER SYNDROME	0.00204918	0.025362972752303075
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00204918	0.025362972752303075
GRANGE SYNDROME; GRNG	0.00204918	0.025362972752303075
OSTEOGLOSPHONIC DYSPLASIA	0.00204918	0.025362972752303075
RHYNS SYNDROME; RHYNS	0.00204918	0.025362972752303075
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.025362972752303075
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00204918	0.025362972752303075
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00204918	0.025362972752303075
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00204918	0.025362972752303075
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00204918	0.025362972752303075
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00204918	0.025362972752303075
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.025362972752303075
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00204918	0.025362972752303075
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.025362972752303075
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.025362972752303075
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00204918	0.025362972752303075
PFEIFFER SYNDROME	0.00204918	0.025362972752303075
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.025362972752303075
608028 THAI SYMPHALANGISM SYNDROME	0.00204918	0.025362972752303075
THANATOPHORIC DYSPLASIA	0.00204918	0.025362972752303075
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.025362972752303075
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00204918	0.025362972752303075
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00204918	0.025362972752303075
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00204918	0.025362972752303075
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00204918	0.025362972752303075
ERYTHROKERATODERMIA VARIABILIS	0.00204918	0.025362972752303075
SILLENCE SYNDROME	0.00204918	0.025362972752303075
CRANIOECTODERMAL DYSPLASIA 1	0.00204918	0.025362972752303075
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00204918	0.025362972752303075
SHORT SYNDROME	0.00204918	0.025362972752303075
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.025362972752303075
PSEUDOACHONDROPLASIA	0.00204918	0.025362972752303075
ODONTOCHONDRODYSPLASIA; ODCD	0.00204918	0.025362972752303075
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.025362972752303075
ATELOSTEOGENESIS TYPE I	0.00204918	0.025362972752303075
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.025362972752303075
BANKI SYNDROME	0.00204918	0.025362972752303075
SYMPHALANGISM, DISTAL	0.00204918	0.025362972752303075
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00204918	0.025362972752303075
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.025362972752303075
THANATOPHORIC DYSPLASIA TYPE 1	0.00204918	0.025362972752303075
LERI PLEONOSTEOSIS	0.00204918	0.025362972752303075
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.025362972752303075
20P13 MICRODELETION SYNDROME	0.00204918	0.025362972752303075
SUMMITT SYNDROME	0.00204918	0.025362972752303075
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00204918	0.025362972752303075
ACRODYSOSTOSIS	0.00204918	0.025362972752303075
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00204918	0.025362972752303075
METATROPIC DYSPLASIA	0.00204918	0.025362972752303075
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.025362972752303075
GENITOPALATOCARDIAC SYNDROME	0.00204918	0.025362972752303075
MONOSOMY 13Q14	0.00204918	0.025362972752303075
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00204918	0.025362972752303075
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00204918	0.025362972752303075
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00204918	0.025362972752303075
DISTAL TRISOMY 5Q	0.00204918	0.025362972752303075
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00204918	0.025362972752303075
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.025362972752303075
FIBROCHONDROGENESIS	0.00204918	0.025362972752303075
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.025362972752303075
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00204918	0.025362972752303075
ENG-STROM SYNDROME	0.00204918	0.025362972752303075
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.00204918	0.025362972752303075
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.00204918	0.025362972752303075
FGFR2-RELATED BENT BONE DYSPLASIA	0.00204918	0.025362972752303075
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.00204918	0.025362972752303075
JACOBSEN SYNDROME	0.00204918	0.025362972752303075
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00204918	0.025362972752303075
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.025362972752303075
COOKS SYNDROME	0.00204918	0.025362972752303075
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.025362972752303075
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.025362972752303075
SHORT RIB-POLYDACTYLY SYNDROME	0.00204918	0.025362972752303075
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.025362972752303075
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.025362972752303075
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00204918	0.025362972752303075
WEYERS ACROFACIAL DYSOSTOSIS	0.00204918	0.025362972752303075
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00204918	0.025362972752303075
CRANIOECTODERMAL DYSPLASIA	0.00204918	0.025362972752303075
ACROCALLOSAL SYNDROME; ACLS	0.00204918	0.025362972752303075
WOLCOTT-RALLISON SYNDROME	0.00204918	0.025362972752303075
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00204918	0.025362972752303075
HYPERTELORISM, TEEBI TYPE	0.00204918	0.025362972752303075
RADIO-RENAL SYNDROME	0.00204918	0.025362972752303075
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00204918	0.025362972752303075
ADAMS-OLIVER SYNDROME	0.00204918	0.025362972752303075
NON-DISTAL MONOSOMY 10Q	0.00204918	0.025362972752303075
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00204918	0.025362972752303075
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.025362972752303075
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.00204918	0.025362972752303075
GREENBERG DYSPLASIA	0.00204918	0.025362972752303075
SYNDACTYLY, TYPE V	0.00204918	0.025362972752303075
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.025362972752303075
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.00204918	0.025362972752303075
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00204918	0.025362972752303075
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.025362972752303075
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00204918	0.025362972752303075
FEINGOLD SYNDROME	0.00204918	0.025362972752303075
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.025362972752303075
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.025362972752303075
CAMPTOBRACHYDACTYLY	0.00204918	0.025362972752303075
HEART-HAND SYNDROME TYPE 3	0.00204918	0.025362972752303075
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00204918	0.025362972752303075
CAREY-FINEMAN-ZITER SYNDROME	0.00204918	0.025362972752303075
PERIPHERAL DYSOSTOSIS	0.00204918	0.025362972752303075
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00204918	0.025362972752303075
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00204918	0.025362972752303075
CHARLIE M SYNDROME	0.00204918	0.025362972752303075
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.025362972752303075
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.025362972752303075
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00204918	0.025362972752303075
PROXIMAL SYMPHALANGISM	0.00204918	0.025362972752303075
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.025362972752303075
HAND-FOOT-GENITAL SYNDROME; HFG	0.00204918	0.025362972752303075
ROIFMAN SYNDROME	0.00204918	0.025362972752303075
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00204918	0.025362972752303075
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.025362972752303075
OPSISMODYSPLASIA	0.00204918	0.025362972752303075
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00204918	0.025362972752303075
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.025362972752303075
ISOLATED BRACHYCEPHALY	0.00204918	0.025362972752303075
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00204918	0.025362972752303075
MULTIPLE METAPHYSEAL DYSPLASIA	0.00204918	0.025362972752303075
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00204918	0.025362972752303075
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00204918	0.025362972752303075
DESBUQUOIS DYSPLASIA 1	0.00204918	0.025362972752303075
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.025362972752303075
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.025362972752303075
THANATOPHORIC DYSPLASIA TYPE 2	0.00204918	0.025362972752303075
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.025362972752303075
OROFACIODIGITAL SYNDROME TYPE 1	0.00204918	0.025362972752303075
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.025362972752303075
ATELOSTEOGENESIS, TYPE I; AO1	0.00204918	0.025362972752303075
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.025362972752303075
LAURENCE-MOON SYNDROME	0.00204918	0.025362972752303075
CAMPTOBRACHYDACTYLY	0.00204918	0.025362972752303075
LÉRI-WEILL DYSCHONDROSTEOSIS	0.00204918	0.025362972752303075
OROFACIODIGITAL SYNDROME IV; OFD4	0.00204918	0.025362972752303075
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00204918	0.025362972752303075
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.025362972752303075
ABRUZZO-ERICKSON SYNDROME	0.00204918	0.025362972752303075
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.025362972752303075
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.025362972752303075
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.025362972752303075
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00204918	0.025362972752303075
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00204918	0.025362972752303075
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.025362972752303075
CHST3-RELATED SKELETAL DYSPLASIA	0.00204918	0.025362972752303075
PYCNODYSOSTOSIS	0.00204918	0.025362972752303075
ROBERTS SYNDROME; RBS	0.00204918	0.025362972752303075
FRONTORHINY	0.00204918	0.025362972752303075
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.025362972752303075
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.00204918	0.025362972752303075
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.025362972752303075
HYPOCHONDROPLASIA	0.00204918	0.025362972752303075
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00204918	0.025362972752303075
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00204918	0.025362972752303075
URBAN-ROGERS-MEYER SYNDROME	0.00204918	0.025362972752303075
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00204918	0.025362972752303075
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.025362972752303075
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00204918	0.025362972752303075
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.025362972752303075
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00204918	0.025362972752303075
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00204918	0.025362972752303075
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00204918	0.025362972752303075
2Q37 MONOSOMY	0.00204918	0.025362972752303075
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.025362972752303075
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00204918	0.025362972752303075
WEILL-MARCHESANI SYNDROME	0.00204918	0.025362972752303075
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.006752394243995135
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.006752394243995135
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.006752394243995135
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.006752394243995135
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.006752394243995135
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.006752394243995135
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000545554	0.006752394243995135
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.006752394243995135
LISSENCEPHALY 1; LIS1	0.000545554	0.006752394243995135
POTOCKI-SHAFFER SYNDROME	0.000545554	0.006752394243995135
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.006752394243995135
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.006752394243995135
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.006752394243995135
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.006752394243995135
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.006752394243995135
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.006752394243995135
JOUBERT SYNDROME 6	0.000545554	0.006752394243995135
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000545554	0.006752394243995135
12Q14 MICRODELETION SYNDROME	0.000545554	0.006752394243995135
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.006752394243995135
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.006752394243995135
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.006752394243995135
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.006752394243995135
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.006752394243995135
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000545554	0.006752394243995135
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.006752394243995135
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.006752394243995135
SCHINDLER DISEASE, TYPE I	0.000545554	0.006752394243995135
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.006752394243995135
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.006752394243995135
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.006752394243995135
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.006752394243995135
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.006752394243995135
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.006752394243995135
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.006752394243995135
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.006752394243995135
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.006752394243995135
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.006752394243995135
WOLMAN DISEASE	0.000545554	0.006752394243995135
PALLISTER-HALL SYNDROME	0.000545554	0.006752394243995135
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000545554	0.006752394243995135
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995135
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.006752394243995135
CURRARINO SYNDROME	0.000545554	0.006752394243995135
LARSEN-LIKE SYNDROME	0.000545554	0.006752394243995135
NOONAN SYNDROME 3; NS3	0.000545554	0.006752394243995135
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.006752394243995135
JOUBERT SYNDROME 2	0.000545554	0.006752394243995135
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.006752394243995135
FRIAS SYNDROME	0.000545554	0.006752394243995135
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.006752394243995135
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.006752394243995135
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.006752394243995135
KAGAMI-OGATA SYNDROME	0.000545554	0.006752394243995135
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.006752394243995135
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.006752394243995135
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.006752394243995135
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000545554	0.006752394243995135
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000545554	0.006752394243995135
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995135
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.006752394243995135
ROTHMUND-THOMSON SYNDROME	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.006752394243995135
HYDROXYKYNURENINURIA	0.000545554	0.006752394243995135
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000545554	0.006752394243995135
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.006752394243995135
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.006752394243995135
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.006752394243995135
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.006752394243995135
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.006752394243995135
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.006752394243995135
PFEIFFER SYNDROME TYPE 2	0.000545554	0.006752394243995135
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.006752394243995135
MEND SYNDROME; MEND	0.000545554	0.006752394243995135
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.006752394243995135
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.006752394243995135
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.006752394243995135
BRESEK SYNDROME	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.006752394243995135
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.006752394243995135
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.006752394243995135
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.006752394243995135
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.006752394243995135
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000545554	0.006752394243995135
KEUTEL SYNDROME	0.000545554	0.006752394243995135
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.006752394243995135
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.006752394243995135
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.006752394243995135
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.006752394243995135
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.006752394243995135
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.006752394243995135
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.006752394243995135
NETHERTON SYNDROME; NETH	0.000545554	0.006752394243995135
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000545554	0.006752394243995135
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.006752394243995135
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.006752394243995135
WALKER-WARBURG SYNDROME	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.006752394243995135
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.006752394243995135
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000545554	0.006752394243995135
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.006752394243995135
3MC SYNDROME 2	0.000545554	0.006752394243995135
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.006752394243995135
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.006752394243995135
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.006752394243995135
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.006752394243995135
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.006752394243995135
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.006752394243995135
WAARDENBURG-SHAH SYNDROME	0.000545554	0.006752394243995135
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.006752394243995135
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.006752394243995135
PELLAGRA-LIKE SYNDROME	0.000545554	0.006752394243995135
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.006752394243995135
HOLOPROSENCEPHALY 7	0.000545554	0.006752394243995135
OROTIC ACIDURIA	0.000545554	0.006752394243995135
DPAGT1-CDG	0.000545554	0.006752394243995135
LISSENCEPHALY 2; LIS2	0.000545554	0.006752394243995135
NAVAJO NEUROHEPATOPATHY	0.000545554	0.006752394243995135
CONGENITAL TOXOPLASMOSIS	0.000545554	0.006752394243995135
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.006752394243995135
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.006752394243995135
ELEJALDE DISEASE	0.000545554	0.006752394243995135
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000545554	0.006752394243995135
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.006752394243995135
WAISMAN SYNDROME; WSMN	0.000545554	0.006752394243995135
TAY-SACHS DISEASE	0.000545554	0.006752394243995135
ALG3-CDG	0.000545554	0.006752394243995135
CURRY-JONES SYNDROME	0.000545554	0.006752394243995135
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.006752394243995135
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.006752394243995135
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.006752394243995135
CDAGS SYNDROME	0.000545554	0.006752394243995135
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995135
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.006752394243995135
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.006752394243995135
ZEBRA BODY MYOPATHY	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000545554	0.006752394243995135
ALG1-CDG	0.000545554	0.006752394243995135
RIGID SPINE SYNDROME	0.000545554	0.006752394243995135
SALLA DISEASE	0.000545554	0.006752394243995135
ALG6-CDG	0.000545554	0.006752394243995135
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.006752394243995135
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.006752394243995135
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.006752394243995135
NOONAN SYNDROME 2; NS2	0.000545554	0.006752394243995135
FRONTOOCULAR SYNDROME	0.000545554	0.006752394243995135
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000545554	0.006752394243995135
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.006752394243995135
PHACE ASSOCIATION	0.000545554	0.006752394243995135
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.006752394243995135
LIG4 SYNDROME	0.000545554	0.006752394243995135
FUMARASE DEFICIENCY; FMRD	0.000545554	0.006752394243995135
BIOTINIDASE DEFICIENCY	0.000545554	0.006752394243995135
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.006752394243995135
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.006752394243995135
GRISCELLI SYNDROME TYPE 1	0.000545554	0.006752394243995135
SCHIZENCEPHALY	0.000545554	0.006752394243995135
TARP SYNDROME; TARPS	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.006752394243995135
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000545554	0.006752394243995135
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000545554	0.006752394243995135
KETOADIPICACIDURIA	0.000545554	0.006752394243995135
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.006752394243995135
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.006752394243995135
PELIZAEUS-MERZBACHER DISEASE	0.000545554	0.006752394243995135
HOLOPROSENCEPHALY 1; HPE1	0.000545554	0.006752394243995135
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000545554	0.006752394243995135
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.006752394243995135
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.006752394243995135
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.006752394243995135
DISTAL MONOSOMY 19P13.3	0.000545554	0.006752394243995135
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.006752394243995135
LOWRY-MACLEAN SYNDROME	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.006752394243995135
CODAS SYNDROME	0.000545554	0.006752394243995135
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.006752394243995135
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.006752394243995135
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.006752394243995135
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.006752394243995135
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000545554	0.006752394243995135
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000545554	0.006752394243995135
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.006752394243995135
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.006752394243995135
COACH SYNDROME	0.000545554	0.006752394243995135
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.006752394243995135
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.006752394243995135
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995135
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.006752394243995135
ISOLATED PLAGIOCEPHALY	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.006752394243995135
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.006752394243995135
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000545554	0.006752394243995135
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.006752394243995135
FARBER DISEASE	0.000545554	0.006752394243995135
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.006752394243995135
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.006752394243995135
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.006752394243995135
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995135
TRISOMY 18	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.006752394243995135
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.006752394243995135
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.006752394243995135
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000545554	0.006752394243995135
CHROMOSOME 1P35 DELETION SYNDROME	0.000545554	0.006752394243995135
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.000545554	0.006752394243995135
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000545554	0.006752394243995135
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000545554	0.006752394243995135
YUNIS-VARON SYNDROME	0.000545554	0.006752394243995135
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.006752394243995135
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000545554	0.006752394243995135
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.006752394243995135
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000545554	0.006752394243995135
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000545554	0.006752394243995135
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.006752394243995135
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.006752394243995135
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.006752394243995135
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.006752394243995135
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000545554	0.006752394243995135
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.006752394243995135
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.006752394243995135
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.006752394243995135
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000545554	0.006752394243995135
ISOVALERIC ACIDEMIA	0.000545554	0.006752394243995135
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.006752394243995135
PROPIONIC ACIDEMIA	0.000545554	0.006752394243995135
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000545554	0.006752394243995135
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.006752394243995135
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.006752394243995135
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.006752394243995135
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.006752394243995135
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000545554	0.006752394243995135
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.006752394243995135
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.006752394243995135
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000545554	0.006752394243995135
OPTIC ATROPHY 11; OPA11	0.000545554	0.006752394243995135
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.006752394243995135
LISSENCEPHALY 8; LIS8	0.000545554	0.006752394243995135
GRISCELLI SYNDROME	0.000545554	0.006752394243995135
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.006752394243995135
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.006752394243995135
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.006752394243995135
JOUBERT SYNDROME 28	0.000545554	0.006752394243995135
JOUBERT SYNDROME 27	0.000545554	0.006752394243995135
MECKEL SYNDROME 13; MKS13	0.000545554	0.006752394243995135
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.006752394243995135
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000545554	0.006752394243995135
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000545554	0.006752394243995135
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.006752394243995135
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.006752394243995135
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.006752394243995135
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.006752394243995135
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.006752394243995135
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.006752394243995135
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000545554	0.006752394243995135
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.006752394243995135
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.006752394243995135
AL KAISSI SYNDROME; ALKAS	0.000545554	0.006752394243995135
DISTAL MONOSOMY 1Q	0.000545554	0.006752394243995135
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.006752394243995135
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.006752394243995135
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.006752394243995135
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.006752394243995135
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.006752394243995135
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.006752394243995135
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.006752394243995135
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.006752394243995135
OTOFACIOCERVICAL SYNDROME	0.000545554	0.006752394243995135
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995135
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.006752394243995135
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.006752394243995135
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.006752394243995135
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.006752394243995135
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.006752394243995135
HYDRANENCEPHALY	0.000545554	0.006752394243995135
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.006752394243995135
ZECHI-CEIDE SYNDROME	0.000545554	0.006752394243995135
DONNAI-BARROW SYNDROME	0.000545554	0.006752394243995135
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.006752394243995135
CUTIS LAXA	0.000545554	0.006752394243995135
OPTIC PATHWAY GLIOMA	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.006752394243995135
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.006752394243995135
GERODERMA OSTEODYSPLASTICA	0.000545554	0.006752394243995135
GERMAN SYNDROME	0.000545554	0.006752394243995135
PERLMAN SYNDROME	0.000545554	0.006752394243995135
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.006752394243995135
COLE-CARPENTER SYNDROME	0.000545554	0.006752394243995135
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.006752394243995135
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.006752394243995135
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.006752394243995135
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.006752394243995135
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.006752394243995135
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.006752394243995135
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.006752394243995135
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.006752394243995135
XP21 MICRODELETION SYNDROME	0.000545554	0.006752394243995135
20P12.3 MICRODELETION SYNDROME	0.000545554	0.006752394243995135
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.006752394243995135
N SYNDROME	0.000545554	0.006752394243995135
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000545554	0.006752394243995135
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.006752394243995135
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.006752394243995135
OPITZ G/BBB SYNDROME	0.000545554	0.006752394243995135
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.006752394243995135
ICF SYNDROME	0.000545554	0.006752394243995135
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.006752394243995135
6Q25 MICRODELETION SYNDROME	0.000545554	0.006752394243995135
MICRO SYNDROME	0.000545554	0.006752394243995135
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.006752394243995135
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.006752394243995135
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.006752394243995135
1Q44 MICRODELETION SYNDROME	0.000545554	0.006752394243995135
MICROVILLUS INCLUSION DISEASE	0.000545554	0.006752394243995135
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995135
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.006752394243995135
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.006752394243995135
EAST SYNDROME	0.000545554	0.006752394243995135
PENTASOMY X	0.000545554	0.006752394243995135
17Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.006752394243995135
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.006752394243995135
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.006752394243995135
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.006752394243995135
OXOGLUTARIC ACIDURIA	0.000545554	0.006752394243995135
AYMÉ-GRIPP SYNDROME	0.000545554	0.006752394243995135
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.006752394243995135
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.006752394243995135
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.006752394243995135
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995135
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.006752394243995135
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000545554	0.006752394243995135
SENIOR-LOKEN SYNDROME	0.000545554	0.006752394243995135
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000545554	0.006752394243995135
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000545554	0.006752394243995135
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.006752394243995135
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.006752394243995135
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000545554	0.006752394243995135
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.006752394243995135
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.006752394243995135
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.006752394243995135
XQ21 MICRODELETION SYNDROME	0.000545554	0.006752394243995135
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.006752394243995135
TOLUENE EMBRYOPATHY	0.000545554	0.006752394243995135
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.006752394243995135
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.006752394243995135
MEVALONIC ACIDURIA	0.000545554	0.006752394243995135
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.006752394243995135
CONGENITAL VARICELLA SYNDROME	0.000545554	0.006752394243995135
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.006752394243995135
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995135
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.006752394243995135
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.006752394243995135
DYSKERATOSIS CONGENITA	0.000545554	0.006752394243995135
DISTAL TRISOMY 6P	0.000545554	0.006752394243995135
MOSAIC TRISOMY 14	0.000545554	0.006752394243995135
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000545554	0.006752394243995135
TRISOMY 12P	0.000545554	0.006752394243995135
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.000545554	0.006752394243995135
DEXTROCARDIA	0.000545554	0.006752394243995135
HEREDITARY OROTIC ACIDURIA	0.000545554	0.006752394243995135
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.006752394243995135
2P21 MICRODELETION SYNDROME	0.000545554	0.006752394243995135
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.006752394243995135
PYRIDOXINE-DEPENDENT EPILEPSY	0.000545554	0.006752394243995135
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.006752394243995135
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.006752394243995135
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.006752394243995135
STEEL SYNDROME; STLS	0.000545554	0.006752394243995135
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.006752394243995135
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.006752394243995135
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.006752394243995135
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000545554	0.006752394243995135
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.006752394243995135
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.006752394243995135
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000545554	0.006752394243995135
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.006752394243995135
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.006752394243995135
MAPLE SYRUP URINE DISEASE	0.000545554	0.006752394243995135
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000545554	0.006752394243995135
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.006752394243995135
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.006752394243995135
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.006752394243995135
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.006752394243995135
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.006752394243995135
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.006752394243995135
CHROMOSOME 5Q12 DELETION SYNDROME	0.000545554	0.006752394243995135
JOUBERT SYNDROME 21	0.000545554	0.006752394243995135
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.006752394243995135
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.006752394243995135
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.006752394243995135
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.006752394243995135
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.006752394243995135
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.006752394243995135
INFANTILE LIVER FAILURE SYNDROME 1	0.000545554	0.006752394243995135
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.006752394243995135
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.006752394243995135
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.006752394243995135
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.006752394243995135
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.006752394243995135
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.006752394243995135
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.006752394243995135
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.006752394243995135
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.006752394243995135
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.006752394243995135
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.006752394243995135
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.006752394243995135
NOONAN SYNDROME 6; NS6	0.000545554	0.006752394243995135
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.006752394243995135
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.006752394243995135
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.006752394243995135
NETHERTON SYNDROME	0.000545554	0.006752394243995135
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.006752394243995135
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000545554	0.006752394243995135
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.006752394243995135
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.006752394243995135
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000545554	0.006752394243995135
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.006752394243995135
JOUBERT SYNDROME 8	0.000545554	0.006752394243995135
LEBER CONGENITAL AMAUROSIS	0.000545554	0.006752394243995135
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.006752394243995135
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.006752394243995135
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.006752394243995135
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.006752394243995135
JOUBERT SYNDROME 7	0.000545554	0.006752394243995135
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000545554	0.006752394243995135
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000545554	0.006752394243995135
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.006752394243995135
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.006752394243995135
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.006752394243995135
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.006752394243995135
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.006752394243995135
JOUBERT SYNDROME 15	0.000545554	0.006752394243995135
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.006752394243995135
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000545554	0.006752394243995135
HOLOPROSENCEPHALY 11	0.000545554	0.006752394243995135
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000545554	0.006752394243995135
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.006752394243995135
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.006752394243995135
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.006752394243995135
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000545554	0.006752394243995135
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.006752394243995135
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.006752394243995135
LISSENCEPHALY 4	0.000545554	0.006752394243995135
ATELOSTEOGENESIS TYPE III	0.000545554	0.006752394243995135
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.006752394243995135
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.006752394243995135
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.006752394243995135
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.006752394243995135
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000545554	0.006752394243995135
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000545554	0.006752394243995135
SECKEL SYNDROME 8; SCKL8	0.000545554	0.006752394243995135
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.006752394243995135
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.006752394243995135
EVEN-PLUS SYNDROME	0.000545554	0.006752394243995135
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.006752394243995135
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.006752394243995135
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.006752394243995135
JOUBERT SYNDROME 26	0.000545554	0.006752394243995135
JOUBERT SYNDROME 25	0.000545554	0.006752394243995135
SECKEL SYNDROME 9; SCKL9	0.000545554	0.006752394243995135
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.006752394243995135
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000545554	0.006752394243995135
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.006752394243995135
PHACE SYNDROME	0.000545554	0.006752394243995135
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995135
JOUBERT SYNDROME 24	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.006752394243995135
SENIOR-LOKEN SYNDROME 9	0.000545554	0.006752394243995135
RING CHROMOSOME 14 SYNDROME	0.000545554	0.006752394243995135
COG2-CDG	0.000545554	0.006752394243995135
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.006752394243995135
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.006752394243995135
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.006752394243995135
MIRAGE SYNDROME; MIRAGE	0.000545554	0.006752394243995135
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995135
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000545554	0.006752394243995135
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.000545554	0.006752394243995135
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.006752394243995135
MEIER-GORLIN SYNDROME 7	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.006752394243995135
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.006752394243995135
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.006752394243995135
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000545554	0.006752394243995135
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.006752394243995135
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.006752394243995135
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.006752394243995135
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.006752394243995135
NOONAN SYNDROME 9; NS9	0.000545554	0.006752394243995135
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.006752394243995135
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.006752394243995135
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.006752394243995135
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.006752394243995135
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.000545554	0.006752394243995135
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.006752394243995135
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.006752394243995135
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.006752394243995135
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.006752394243995135
BARDET-BIEDL SYNDROME 2	0.000545554	0.006752394243995135
CATEL-MANZKE SYNDROME; CATMANS	0.000545554	0.006752394243995135
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.006752394243995135
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.006752394243995135
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000545554	0.006752394243995135
CULLER-JONES SYNDROME; CJS	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.006752394243995135
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.006752394243995135
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.006752394243995135
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000545554	0.006752394243995135
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.006752394243995135
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.006752394243995135
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.006752394243995135
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.006752394243995135
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000545554	0.006752394243995135
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000545554	0.006752394243995135
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.006752394243995135
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000545554	0.006752394243995135
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.006752394243995135
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.006752394243995135
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.006752394243995135
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.006752394243995135
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.006752394243995135
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000545554	0.006752394243995135
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.006752394243995135
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.006752394243995135
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.006752394243995135
